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Congenital heart defects (CHD) affect over 1% of the American population
and are the origin of substantial healthcare costs. A majority of these defects in-
volve malformations of the valvuloseptal apparatus, which is the precursor to
the valves of the heart. Due to the necessity of valves for proper heart function,
most moderate to severe valve defects require surgical intervention. Correc-
tive surgery is costly and can result in complications and/or restrictions on the
patient’s lifestyle. Current genetic evidence for CHD is inadequate to explain
the variety and prevalence of these defects, suggesting that misguided molec-
ular and mechanical signaling may be responsible. Unfortunately, the role of
mechanical and molecular signaling in normal valve development is only be-
ginning to be elucidated, making the detection of defective valves difficult. An
understanding of these mechanical and molecular cues and their effect on valve
mechanics in normal development is essential for effective treatment of CHDs.
In this dissertation, we focus on the capacity of mechanical and molecular
signals to direct valve morphology and mechanical properties. We first validate
two mechanical testing techniques to characterize the mechanical properties of
avian valves through development. This revealed a monotonic increase in valve
stiffness which was concomitant with a rapid transition from globular to pla-
nar geometry. We then investigated the capacity of transforming growth factor
beta 3 (TGF3) and serotonin (5-HT) to stimulate biomechanical remodeling in
avian valves. TGF3 significantly increased valve stiffness through cell contrac-
tion, proliferation, and extracellular matrix synthesis. 5-HT modulated TGF3
remodeling in both in vitro and in vivo models. This demonstrated a plausible
molecular mechanism for the stiffness increase observed during development.
To investigate the role of mechanical signaling, we developed a model of
growth and remodeling (shape change) that is driven by mechanical stimuli.
The consequences of particular assumptions about growth were illustrated with
numerical examples. We then built a computational model of valve growth in-
volving both the fluid and solid domains of the atrioventricular (AV) canal and
valve. The distribution of the fluid loads on the valve was correlated with the
natural morphology of the valve. The computational framework allowed the ef-
fects of pressure and shear tractions to be individually interpreted. These results
provided a potential mechanical mechanism to explain the valve morphology
observed during development.
The dissertation concludes with a chapter on teaching and outreach that
stemmed from my involvement in the NSF GK-12 program. Conclusions and
future directions are discussed.
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CHAPTER 1
INTRODUCTION
Over 1% percent of Americans possess some form of congenital heart defect
(CHD) [77]. The life-time economic cost of CHD-related illness is over $1.2 bil-
lion for all of CHD births each year [184]. Malformations involving the valvu-
loseptal apparatus are the predominant CHD that occur [155]. Severe defects
can result in embryonic lethality, or require multiple highly invasive surgeries
during the first few years of life. Small to moderate valve defects may remain
undetected until adulthood, when other health issues such as high blood pres-
sure exacerbate the inferior valve. Almost all corrective therapies for valves
require surgical intervention, whether repair or replacement, which run the risk
of complications, and can significantly alter a patient’s lifestyle.
Genetic basis of CHD formation
The causes of valve defect formation are not well established. A few gene-
specific heart valve defects have been identified, such as fibrillin 1 in Marfan’s
syndrome [43] and elastin in William’s syndrome [106]. Other examples of ge-
netically based CHDs are shown in Table 1.1. However, such genetic evidence
does not adequately explain the number and variety of CHDs currently ob-
served [96, 167]. This suggests that the issue is not a deficient genome, but
instead a misregulation of gene expression and/or signalling during develop-
ment, whether by molecular, biochemical, or mechanical cues. Unfortunately
there are still several gaps in our understanding of normal valve development.
A thorough understanding of mechanical and molecular regulation in normal
development is essential for effectively identifying mechanisms of CHD forma-
tion.
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Table 1.1: Common CHDs with Genetic Basis, compiled from [26]
Syndrome Gene(s) Description Ref.
Marfan fibrillin1 MV prolapse, bicuspid AoV [43, 145]
Williams elastin AoV stenosis, MV defects [54, 87]
Ehlers-Danlos col5a1 AoV & MV defects [22]
Stickler col2a1, col1a1 MV dysfunction [107]
22q11 deletion - outflow tract defects [162]
Holt-Oram TBX5 MV prolapse [132]
Noonan PTPN11 MV defects [68]
Legend MV - mitral valve AoV - aortic valve
Basics of Atrioventricular Valve Development
Atrioventricular valve formation is thought to be regulated by dynamic in-
teractions between molecular and mechanical signaling. The primitive valves
(cushions) initiate as gelatinous masses of hyaluronan and other glycoamino-
glycans extending outward from the myocardial wall of the heart tube [65]. A
layer of endothelial cells line the inner surface of the heart tube, with the outer
wall consisting of cardiomyocytes [67]. The endocardial cells lining the cushion
invade the underlying matrix and acquire a mesenchymal phenotype through a
process called the endocardial to mesenchymal transformation (EMT) (see illus-
trated reviews [140, 163, 27]). As the cushion matures, these mesenchymal cells
remodel the matrix directing a transition from hyaluronan to collagen based
matrix, and a transition from globular to planar morphology [94, 88], (see Fig-
ure 1.1). The mechanical consequences of this biomechanical remodeling are
currently unknown.
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Figure 1.1: Schematic of AV valve development. Initiation: GAG rich,
globular, cushion (light blue) forms as a protrusion from the
myocardial wall (red). EMT: the endocardial cells lining the
cushion invade and transform into mesenchymal cells. Post-
EMT Remodeling: mesenchymal cell remodel the matrix, al-
tering both composition and shape of the valve. Maturity: AV
valve has planar form and consists of fibrous structural pro-
teins. Image modified from [27]
The role of TGF in AV valve development
Significant advances have been made in identifying the key molecular sig-
nals needed for this initiation and maturation [27, 46, 140]. The transforming
growth factor-beta (TGF) superfamily is critically important for a wide range
of cellular processes [9, 116, 165], and is heavily involved in directing morpho-
genesis of AV cushions [143, 21, 29, 14, 11]. In the chick, TGF2 and TGF3 iso-
forms are necessary for EMT [144]. TGF2 induces initial cell-cell separation of
valve endothelial cells, while TGF3 stimulates their invasion and subsequent
mesenchymal phenotype shift [21, 29]. In mouse, the TGF2 isoform is essential
for proper valve initiation [14], and is also required to achieve correct morphol-
ogy during post-EMT stages [10]. As shown in Figure 1.2, the TGF2 KOmouse
exhibits enlarged AV valves that are rich in glycoaminoglycans, which are less
present in post-EMT wildtype valves.
Normally during post-EMT, the mesenchymal cells facilitate a transition in
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Figure 1.2: Altered molecular signals result in defective valve morphol-
ogy. E18.5 WT and TGF2 KO AV valve sections stained with
Alcian blue. Image modified from [10]
the cushion microstructure from glycosaminogylcans (GAGs) (hyaluron, versi-
can) toward fibrous structural proteins (collagen I, V,VI, fibronectin, periostin)
[94, 133, 28]. We hypothesize that this shift in extra-cellular matrix (ECM) con-
tent translates into increased valve stiffness, but this has yet to be experimen-
tally verified. TGF3 expression is elevated in the AV cushions and canal during
post-EMT remodeling stages in both chicken [31] and mice [29] (see Figure 1.3).
Furthermore, TGF3 upregulates collagen I and periostin in post-EMTAV cush-
ion explants [134], suggesting that TGF3 is a key modulator of cushion ECM
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Figure 1.3: Spatial distribution of TGF1,2 and 3 ligands in chick and
mouse AV valves during post-EMT remodeling. AVC - atri-
oventricular canal. Image modified from [29]
content, and consequently mechanical properties. An aim of this thesis is to
determine the remodeling potential of TGF3 during post-EMT.
Potential interaction of serotonin and TGF in AV valves
Recent studies indicate that serotonin (5-HT) interacts with TGF signaling
in adult heart valves [86, 44], and can also alter valve mechanical properties [47,
186]. 5-HT is a monoamine neurotransmitter that is derived from the essential
amino acid tryptophan [156]. 5-HT has been shown to increase the stiffness of
porcine aortic valves under cyclic stretch [12], or when endothelium is removed
[47]. 5-HT can increase the synthesis of collagen in human and sheep valve
interstitial cells (VICs) [86, 73]. Reports in adult VICs indicate that 5-HT can
also upregulate TGF, resulting in cell differentiation and aberrant connective
tissue accumulation [86, 44, 138]. This known interaction of 5-HT with TGF in
adult valves motivates an investigation into whether a similar interaction exists
during embryonic development.
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Figure 1.4: 5-HT2b receptor is localized to the embryonic heart. 5-HT2b
in situ stain of E8.0 mouse embyro. b - brain, h - heart. Image
modified from [32]
The role of mechanical forces in AV valve development
The mechanical environment of the AV cushion is also critical for proper
valve formation. Surgical manipulations of hemodynamic flows have resulted
in defective cardiac morphology [78, 182]. The perturbedmechanical loads have
included differences in local shear stress [79, 69], pressure [164], andmyocardial
activity [13]. For examples, Sedmera et al. [164] ligated the left atrium of chick
embryos with sutures, which reduced the pressure drop across the AV canal.
The reduced pressure resulted in enlarged leaflets in both the left and right AV
valves at later developmental stages (Figure 1.5). These perturbations are in ad-
dition to the already significant increases in loading the valves experience dur-
ing development. In the chick embryo, the heart rate nearly doubles from day 2
to day 6 of incubation, and the right ventricular systolic pressure triples in that
time (see Table 1.2). The shear stresses on the AV valves due to blood flow have
been approximated with fluid dynamics simulations [191, 124, 18]. The differ-
ential roles of pressure versus wall shear stresses in directing AV valve morpho-
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genesis are unknown. By understanding their specific roles, we could better
identify loading profiles that are defective, and/or determine which mechano-
sensors to target in order to block the effect of the defective mechanical loading.
However, uncoupling the effects of pressure and shear tractions is difficult to
do experimentally.
Figure 1.5: Alteredmechanical loads can generate valve defects. Left atrial
ligation results in enlarged left and right AV valves, as seen
in these HH40 heart cross-sections. Scale bar 1 mm. Image
modified from [164]
We propose studying the mechanical regulation of AV valve formation by
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Table 1.2: Heart rate and right ventricular blood pressure in avian embry-
onic heart, taken from [111]
Stage (HH) bpm Systolic (mmHg) Diastolic (mmHg)
16 110 1.15 0.25
18 147.5 1.31 0.33
21 145 1.61 0.34
24 155 1.96 0.4
27 155 2.35 0.56
29 194 3.45 0.82
Note: bpm - beats per minute; Refs: [80, 81, 141]
using a computational model of growth and shape change. Numerical models
have provided insights into the fluid dynamics of the embryonic heart, such as
the transition of peristaltic to pulsatile flow [178] and the distribution of normal
and shear forces in AV canal [18, 124]. Previous growth models have qualita-
tively captured the morphology of several developmental phenomenona such
as invagination [127], gastrulation [173, 174], cardiac looping [149], and ven-
tricle growth [108]. However, no computational growth model has yet been
employed to study the morphogenesis of the AV valves. In this work, we de-
velop a theory of growth and shape change stimulated by mechanical loading,
and then evaluate what insights it gives into how fluid loads may alter valve
morphology.
This thesis contributes to these current knowledge gaps through experimen-
tal, analytical and computational approaches. Each chapter is motivated with
an introduction section, and placed in the context of current work with a dis-
cussion section. The content and inter-relatedness of each chapter are outlined
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below.
In chapter 2, pipette aspiration and deformable posts are presented as two
viable micro-mechanical testing techniques for soft tissue. A new method of
interpreting the experimental data from the pipette aspiration technique was
validated through finite element (FE) analysis. Using these methods, we quan-
tified the mechanical properties of avian AV valves during valvulogenesis. This
data showed that valve stiffness increases monotonically during development,
with leaflet-specific values. We also quantified the transition in AV valve ge-
ometry during this period, observing a distinct shift from globular to planar
shape. The valve also transitioned from a relatively isotropic material toward
an anisotropic material by the end of valvulogenesis. Evidence of this was seen
through the substantially different magnitudes of stiffness between the in-plane
and transverse plane. This chapter highlighted the rapid growth and remodel-
ing of the embryonic valve, and provides mechanical data about this period of
development that was previously unknown.
In chapter 3, we investigated a potential molecular mechanism of stiffness
generation in valve development which was motivated by the mechanical data
of the preceding chapter. We focused on the role of transforming growth factor
beta 3 (TGF3) and serotonin (5-HT) signaling cascades in modulating post-
EMT AV valve mechanics. Using the pipette aspiration method, we show that
TGF3 increases AV valve stiffness over 2-fold after 24 hours of treatment. 5-HT
treatment alone did not alter valve stiffness in this time frame, but did exacer-
bate the stiffening effect of TGF3 when co-treated with TGF. The stiffness
increase was generated through increased cell contraction, elevated prolifera-
tion, and ECM synthesis. Through selective inhibition of TGF and 5-HT recep-
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tors, we determined that the interaction between these two pathways was de-
pendant on the 5-HT2b receptor and on canonical TGF signaling through the
Alk5 receptor. The interaction between these pathways was further confirmed
in ovo through systemic 5-HT treatment. This study provided direct evidence
of a specific mechanism of molecular regulation of AV valve mechanical prop-
erties. Although several other genes are undoubtedly involved in post-EMT
biomechanical remodeling, this study contributes to the current understanding
of mechano-molecular interactions.
Having explored a molecular stimulus, we then turned our focus toward
understanding the role of mechanical forces in AV valvulogenesis. In chapter 4,
we developed a theoretical model of tissue growth (volume change) and shape
change based primarily on mechanical stimuli. We evaluated the conservation
of mass, momentum, and energy in the context of the growing body. We im-
plemented a multiplicative split of the deformation gradient into an elastic and
inelastic deformation. Then using the entropy inequality, we derived an evolu-
tion equation for the growth and remodeling deformation. Through this anal-
ysis, we encountered many open questions remaining in the growth mechanics
field [5]. For instance, what is the nature of the homeostatic reference state? Is
it stress based or strain based, or neither? Does new tissue enter with mechan-
ical energy? When can growth be defined as a displacement field? Although
not all were conclusively answered, these questions and others are discussed in
chapter 3. This analysis contributes to the ongoing effort to connect the pow-
erful tools of continuum mechanics with the intricate complexities of biological
systems.
In chapter 5, we employed the growth law of the preceding chapter to simu-
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late the role of hemodynamic loading in AV valvulogenesis. Using a previously
publishedAV canal geometry [18] and hemodynamic parameters [191], we eval-
uated the relative effects of pressure, shear, and the homeostatic state on valve
morphology. The model showed that the fluid forces were capable of directing
the initial globular valve toward an elongated and condensed shape. Interest-
ingly, as the valve evolved the distribution of fluid forces on the valve surface
became increasingly more favorable for valve elongation. We also identified
regions of residual stress due to growth, and evaluated how these stresses af-
fected the overall evolution of the valve. The simulations were all implemented
in the ANSYS, a commercial FE package, through a custommaterial subroutine.
This growth model provides a useful theoretical and computational framework
upon which to incorporate more biological details and to analyze other clini-
cally relevant loading situations.
In chapter 6, I discuss my experience in the NSF GK-12 STEM teaching
fellowship program which was facilitated by the Cornell BME department.
Through this program, I assisted with science activities at a regional high school
and discussed current research trends with the students. I developed two teach-
ing curriculums on embryonic development using the shell-less chick culture
technique (ex ovo) used in my lab. I treated embryos with elevated levels of
retinoic acid which is a metabolite of vitamin A. The development of the em-
bryo and the surrounding vasculature was stunted. The students compared
this treatment to control embryos through image analysis. The teaching con-
cepts of the lesson included, 1) how environmental factors, even good ones like
vitamin A, need to be regulated, 2) that the embryo is highly sensitive to pertur-
bations in the mechanical and molecular environment, 3) that local treatment
can have a global consequence because of the vasculature system, and 4) that
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animal research is importanct for gaining a mechanistic understanding of how
living systems operate. This was a particularly meaningful experience because
while the practical applications of my research are several years away, the atti-
tude and excitement of these students toward science was immediately affected
by my work.
The thesis is concluded with a summary of the major contributions of this
work, and possible future research directions are discussed.
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CHAPTER 2
MECHANICAL TESTING TECHNIQUES FOR SOFT TISSUES
Tissue assembly in the developing embryo is a rapid and complex pro-
cess. While much research has focused on genetic regulatory machinery, un-
derstanding tissue level changes such as biomechanical remodeling remains a
challenging experimental enigma. In the particular case of embryonic atrioven-
tricular valves, micro-scale, amorphous cushions rapidly remodel into fibrous
leaflets while simultaneously interacting with a demanding mechanical envi-
ronment. In this study we employ two microscale mechanical measurement
systems in conjunction with finite element analysis to quantify valve stiffening
during valvulogenesis. The pipette aspiration technique is compared to a uni-
axial load deformation, and the analytic expression for a uniaxially loaded bar
is used to estimate the nonlinear material parameters of the experimental data.
Effective modulus and strain energy density are analyzed as potential metrics
for comparingmechanical stiffness. Avian atrioventricular valves from globular
Hamburger-Hamilton stages HH25-HH34 were tested via the pipette methods,
while the planar HH36 leaflets were tested using the deformable post technique.
Strain energy density between HH25 and HH34 septal leaflets increased 4.6 
1.8 fold ( SD). The strain energy density of the HH36 septal leaflet was four
orders of magnitude greater than the HH34 pipette result. Our results estab-
lish morphological thresholds for employing the micropipette aspiration and
deformable post techniques for measuring uniaxial mechanical properties of
embryonic tissues. Quantitative biomechanical analysis is an important and un-
derserved complement to molecular and genetic experimentation of embryonic
morphogenesis.
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2.1 Introduction
Morphogenetic events in the developing embryo are the result of dynamic in-
teractions between cells and their environments. Many technologies exist to
decipher the molecular and genetic regulation of cell behavior, but far less is
known about the role of micro-environmental signaling. In the case of the heart,
it is well known that virtually all mechanically relevant indices increase over
development (e.g. blood pressure, wall shear stress, myocardial wall strain
[37, 80, 191]). While it is appreciated that the resident tissue must somehow
strengthen to withstand these increased loads, quantifying these material prop-
erties is extremely challenging. In the case of heart valve development, globular
gelatinous masses, dubbed cushions, are rapidly remodeled into thin, fibrous
leaflets, rich in matrix fiber striation [29, 140]. In common animal models such
as chick and mouse, these tissues barely reach beyond 1 mm in length, which is
much too small for traditional uniaxial testing. Conversely, in using micro-scale
techniques such as atomic force microscopy [85] or optical trapping methods
[98], the continuum approximation is lost as the devices are probing individ-
ual cells or extracellular matrix components. Previous experiments have shown
that many embryonic tissues including valves are super-compliant, with elas-
tic moduli less than 40 Pa [28, 183]. Unlike relatively stable postnatal tissues,
the constant and significant shape and size change over time may selectively
invalidate some testing methodologies.
Many techniques have been developed to assess the biomechanics of micro-
scale tissues (generally a few millimeters or less in length). Pipette aspiration
(PA) applies a local vacuum pressure and monitors resultant tissue displace-
ment within the tip. PA has previously been used to measure material proper-
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ties of early embryonic valve cushion primordia [28], as well as adult pig and
mice valves [93, 195], and blood vessel walls [136]. The ability to relate experi-
mental data in these studies to meaningful material properties has varied. Early
work derived Young’s modulus, E, of a linear elastic material in terms of the
applied pressure, P , and aspirated length, L, for an infinite half-space under-
going small strain [180]. While some recent studies utilize this model directly
for tissues [93], others have modified the approach for such factors as viscoelas-
ticity [120, 161], different material layers [3], or accounting for pipette-tissue
adhesion [20]. A previous finite element (FE) analysis of the pipette method de-
veloped a similar small-strain expression for E for a finite tissue geometry [8].
Such soft tissues, however, predominantly demonstrate marked nonlinear ma-
terial behavior with large deformations, and therefore need to be considered in a
finite elasticity context. Recent inverse FE simulations enable nonlinear material
property identification [196, 195], but with significant time and computational
resource cost. To overcome these challenges, we will compare the pipette tech-
nique to a uniaxial load and use the analytical solution of a uniaxially loaded
bar to fit our experimental data.
A second common technique is the use of deformable microfabricated posts
that measure applied force via traditional cantilever deflection. Deformable
posts (DP) are commonly fabricated in a subcellular array to measure local cell
traction forces [102, 179]. We hypothesized that a similar system could func-
tion for planar embryonic soft tissues like heart valve leaflets. Furthermore, by
analyzing the two techniques (PA and DP) with the same nonlinear material
law, we should be able to relate the material parameters between each device.
We here establish the appropriate morphological regimes where each device is
viable for stiffness measurement, and demonstrate their utility for soft, short
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length scale embryonic heart valve tissues. We further present strain energy as
an alternative metric for representing stiffness for nonlinear materials.
2.2 Materials and Methods
2.2.1 AV Cushion Geometry Transition
The geometries of AV valve primordia were measured for HH25, HH29, HH34,
and HH36 embryonic stages. Cushion length, Lc, was taken to be the dimen-
sion protruding perpendicular from the AV canal wall. Thickness, tc, was the
cushion dimension perpendicular to Lc along the anterior-posterior axis. Lastly
cushionwidth,wc, was defined as themaximumdimension of the cushion along
the dorsal-ventral axis of the heart. Measurements were taken from magnified
images of cushions immediately after isolation using Zeiss Discovery v20 stereo
microscope and ImageJ.
2.2.2 Pipette Aspiration Experiments
PA Simulation
A FE model of the pipette technique was developed to: 1) characterize the
effects of tissue geometry on the experimental measurements of applied pres-
sure and aspiration length, and 2) construct an analytical model to interpret
the experimental data. In all simulations the tissue was modeled as an incom-
pressible, isotropic, hyperelastic disk with thickness D, and radius R (see Figure
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2.1). A vacuum pressure, P , was applied to the tissue surface in the pipette
interior, and all exterior surfaces were assumed traction free. The pipette was
modeled as an analytically rigid surface with filleted edges for smooth tissue
contact. The pipette thickness was 25% of the pipette inner radius, rp, compa-
rable to the pipettes used in the experiments. Free-sliding contact was assumed
between the tissue and pipette tip. An axisymmetric model using 2D, 8-node
quadrilateral, second order elements with displacement-pressure (u-p) hybrid
formulation were used for optimal handling of the incompressibility condition.
FE simulations were performed in ANSYS v12.1 (ANSYS Inc., Canonsburg, PA)
using approximately 3600 elements.
First, using a Neo-Hookean material law, the effect of tissue geometry was
investigated by varying the ratio of tissue thickness and radius relative to the
pipette radius, D = D
rp
, and R = R
rp
, respectively. The slopes of the P versus
 curves, where  = L+rp
rp
and L is the aspirated length, were evaluated to de-
termine D and R regimes where PA yields consistent slope values. Second, to
interpret the pipette data, FE simulation results were compared to the analyti-
cal expression for the axial stress of a uniaxially loaded, incompressible bar (Eq.
2.2.2). The Neo-Hookean material was implemented to evaluate the P versus
 curve behavior relative to the Cauchy, 1st Piola Kirchhoff (PK) and 2nd PK
stress measures for a uniaxial load, as it was unclear which stress measure the
P would best mimic. Third, given the exponential nature of the experimental
data, an exponential material law [195],
W =
C
2
[exp ((IB   3))  1] ; (2.2.1)
was also analyzed numerically via the USERHYPER subroutine (see Appendix
C), where IB = tr(FF T ), F is the deformation gradient, and , C are mate-
rial parameters. Agreement between the axial Cauchy stress, yy , and the P
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Figure 2.1: Axisymmetric schematic of a pipette-aspirated tissue disk. The
reference tissue is denoted by the dashed box and has dimen-
sions of radius, R, and thickness, D. The region inside of the
pipette with radius, rp, is loaded with aspiration pressure,P ,
resulting in an aspirated length, L.
versus  curve was quantified for the exponential material law.
PA Experimental Technique
Avian left atrioventricular (AV) valve primordia mechanical properties were
quantified using PA. Hamburger-Hamilton (HH) stages 25-34 septal and mu-
ral leaflets were isolated and placed directly in phosphate-buffered saline (PBS,
Gibco) prior to testing. A glass micropipette (rp  35 m) was placed adja-
cent to the cushion surface collinear with the AV canal axis for HH25, while it
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was placed on leaflet surface facing the atrium for HH29 and HH34. Vacuum
pressure was incrementally applied via a 200 L pipetter calibrated with a cus-
tommanometer. Previous strain history was mitigated by preconditioning with
 20 cycles of low pressurization (< 1 Pa). The preconditioning step ensured
the tissue and pipette tip were in full contact. Incremental pressure loads were
then applied, at which images were captured for each static load at 150x magni-
fication using a Zeiss Discovery v20 stereo microscope (Spectra Services, Inc.).
The aspirated length was measured using calibrated images in NIH ImageJ.
An experimental “stretch ratio”,  = L+rp
rp
, was defined by normalizing the
aspirated length to the pipette radius. The experiment stretch ratio is a measure
of geometry change during aspiration, which is related, but not identical to the
local stretch of the tissue (see Supplemental Fig. S3B). The P versus  curves
were fitted using the axial Cauchy stress for a uniaxial load of an incompressible
material with an assumed exponential material law (Eq. 2.2.1), specifically,
yy = C exp



2 +
2

  3

2   1


(2.2.2)
The fitting parameters  and C were determined by minimizing the sum of
the errors squared between Eq. 2.2.2 and the P versus  data curves. The C
parameter was modified using a scale factor determined from FE simulation,
Cmod = ()C. Effective modulus, EEff = Cmod, and strain energy density
were evaluated as metrics for comparing mechanical testing data. Strain energy
density (Pa or kPa) was calculated as the stored energy of the uniaxial deforma-
tion with axial stretch ratio ranging from = 1 to 2, namely,
W1 2 =
Cmod
2
[exp(2)  1] : (2.2.3)
Data is presented with representative stress response curves and strain energy
density values presented as mean  SD with n=8-11. Statistical comparisons
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were performed using ANOVA with Tukey post-tests or Student’s t-test, *p <
0.05.
2.2.3 Deformable Post Experiments
DP Experimental Technique
To measure the mechanical properties of planar tissue, a custom device was
fabricated which measures force based on beam deflection theory. Deformable
cantilevers constructed from polydimethylsiloxane (PDMS, Sylgard 184) were
used to determine the forces in the micro-milliNewton range (N-mN). To cre-
ate the DPs, negative molds were machined into a Teflon block. We generated
three different post sizes, but each had the same height, hp, to diameter, p, ra-
tio ( p=hp = 3 mm/1 mm = 6 mm/2 mm = 9 mm/3 mm = 3). However, the
3mm/1mm cantilever was optimal, due to the size and generated force range of
the HH36 valves. The PDMS was mixed at a ratio of 10:1 (base/curing agent),
poured into mold geometry, cured at 65 C for 12 hours, and then autoclaved
to complete the curing process. Post bending stiffness and batch variability
were measured using a previously described method [160]. Filter paper patches
(CFP4, Whatman) were secured to the top of each post to provide a substrate for
tissue attachment. The silicone posts were mounted on two horizontal sliding
arms which were capable of positive and negative translation. The freshly iso-
lated HH36 valves were delicately transferred to a glass slide using a transfer
pipette, and the residual saline was wicked away. The glass slide was then in-
verted, placed over the DP, and leaflet edges brought in contact with filter paper.
Once the valve was placed across the DPs in a planar fashion, two small drops
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of cyanoacrylate (454 Prism, Loctite) applied with micropipette (100 m diam-
eter) secured the valve to the DP. The mechanical testing was then conducted
in PBS at 20 C. Deflection was determined as half the difference between the
displacements of the base and the tip of the post, specifically,
 =
xb   xt
2
; (2.2.4)
(Figure 2.12A). From the deflection and the bending stiffness calibration, the
axial force in the plane of the tissue was approximated. The axial force was
normalized to the initial reference area, approximated as the product of the un-
loaded thickness and width. An average stretch ratio for the deformable post
tissue was defined as,
p =
xt   x0
x0
: (2.2.5)
The 1st PK form of the axial stress for a uniaxial load, Eq. 2.2.2 , was used to
fit the post data. The 1st PK stress versus p curves are presented for the HH36
septal leaflet along with the averageW1 2 value for n=9.
DP Simulation
A FE model of a post with fixed base and transverse applied force at tip
was investigated. The post was modeled as an incompressible, Neo-Hookean
material using 8-node 3D solid-structural elements with u-p formulation. Force-
deflection profiles were calculated for differing post geometries by varying post
height and diameter. Scaling of bending stiffness between differing post ge-
ometries was compared to Euler beam theory. The analysis was performed to
determine maximum tissue contact area within the required force transduction
range. Maximal contact area is beneficial for the attachment of tissue to the DPs.
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2.3 Results
Pipette stiffness results sensitive to tissue geometry
The geometry of aspirated tissues, both thickness and radius, can influ-
ence pipette technique’s stiffness measurements. FE simulations with a Neo-
Hookean material demonstrate that the slope ofP versus  decreases as tissue
thickness, D = D
rp
, goes to zero (Figure 2.2). The measured stiffness decreases
rapidly for D < 2, with a 50 % decrease between D = 2 and D = 0:75. The
decrease in stiffness is a direct result of higher aspirated lengths, due to con-
tributions from tissue bending. Evidence for bending is seen in the change of
sign () of the radial stress (^rr) along the axis of symmetry for tissue thickness
D  2 (Figure 2.3). The pipette aspiration method assumes local stretching at
the location of applied pressure, not bending of the global tissue. While the er-
ror in stiffness measurement between D = 2 and D = 4 may be small ( 2%),
the assumption of no tissue bending is not valid until D  4. Similarly, mea-
sured stiffness decreases as tissue radius R = R
rp
approaches unity (Figure 2.4).
Measured stiffness values converged for R  2, but errors were introduced for
smaller R. The maximum error calculated was 9.7% between R = 1:25 and
R = 2.
PA approximates uniaxial deformation in tissue interior
FE simulations of the pipette method, using either Neo-Hookean or expo-
nential material laws (Eq. 2.2.1), demonstrate a heterogeneous strain field, with
maximummagnitudes located at the contact surface between the tissue and the
pipette (Figure 2.5). Near the axis of symmetry the strain field is more uniform,
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Figure 2.2: Plot of measured tissue stiffness normalized to Young’s Mod-
ulus, E, of a Neo-Hookean material versus tissue thickness, D.
Inset: FE generated P versus  curves from which stiffness
was calculated as the slope.
with the only significant gradient in the y direction. The radial and meridian
stretch ratios, r and  respectively, along the axis of symmetry were equal
and transitioned from elongation to compression with depth into tissue (Fig-
ure 2.6A). Conversely, the stretch in the y direction, y, was in compression at
the pressurized tissue surface, but transitioned toward elongation in the tissue
interior. This depicts a transition from equibiaxial extension (gray region Fig-
ure 2.6A) toward uniaxial with depth. The y location of this transition, ytrans,
varies with applied load, but remains near the surface, never exceeding rp
2
in
any of the simulations and therefore lying within the initial ”cap” of distended
tissue (Figure 2.7A). The geometric ”stretch ratio”  = L+rp
rp
was implemented to
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Figure 2.3: Plot of radial stress normalized to stress at applied load sur-
face as a function of depth along the axis of the symmetry. For
D < 4, the radial component (likewise meridianal) experiences
a compressive stress at the bottom edge, evidence of the tis-
sue undergoing bending. Inset: Schematic of axi-symmetric
pipette geometry
approximate the y-axis stretch which varied with depth along the axis of sym-
metry. The average of y along the axis of symmetry was always greater than
or equal to one, and was linearly related to  (Figure 2.7B). We calculated the
average of y through the entire depth of the tissue ( D = 4). The stretch ratio
values away from the pipette interface were near unity, which explains why the
slope of avg(y) in Figure 2.7B is less than one.
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Figure 2.4: Pipette stiffness measurement consistent for R > 2rp. Slope of
P versus  profiles for varying R and D. The error introduced
by small tissue thickness dominates the error that results from
small tissue radius. Yet a minimum tissue radius is required
for the pipette technique to even work.
P proportional to axial stress of uniaxial deformation
An analytic model was developed for the purpose of interpreting the exper-
imental data by comparing the pipette pressure P versus  to the axial stress
versus axial stretch of a uniaxial load (Eq. 2.2.2). FE-generated P versus 
curves aligned closest to the axial Cauchy stress, yy, for the Neo-Hookean ma-
terial, and poorly with the 1st PK (Figure 2.6B). The slopes of the P versus
 and the yy versus  curves differed by a factor,, which correlated with the
stiffness offset from unity for D > 4 in Figure 2.4A. Similarly, with the expo-
nential material, the P versus  curve differed only by a scalar factor from
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Figure 2.5: Axial component is the dominant stretch ratio in the tissue inte-
rior. Contour images of the elastic stretch ratio fields, presented
as stretch ratios along the orthogonal reference axes. Note r
and  have identical strain profiles along the axis of symme-
try. The axial stretch transitions from elongation at load surface
to compression in the tissue interior. Data was generated from
FE simulation run with exponential material law with C=10, 
= 0.5 evaluated at P = 21, and tissue geometry R = 3 and
D = 4.
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Figure 2.6: Pipette aspiration is approximately a uniaxial load. A) Along
the axis of symmetry, the deformation transitions from equi-
biaxial (gray region) extension toward uniaxial extension with
depth into the tissue. B) The P versus  curve of an in-
compressible, Neo-Hookean material closely aligns with the
Cauchy stress of a uniaxially loaded bar, not the 1st Piola Kirch-
hoff stress. C) The P versus  curve of an exponential mate-
rial differs by a scale factor, , from the axial stress of a uniaxial
load compared at the same stretch ratios. D) The scale factor,
, is a function of  only, which is approximated with a cubic
polynomial shown for  = [0; 2]. A = -0.052, B = 0.252, C =
0.053, 0 = 1.09
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Figure 2.7: Location of stretch ratio features depend on applied load. A)
The y location along the axis of symmetry where the deforma-
tion transitions from equibiaxial to uniaxial is a function of the
observed stretch ratio,  = (L+rp)
rp
. Similarly, the location of
maximum y also depends on . B) The average of y along
the axis of symmetry is linearly related with , and is greater
than unity for all . The observed stretch ratio  overestimates
the maximum of y, and is nonlinearly related. Data was gen-
erated from FE simulations using an exponential material law
with C=10,  = 0.5 evaluated from P = [0; 21], and tissue
geometry R = 3 and D = 4.
the assumed uniaxial model (Figure 2.6C). A parameter sweep of both  and C
demonstrated that the scale factor  was a function solely of  (parameter range
C 2 [0:01   100] and  2 [0:01   5]). The relationship between  and the scale
factor was fitted to a cubic order polynomial:  = A3 + B2 + C + 0, where
A =  0:052; B = 0:252; C = 0:053; 0 = 1:09 (Figure 2.6D). For  > 2, the fit
quality between the simulation and analytic model was unsatisfactory, hence
 = 2was considered an upper bound for relating PA to a uniaxial load test.
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Strain energy density as an alternative to effective modulus
An effective modulus, EEff = C, has been suggested as a stiffness metric
for two-parameter exponential models [28, 195]. For small , ( < 0:2), EEff
approximates the slope of the P versus  curve, as the exponential term is
near one. Unfortunately,  < 0:2 is too strict a condition for sufficient curve
fitting of experimental data, and EEff loses its physical significance outside this
range. Furthermore, EEff is not a unique parameter, as an infinite combina-
tion of  and C values will equal the same EEff value. Strain energy density
is therefore proposed as an alternative, physically significant, metric for com-
paring mechanical properties. Continuing with the uniaxial analog, the strain
energy density from  = [1; 2] has a simple form for the pipette deformation:
W1 2 = Cmod2 [exp(2)  1]. This strain energy parameter is also not unique,
but for a given set of  values it produces a narrower range of material re-
sponse curves compared to fixed EEff over the same range (Figure 2.8). For
 = [0:5; 1; 1:5; 2], the range of material response curves with fixed EEff = 1
is quite wide with approximately a 3-fold difference in strain energy density,
while for fixed W1 2 the curve spread is tighter. The enhanced consistency of
strain energy density at these higher  values gives it an advantage over EEff ,
even if not a direct measure of stiffness.
Globular to planar geometry transition concomitant with stiffness increase
The leaflet thickness decreased 3-fold from stage HH25 to HH36 (Figure 2.9),
ending with a thickness of 110.4 9.7 m (mean  SD) at HH36. With the D  4
criteria and assuming continuum measurements require rp  35m, the pipette
method is best suited for leaflet thickness greater than 140 m. Hence HH36 tis-
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Figure 2.8: Strain energy density is a meaningful parameter for nonlinear
material comparison. Plot of Cauchy axial stress for an expo-
nential material with 1) fixed effective modulus, EEff = C
(circles), and 2) fixed strain energy density from W1 2 (solid
lines) evaluated for  = [0:5; 1; 1:5; 2]. Though both parameters
are non-unique, the strain energy density generates a tighter
range of material response curves for the same set of  values,
while EEff has a larger spread of material response curves and
no physical meaning for large .
sue was tested using the deformable post test device. The significant decrease
in leaflet thickness was concomitant with 2.46  0.28 and 1.85  0.18 (fold 
SD) increases in leaflet length, Lc and width, wc, respectively. The thickness to
length ratio, tc
Lc
, decreased 6-fold from HH25 to HH36 as the globular cush-
ion transitions into a planar leaflet (Figure 2.9B). This shift of aspect ratio occurs
over five days of incubation, underscoring the rapidity of this complex morpho-
genesis. TheP versus  curves from the pipette data demonstrate a nonlinear,
exponential behavior (Figure 2.10A), exhibiting an increased slope with devel-
opment. The strain energy density increased 4.6  1.8 (fold  SD) between
HH25 inferior and HH34 septal cushions (Figure 2.10B). Similarly, the HH29
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Figure 2.9: AV cushion geometry transition necessitates alternative me-
chanical testing devices. A) Cushion thickness, tc, relative to
pipette placement decreases during development. HH36 vio-
lates theD = 4 rp testing criteria for 70 m pipette diameter. B)
Ratio of thickness to cushion apex to base length, Lc, shows a
transition to a more planar configuration at the completion of
valvulogenesis (HH36). n = 8-10 mean  SD, all pairs of differ-
ent letters are statistically significant, ANOVA, p < 0.001
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septal cushion increased 2.5  0.9 fold from the HH25 inferior cushions. The
HH25 superior cushion was slightly stiffer than the inferior cushion with strain
energy density of 0.44 0.14 Pa versus 0.34 0.08 Pa (mean SD). Mural leaflet
strain energy increased from 0.69 0.11 Pa to 0.96 0.21 Pa between HH29 and
HH34. The mural and septal leaflet strain energies differed statistically only at
HH34. TheHH36 septal material behavior well fit the 1st PK stress for a uniaxial
load of the exponential material law used to model the pipette experiment (Fig-
ure 2.11). The average strain energy density of the HH36 cushion in the plane
of the tissue was W1 2= 59.2  14.2 kPa. The in-plane strain energy density at
HH36 was 4 orders of magnitude greater than the strain energy density in the
transverse direction measured by PA.
DP force range is tunable according the Euler beam theory
The HH36 AV leaflets were tested with a DP uniaxial testing device (Figure
2.12B,C). FE simulations demonstrated that for ratios of post height to diameter,
hp
p
> 2 , the force versus deflection curve agreed with the Euler bending theory
up to a deflection of  = hp
4
. For constant hp
p
, the bending stiffness scales linearly
with cantilever diameter (Figure 2.12D). For diameters 1, 2, 3 mm, the bending
stiffness was measured as 10.3 1.5, 20.2 1.9, and 29.9 0.9 mN/mm, respec-
tively (mean  SD n=6). The small deviations in bending stiffness demonstrate
the consistency of the fabrication technique and the low variability between sil-
icone batches.
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Figure 2.10: Monotonic increase in AV cushions stiffness during devel-
opment. A) Representative septal leaflet aspiration data for
stages HH25-HH34, (n=4) B) Calculated strain energy data for
septal (black), mural (gray) cushions. HH25 inferior denoted
as septal (black) and superior (white) bar. n = 8-11 mean SD
1-way ANOVA or t-test *p<0.05, # p<0.001 wrt. HH25 septal
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Figure 2.11: In-plane stiffness is much higher than trans-planar stiffness.
Plot of applied force over initial cross-sectional area (1st PK)
for HH36 septal leaflet measured using deformable posts. Av-
erage strain energy density denoted on figure as mean  SD
[kPa]. The in-plane tissue stiffness is 4 orders of magnitude
greater than normal stiffness, suggesting material anisotropy.
2.4 Discussion
Increasing evidence in developmental biology suggests that mechanical cues
from the microenvironment are instrumental in directing cardiogenesis [79,
164]. Furthermore, the pivotal role AV valves play in manipulating blood flow
highlights the importance of understanding their mechanical behavior even
in the embryonic period [182]. The results of this study demonstrate that PA
and DP techniques are effective and complimentary for quantifying the ultra-
compliant properties of complex-shaped, microscale, embryonic tissues.
We confirmed the previously shown result that tissue thickness less than two
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Figure 2.12: Deformable post testing device for planar tissues. A)
Schematic of deformable cantilevers of height, hp, and diam-
eter, p, in reference (dashed) and deformed configurations
(solid). Cantilever deflection equals  = (xb   xt)/2 , where
xt is the distance between the top of the posts, and xb is the
distance between the bases. B) Side view of DP device, scale
bar = 1 mm C) Top view of device with attached HH36 septal
leaflet, and tip of posts highlighted for reference (dashed cir-
cles). Scale bar = 500 m. D) Euler beam theory (dashed line)
predicts a linear increase in bending stiffness with diameter
for a fixed hp/p . Measured bending stiffness for three diam-
eters with hp/p =3 showed agreement with theory, n = 6 (3
silicone batches) mean  SD
pipette radii influences measured aspiration length [8, 195]. However, as shown
in Figure 2B, compressive stress occurs in the radial direction when D < 4. The
compressive stress denotes global bending which elevates the measured aspi-
ration length because tissue is deflecting, as well as stretching into the pipette.
Therefore a D  4 criterion ensures no error due to tissue thickness. This crite-
rion was satisfied for HH25-HH34 AV cushions, but the more planar HH36 tis-
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sue required a different technique. Furthermore, we showed that the radial di-
mension of the tested tissue must exceed R = 2rp for consistent results, though
the errors introduced are not as large as those for the thickness criteria. This
supports and extends recent work by Zhao et al. [195], who considered material
nonlinearity through the implementation of an exponential hyperelastic mate-
rial law in an inverse FE analysis. In the current approach, we related the P
versus  data from the pipette experiment to the Cauchy stress curve of a uni-
axial load through a numerically determined scale factor. This result simplified
the determination of  and C to an error minimization of an analytic expres-
sion, potentially saving significant post-testing computation time employed in
inverse approaches. It is important to note that our uniaxial approximation was
valid for  < 2. Although this range satisfactorily fit the AV cushion data, an FE
inverse approach would be necessary for tissues with larger . Examples of this
would be tissues with a short toe region and a steep exponential region, where
the non-linear parameter  >> 1
PA has previously been compared to equibiaxial loading [53], which was in
the context of red cell mechanics, where in-plane membrane surface tensions
were assumed to dominate. For solid tissues with finite thickness, deformation
along the pipette axis must be considered. Our FE simulations determined that
the mode of deformation quickly transitioned from equi-biaxial at the pressur-
ized surface to uniaxial within the tissue along the axis of symmetry (Figure
2.6A). The equibiaxial regime was very narrow (ytrans <
rp
2
), and did not ex-
perience the high stretch ratios seen in y in the tissue interior. This supports
and extends the previous findings by Aoki et al, who suggested that the nor-
mal extension and shear components in the axial direction were the dominant
contributions to the strain energy [8]. Taken together, these results support the
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uniaxial model as an intuitive and computationally inexpensive way to iden-
tify the material parameters of nonlinear materials. Nonlinear material models
lack direct, simple stiffness metrics for comparing test samples. Exponential, or
Fung-like, materials are particularly difficult, as even linear fitting of sections of
the stress-strain curve require tedious (and arbitrary) conditions to consistently
apply fits (i.e., where does the toe region end, does a bi-linear fit effectively cap-
ture material nonlinearity, etc.). Others have compared stress values at a par-
ticular stretch [112], but this does not adequately represent the stress response
curve nonlinearity. An effective modulus, EEff , defined as the product of the
fit parameters, has previously been used as a stiffness measure for an exponen-
tial material model [28, 195]. Yet EEff relates directly to stiffness only for small
 and is non-unique, prompting instead our analysis of strain energy densities
under a given deformation between samples. Our results determined that strain
energy was a much more consistent metric of tissue stiffness for a given mate-
rial response. This parameter is similar to toughness measures used in fracture
mechanics, except here it is integrated to a non-failure strain to approximate
material behavior in physiological conditions.
Experiments using the PA method showed a stiffness increase over the
course of embryonic AV cushion valvulogenesis. The over 4-fold stiffness in-
crease between HH25 and HH34 septal cushions is indicative of substantial
biomechanical remodeling of the microstructure. Similar rates of stiffness in-
creases in earlier embryonic stage AV cushions have been reported [28]. AV
valves of fetal chick and mice have demonstrated an increase in extra-cellular
matrix (ECM) protein synthesis, particular in the collagen and elastin structural
protein families [94, 140], as well as an increase in their structural organization
[88, 83]. The mural leaflet stiffness lags the septal leaflet stiffness at HH34. This
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is possibly because themural leaflet orginates from amyocardial sheet in the AV
canal wall after the superior and inferior cushions, which form the septal leaflet,
have fused [40]. The in-plane stiffness of the HH36 valves was approximately
four orders of magnitude larger than all the pipette data sets. This indicates
that tissue anisotropy is significant by HH36, with in-plane stiffness the dom-
inant player. FE simulations of a linear elastic, transversely isotropic material
showed that the transverse stiffness contributed one-fifth of the measured stiff-
ness compared to four-fifths from the stiffness in the direction of the pipette axis
[136]. The effect of a nonlinear, highly aniosotropic tissue on measured tissue
stiffness with the pipette method is unclear, but could potentially be teased out
with a more complicated FE simulation.
As the valve transitions toward a planar geometry, the tissue thickness crite-
ria and continuum testing assumption become mutually exclusive. The DP de-
vice effectively measured tissue stiffness in this planar regime. Tan, et al., first
used this approach at the cellular scale, to measure sub-cellular traction forces
[179]. By constructing an array of micro-fabricated DPs (length 11 m), mechan-
ical interactions between cells and their underlying substrates were possible to
measure through the DP deflection. Furthermore, DP bending rigidity could be
easily tuned by altering their geometry [56]. DPs have also been used to test
the mechanical properties of microscale constructs of cells embedded within 3D
matrices [103, 102]. During the remodeling of 3D collagen matrices, cellular
contractile forces and changes in tissue morphology were quantified through
the deflection of DPs of length 250 m. By securing the HH36 embryonic tissue
between DPs of length 3 mm, deflection of the silicone cantilevers provided a
precise measurement of force within the mN range. Although this system was
used for embryonic valves, it could be easily applied to other embryonic tissues.
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In conclusion, PA and the DP techniques are two viable methods for eval-
uating the mechanical properties of ultra-soft, small-sized globular and planar
tissues, respectively. AV cushions rapidly increase in stiffness during valvulo-
genesis, keeping pace with the demanding mechanical loading of its microen-
vironment. Selection of pipette dimension and point of application on tissue
surface require consideration of an appropriate continuum approximation and
specimen geometry, especially thickness. Strain energy density is a physically
meaningful parameter for which to compare tissue stiffness, and can translate
to any material model. Both techniques are applicable to soft, short-length scale
tissues, and further integration of the devices’ data sets will provide a richer
understanding of other tissues with complex material properties.
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CHAPTER 3
SEROTONIN POTENTIATES TRANSFORMING GROWTH
FACTOR-BETA3 INDUCED BIOMECHANICAL REMODELING IN
AVIAN EMBRYONIC ATRIOVENTRICULAR VALVES
Embryonic heart valve primordia (cushions) maintain unidirectional blood
flow during development despite an increasingly demanding mechanical en-
vironment. Recent studies demonstrate that atrioventricular (AV) cushions
stiffen over gestation, but the molecular mechanisms of this process are un-
known. Transforming growth factor-beta (TGF) and serotonin (5-HT) signal-
ing modulate tissue biomechanics of postnatal valves, but less is known of their
role in the biomechanical remodeling of embryonic valves. In this study, we
demonstrate that exogenous TGF3 increases AV cushion biomechanical stiff-
ness and residual stress, but paradoxically reduces matrix compaction. We then
show that TGF3 induces contractile gene expression (RhoA, SMA) and extra-
cellular matrix expression (col12) in cushion mesenchyme, while simultane-
ously stimulating a two-fold increase in proliferation. In this way, local com-
paction increased because of the elevated contractile phenotype, but global com-
paction appeared reduced because of proliferation and ECM synthesis. Block-
ade of TGF type I receptors via SB431542 inhibited the TGF3 effects. We
next showed that exogenous 5-HT does not influence cushion stiffness by it-
self, but synergistically increased cushion stiffness with TGF3 in physiological
ranges. 5-HT increased TGF3 gene expression and also potentiated TGF3 in-
duced gene expression in a dose dependent manner. Blockade of the 5HT2b
receptor, but not 5-HT2a receptor or serotonin transporter (SERT), resulted in
complete cessation of TGF3 induced mechanical strengthening. Finally, 5-HT
administration to in ovo cultured embryos induced cushion remodeling related
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defects, including thickened/atretic AV valves, ventricular septal defects, and
outflow rotation defects. Elevated 5-HT in ovo resulted in elevated remodeling
gene expression and increased TGF3 signaling activity, supporting our ex vivo
findings. Collectively, these results highlight TGF/5-HT signaling as a potent
mechanism for control of biomechanical remodeling of AV cushions during de-
velopment.
3.1 Introduction
Biomechanical remodeling is the process by which living tissues reorganize, re-
shape, and refit their microstructure in adaptation to changing internal and ex-
ternal forces. This process defines much of embryogenesis, during which ini-
tially indistinct cellular masses acquire shape and functional specificity through
production and manipulation of the extracellular matrix (ECM). This is par-
ticularly important for the morphogenesis of the heart, which is critically re-
sponsible for distributing nutrients as the embryo grows. The heart transitions
rapidly from a tubular structure into a multi-chambered pumping organ, si-
multaneously growing over 100 fold in volume [28]. The hemodynamic envi-
ronment inside the heart increases dramatically in severity during this process
[80, 89, 191], which necessitates precisely tuned biomechanical properties of the
forming valves to maintain efficient unidirectional blood flow. Atrioventric-
ular (AV) valve morphogenesis is characterized by rapid ECM accretion and
turnover [94, 88], which is hypothesized to be stimulated by a dynamic interac-
tion of molecular and mechanical signaling. While numerous molecular agents
important for valve morphogenesis have been identified [140, 35, 27, 46], less is
known about how these signals affect valve mechanics, which is a key readout
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of valve function.
The transforming growth factor-beta (TGF) superfamily is critically impor-
tant for a wide range of cellular processes [9, 116, 165], and is heavily involved
in directing morphogenesis of AV cushions [143, 21, 29, 14, 11]. In the chick,
TGF2 and TGF3 isoforms are necessary for the endothelial to mesenchymal
transition (EMT) which initiates AV cushion development [144]. TGF2 induces
initial cell-cell separation of valve endothelial cells, while TGF3 stimulates
their invasion and subsequent mesenchymal phenotype shift [21, 29]. During
post-EMT, these mesenchymal cells facilitate a transition in the cushion mi-
crostructure from glycosaminogylcans (GAGs) (hyaluron, versican) toward fi-
brous structural proteins (collagen I, V,VI, fibronectin, periostin) [94, 133, 28].
This shift in ECM content translates into increased valve stiffness [24], and coin-
cides with elevated expression of TGF3 in the cushions and AV canal [31]. Fur-
thermore, TGF3 upregulated collagen I and periostin in post-EMT AV cushion
explants [134], suggesting that TGF3 is a key modulator of cushion ECM con-
tent, and consequent mechanical properties. An aim of this study is to better
understand this remodeling potential of TGF3 through a combined analysis of
cushion stiffness, matrix compaction, cell proliferation, and ECM synthesis.
The capacity of TGF3 to stimulate valvular remodeling events underscores
the importance of identifying molecular signals which modulate TGF activi-
ties. Recent studies indicate that serotonin (5-HT) interacts with TGF signal-
ing in adult heart valves [86, 44], and can also alter valve mechanical properties
[47, 186]. 5-HT, which is a monoamine neurotransmitter derived from the essen-
tial amino acid tryptophan [156], increased the stiffness of porcine aortic valve
cusps with the endothelial layer denuded [47], and under cyclic stretch [12].
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Figure 3.1: Schematic of TGF and 5-HT signaling pathways. TGF
phosporylates Smad2/3 which localizes to the nucleus to ac-
tivate gene expression. 5-HT binds to the Gq receptors 5-HT2a
and 5-HT2b, or may be transported into the cytosol via the
serotonin transporter, SERT.
Serotonin also increased collagen synthesis in human and sheep valve intersti-
tial cells (VICs) [86, 73]. Reports in adult VICs indicate that 5-HT can upregulate
TGF, resulting in cell differentiation and aberrant connective tissue accumula-
tion [86, 44, 138]. In development, serotonin is active in key events such as
cardiac progenitor patterning, left-right laterality, and migration of the neural
crest [99, 105, 125, 57, 158]. Murine AV cushions express the serotonin receptors
5-HT2a and 5-HT2b, and the serotonin transporter (SERT) (Figure 3.1 by the
completion of EMT [100, 32], which is when TGF3 expression increases in the
cushions [11, 122]. Latent TGF binding protein and serotonin binding protein
are also expressed in murine post-EMT endocardial cushions [193, 129], high-
lighting each pathway’s capacity to regulate expression of their ligands. The
proximity of these TGF and 5-HT signaling components suggests that may be
interacting partners in post-EMT cushion development. Furthermore, a recent
study reported TGF1 upregulation in murine SERT KO hearts at near fetal
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stages, which was hypothesized to be a consequence of excess 5-HT signaling
due to SERT inhibition [139]. In light of these signaling interactions in both
adult and development models, we hypothesize that this mechanically relevant
crosstalk of TGF and 5-HT may play a role in modulating embryonic AV cush-
ion biomechanics.
The objectives of this study therefore were to characterize the remodeling
capacity of TGF3 in AV cushions, and determine how TGF3 and 5-HT may
act together to regulate cushion biomechanical remodeling. Chick AV cush-
ion biomechanics, compaction, and candidate gene expression were quantified
through implementation of an ex vivo cushion culture system. We determined
that TGF3 induces AV valve stiffening through increases in cell proliferation,
myofibroblastic differentiation, and collagen synthesis. 5-HT enhances the AV
valve stiffening effect of TGF3 in a dose dependent manner. Crosstalk between
TGF3 and 5-HT signaling was investigated via molecular inhibition studies.
The ex vivo results were then tested in ovo through an elevated 5-HT model.
These results suggest that 5-HT may be an important potentiator of TGF3 sig-
naling in embryonic valve morphogenesis and biomechanical stiffening.
3.2 Materials & Methods
AV cushion organ culture model
Fertilized leghorn chicken eggswere incubated until Hamburger andHamil-
ton (HH) stage 25 (Day 4.5). The AV cushions were isolated from their myocar-
dial attachment in ice-cold sterile Earle’s Balanced Salt Solution (EBSS; Quality
Biological, Inc.). Single cushions were cultured in 20L hanging drops for 24
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hours at 38 C in a 5% CO2 environment. Control culture media consisted of
Medium 199 (M199 w/ phenol red and L-glutamine; Gibco) with 1% concen-
trations of penicillin/streptomycin (Gibco), Insulin-Transferrin-Selenium (ITS,
Gibco), and chick serum (Gibco). For experiments, control media was treated
with one or more of the following reagents: human recombinant TGF3 (1
ng/ml, Sigma), serotonin hydrochloride (0.47 - 47 M, Sigma), Cytochalasin D
(1 M, Sigma), 5-HT2a inhibitor MDL100,907 (0.01 - 1 M, Axon Medchem BV),
5-HT2b inhibitor SB204741 (0.35-35 M, Sigma), serotonin transporter inhibitor
Fluoxetine (10 M), and Alk 4,5, and 7 inhibitor SB431542 hydrate (0.26 - 26 M,
Sigma). TGF3 was reconstituted in 4 mM HCL solution containing 1 mg/ml
BSA, all other reagents were dissolved in DMSO. Figure 3.1 contains a schematic
of the TGF and 5-HT signaling pathways considered in this study. The 470nM
5-HT dose was considered physiological, based on HPLC measured concentra-
tions in 10% fetal bovine serum media ( 100 nM [187]). The 47 M 5-HT dosage
is similar to prior in vitro/ex vivo studies in postnatal valves [86, 47, 186, 12, 84],
so we conservatively considered this dose high for our studies.
Micromechanical testing
Cushionmechanical properties weremeasured after 24 hour treatment in the
ex ovo study and at HH25 in the in ovo study using the micromechanical pipette
aspiration technique [24, 8, 195]. A glass micropipette (70-100 m in diameter)
was placed adjacent to the cushion surface, and a small vacuum pressure was
incrementally applied. The pressure source was a 200 L pipetter calibrated
with a custom manometer. Previous strain history was mitigated by precondi-
tioning with approximately 20 cycles of low pressurization (< 1 Pa). The tissue
was then monotonically loaded with increasing static pressure loads, at which
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images were captured. Aspirated length L, measured as the length from the tip
of the pipette to tip of the tissue furthest inside the pipette, was converted into
an experimental “stretch ratio”, , by normalizing to the pipette radius, rp. The
cushion was assumed to be an isotropic, incompressible, hyperelastic material
with an exponential free energy law,
W =
C
2
[exp ((IB   3))  1] ; (3.2.1)
where IB is the first invariant of left Cauchy Green stretch tensor. AV cushion
material isotropy at HH25 was supported by a lack of preferred matrix orien-
tation as determined by ubiquitous protein stain 5-DTAF (50 M Invitrogen;
Figure 3.2). The P vs.  data was then fit to the axial stress equation of a
uni-axially loaded bar of this exponential material, specifically,
axial = C exp



2 +
2

  3

2   1


(3.2.2)
From previous analysis [24] (see chapter 2), the P vs.  curve differs from
the uniaxial load expression by a scale factor, . This scale factor was numer-
ically determined to be a function of only the material parameter . Due to
the nonlinear nature of the data, the mechanical testing data is presented as
strain energy density. This was calculated as the area under the P vs.  curve
fit from  = [1; 2] (Figure 3.3A), which from our assumed material model is
W1 2 = Cmod2 [exp(2)  1], where Cmod = ()C. See Section 2 for more details
of this analysis.
Compaction & Opening Angle Assays
Compaction of the AV cushions was quantified as the ratio of cross-sectional
area before (A0) and after (A) 24 hours of culture in the different treatment con-
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Figure 3.2: Minimal ECM organization in HH25 cushion supports use of
an isotropic mechanical testing technique. A) Confocal image
of a HH25 cushion with ECM labeled via 5-DTAF protein stain
at 10xmagnification. B) 40xmagnification. Note the lack ofma-
trix fiber density or preferential fiber orientation at this stage of
development.
ditions, denoted A
A0
. This ratio measures the combined biomechanical remodel-
ing effects of cell traction, proliferation, and ECM synthesis. To isolate cell trac-
tion effects, we quantified the opening angles created by micro-slit incision in
AV cushions after 24 hours of treatment. The incision was made along the cen-
terline of the spherical cushion mass, extending approximately one radius into
the cushion, and immediately created a pie-wedge with defined opening angle.
Opening angles are an established indicator of tissue residual stress [58], which
is primarily a function of cell traction forces in our culture system. Images were
taken at 150x magnification using Zeiss Discovery v20 stereomicroscope (Spec-
tra Services, Inc.) and QImaging Retiga 4000R Fast camera (Spectra Services,
Inc). Cross-sectional area and opening angle were measured from calibrated
images using NIH ImageJ image analysis software.
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Immunohistochemistry (IHC)
Proliferation was assessed through bromodeoxyuridine (BrdU) incorpora-
tion into HH25 AV cushion hanging drops. BrdU reagent (Invitrogen) was
added at 1:100 dilution in culture medium 6 hours prior to completion of 24
hour culture. AV cushions were then rinsed and fixed in 4% paraformelde-
hyde (PFA). BrdU incorporation was assessed via immunofluorescent antibody
staining and confocal microscopy using anti-BrdU 488 (1:100, Invitrogen), with
DRAQ5 (1:1000, Biostatus) as a DNA counterstain. Images were processed via
ImageJ, and BrdU incorporation was quantified as the ratio of BrdU positive
cells to total cell count. IHC was also used to label phosphorylated Smad2/3
(pSmad2/3) complex in HH25 cushions isolated from the systemic 5-HT in ovo
model. Isolated cushions were fixed in 4% PFA and then stained via standard
whole mount IHC protocol. The cushions were stainedwith primary pSmad2/3
polyclonal goat anti-human antibody (1:50, Santa Cruz) followed with 488 flu-
orescent secondary (1:100, Santa Cruz) and cell nuclei counter stain DRAQ5
(1:1000). pSmad2/3 was quantified as the number of cell nuclei with localized
pSmad2/3 divided by the total number of cell nuclei.
PCR quantification of gene expression
At the end of 24 hour treatment, AV cushion mRNA was isolated and puri-
fied using RNEasy Isolation Kit (Qiagen). A set of 8-10 cushions were pooled
per test sample. RNA integrity was determined by NanoDrop spectrometry, us-
ing A260/A280 ratio between 1.8 and 2.2 as quality control. cDNA synthesis
was completed using SuperScript III first strand RT-PCR kit (Invitrogen) with
oligo(dT) primers. Amplification reactions were as follows: (95 C 15s), (54 C
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Table 3.1: RT-PCR Primers & Accession Number Summary
Gene Size Primer Sequence
18s 275 5’- CGGAGAGGGAGCCTGCGAA - 3’
AF173612.1 5’ - CGCCAGCTCGATCCCAAGA - 3’
TGF3 142 5’ - GGCTTGTACAACACGCTGAA - 3’
NM205454.1 5’ - TGCAGGATTTCACCACCATA - 3’
ACTA2 126 5’ - CAGTTTTCCCTTCCATCGTG - 3’
NM001031229.1 5’ - TGGGGTATTTCAAGGTCAGG - 3’
Col12 201 5’ - GGCAGCAGGTTTCTGCTAAG - 3’
NM001079714.2 5’ - CTCACATGTTGGCTTGTTGC - 3’
Cyclin b2 167 5’ - AGGGGTGGAGAATGCCGTGA - 3’
NM001004369 5’ - TGCCAGGTCCTTTCGTAGCCTT - 3’
RhoA 159 5’ - GTTGGCTTTGTGGGATAC - 3’
NM204704.1 5’ - CAGAAATGCTTCACTTCCG - 3’
SERT 146 5’ - GCAGTGGCTTGGTTCTACGGCAT - 3’
AY573844 5’ - TTGGACAGAAAGCTGCAAGTGACA - 3’
TGM2 120 5’ - GGTGGACAAACTCGCCTTCGACG - 3’
NM205448.1 5’ - TGCAACACTGCACTCCAGGTCC - 3’
15s), (72 C 30s). Power Syber Green (Applied Biosystems) replication indicator
was read at the completion of each 72 C stage. Standard curves for all primers
(listed in Figure 3.1) were generated from HH34 brain mRNA and normalized
to 18s ribosomal RNA. Threshold cycle count, C(t), was used to calculate gene
expression via the Ct method using 18s rRNA as a housekeeping reference
gene [19].
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5-HT administration in ovo
HH17 stage fertilized leghorn chicken eggs were windowed on their blunt
side. Up to 1.0 mg of serotonin (Sigma) was diluted into 100 L of PBS and
dispensed directly onto the chorionic membrane at HH17, HH25, or HH31. The
max 5-HT dosage was equivalent to 18 mg/kg which is comparable to other
elevated 5-HT animal models (25 mg/kg and 75 mg/kg) [48, 76]. After 5-HT
treatment, chicks were then sealed and cultured at 55% humidity and 38 C until
HH36 (Day 10). Preliminary experiments demonstrated that 5-HT treatment
sometimes resulted in an ectopic heart, so additional embryos were alterna-
tively subjected to a thoracotomy that mimicked an ectopic heart without sero-
tonin administration as a control. Embryos were then dissected and analyzed
for gross anatomical defects. Hearts with intact great artery connections were
then removed, cleared, and analyzed with 3D confocal microscopy or serial sec-
tion histology using Movat’s pentachrome stain. Optical fluorescence tomog-
raphy (OFT) of ventricular, valve, and outflow vessel anatomy was performed
as previously described [123, 90]. Briefly, HH36 hearts were freshly isolated
and rinsed with 1% lidocaine in PBS buffer. Following rinse, hearts were per-
fused with fluorescein isothiocyanate-poly-L-lysine(Sigma) via micro injection
and then fixed in 4% PFA. The poly-L-lysine binds to the negatively charged en-
dothelial glycocalyx. Hearts were then cleared using Murray’s Clear, followed
by deep tissue 3D imaging via fluorescence confocal microscopy. Hearts were
screened for major defects, and valve morphometry were quantified from this
using ImageJ. Valve measurements included leaflet length, average thickness,
andminimal thicknesswith control n=3 and 5-HT treatment n=6. Average thick-
ness (tavg) was calculated as tavg = ALL , where L is the annulus-tip length of the
leaflet, and AL is cross-sectional area of leaflet. The location of minimum thick-
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ness was generally the same for all specimens regardless of treatment.
Statistical Analyses
All data is presented as mean  standard error of the mean for the number
of samples reported. Statistical comparisons between groups were performed
using ANOVA for data sets involving more than two groups, or two-tailed t
test when only two groups were compared. Defect prevalence in the in ovo
model was compared using a chi-squared statistical test. In all comparisons,
differences between groups was considered statistically significant for p valves
smaller than 0.05.
3.3 Results
TGF3 increases AV cushion stiffness
Ex vivo cultured AV cushions exhibited nonlinear mechanical behavior that
was well described by the exponential constitutive model (Figure 3.3A). Ad-
ministration of exogenous TGF3 (1ng/ml) increased cushion stiffness 2.5 fold
over controls (WTGF3 = 0.965  0.051 vs. WContr = 0.378  0.021, p<0.0001 Fig-
ure 3.3B). Inhibition of canonical TGF signaling via the TGF type 1 receptor
Alk5 (2.6 M SB431542 [54]) blocked the increase in cushion stiffness (WT+TI =
0.245  0.043 Figure 3.3B). The Alk5 inhibitor alone had no effect on cushion
biomechanics. TGF3 treated cushions compacted less than controls, with com-
paction quantified as the ratio of cross-sectional area before and after treatment
(A/A0 = 0.925  0.028 vs. A/A0 = 0.508  0.017, p<0.0001 Figure 3.4A). This
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Figure 3.3: TGF3 treatment increases stiffness of AV cushions through
Alk5mediated pathway. A) Representative pipette test data for
TGF3 (1ng/ml, TGF3+) and control media (TGF3-) treated
cushions, n = 4. Strain energy density was calculated from
the shaded regions beneath the P vs  curves. Inset: image
of aspirated HH25 AV cushion after 24 hours of culture. The
pipette radius, rp, and the aspirated length, L are indicated.
Scale bar = 70 m. B) AV cushion strain energy density in-
creased with TGF3 treatment, but was blocked by Alk5 inhi-
bition (SB431542, 2.6 M). mean  SEM, n  7, *p < 0.0001,
2-way ANOVA.
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Figure 3.4: TGF3 treated cushions compact less than controls, but are un-
der more residual tension. A) Bar graph of area ratios calcu-
lated from before and after images of 24 hour TGF3 treated
cushions. Representative cushion images shown, scale bar =
100 m. mean  SEM, n  12, *p < 0.0001, t-test B) Opening
angle of 24 hour TGF3 treated cushions is greater than con-
trol, indicating tissue is under greater residual tension. Inset
shows representative images with opening angle, . mean 
SEM, n = 10-11, *p < 0.001 t-test.
was unexpected because the Cytochalasin D (CytD, 1 M) results suggested
that compaction and stiffness are directly related. CytD inhibited cytoskele-
tal actin polymerization which resulted in a 5.3 fold decrease in strain energy
density of the AV cushions relative to control (WCytD = 0.072  0.016, Figure
53
3.5A). Without actin polymerization the AV cushion cells did not compact the
matrix, and the cushion did not remodel into the spherical configuration ob-
served in all other treatments. Instead, the post treatment cushion area was
significantly larger than initial area, suggesting a relaxation of pre-treatment
actin forces (A/A0 = 1.60  0.03, Figure 3.5B). The TGF3 results of stiffness in-
crease with compaction decrease did not align with this trend. Alk5 inhibition
did return compaction behavior to control levels (A/A0 = 0.570  0.035 Fig-
ure 3.6), indicating that the stiffness and compaction results are both dependent
on activation of canonical TGF3 signaling. To better understand the relation-
ship between stiffness and compaction, cushion opening angles were quantified
to approximate difference in cell traction forces. The opening angle of TGF3
cushions was 1.29 fold larger than controls (74.6  2.0 vs. 57.7 1.4, p<0.001
Figure 3.4B), indicating that TGF3 treated cushions did indeed have higher cell
traction forces. Together, these results demonstrate that TGF3 induces cushion
stiffening through Alk5, but with a concurrent reduction in tissue compaction
that suggests other processes are also affected.
TGF3 increases AV cushion proliferation and mesenchymal phenotype
Contractile phenotype markers SMA and RhoA were significantly upreg-
ulated with TGF3 treatment, 5.3  0.4 and 2.1  0.3 fold ( SEM) respec-
tively (Figure 3.7), suggesting that TGF3 induced residual tension is par-
tially due to an increased migratory/contractile phenotype of resident cushion
mesenchyme. TGF3 treatment also upregulated mRNA expression of col12
mRNA (3.8  0.9, p<0.05) and cyclin b2 (3.9  0.7 fold, p< 0.05), indicative of
increased collagen I synthesis and cell proliferation, respectively. BrdU incor-
poration confirmed that TGF3 increased cushion cell proliferation 2.26  0.36
54
Figure 3.5: Compaction related stiffness control. A) Molecular inhibition
of actin polymerization (Cytochalasin D, 1 M) caused an 80-
85% reduction in effective modulus. mean  SEM, n  6
*p<0.0001, t-test B) Cushion area increased with actin inhibi-
tion, resulting in a 3 fold decrease in measured compaction
compared to control. Insets: Representative images of AV cush-
ions before and after treatment, scale bar = 100 m. mean 
SEM, n  12, *p<0.0001, t-test
fold over controls (p<0.0001, Figure 3.8). Collectively, these results strongly
suggest that while TGF3 treated AV cushion mesenchyme are more migrato-
ry/contractile, concomitant increases in cell proliferation and matrix synthesis
work to counteract aggregate matrix compaction. This explains how the TGF3
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Figure 3.6: TGF3 induced decrease in compaction was blocked through
inhibition of Alk 5 (SB431542, 2.6 M) or 5-HTR2b (SD204741
35 M, anti-5-HT2b). Neither 5-HTR2a inhibitor (MDL100907
10 nM, anti-5-HT2a) nor serotonin transporter inhibitor (Fluox-
etine 10 M, anti-SERT) affected TGF3 compaction behavior.
mean  SEM, n  7, *p<0.05, t-test with respect to untreated
controls.
treated cushions are biomechanically stiffer, but appear minimally compacted.
Furthermore, TGF3 treatment increased TGF3 transcription (2.2  0.6 fold,
p< 0.05), indicating a potential positive feedback loop for TGF3 control of AV
cushion biomechanical remodeling.
5-HT potentiates TGF3 signaling through 5-HT2b receptor
The effect of 5-HT dose on biomechanical remodeling, independently and in
combination with TGF3, was systematically evaluated through the stiffness
and compaction metrics of the AV cushion organ culture system. 5-HT ad-
ministration by itself had no statistically significant effect on cushion stiffness.
Combined treatment of TGF3 with physiological 5-HT (470 nM) increased AV
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Figure 3.7: 24 hour TGF3 treated cushions upregulate contractile (SMA,
RhoA), proliferation (cyclin b), and extracellular matrix pro-
tein (col12) encoding genes. TGF3 administration also sig-
nificantly stimulated its own production. mean  SEM, n=3-4
pooled samples of 8-10 cushions, *p < 0.05, t-test
cushion stiffness (WT+5 HT = 1.136  0.035), but high 5-HT dose (5-HT+ = 47
M) eliminated any TGF3 induced stiffening effect (WT+5 HT+ = 0.457 0.025,
Figure 3.9). Neither selective inhibition of the 5-HT2a (MDL100907 10 nM), 5-
HT2b (SB204741 2.6 M) receptors, or the serotonin transporter SERT (Floux-
etine 10 M) alone affected cushion stiffness (Figure 3.9). Yet in combination
with TGF3, the anti-5-HT2b treatment completely blocked TGF3 dependent
stiffness and compaction behavior (Figure 3.9 and Figure 3.6). Inhibition of the
5-HT2a receptor or SERT had no measurable effect on TGF3 induced cushion
biomechanics. The compaction and stiffness changes induced by 5-HT poten-
tiated TGF3 followed the same trend of TGF3 treatment alone, with com-
paction decreasing as stiffness increased and vice versa (Figure 3.9 and Figure
3.6). The additional stiffening effect of 5-HT with TGF3 was also eliminated
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Figure 3.8: BrdU incorporation data (red) of TGF3 treated cushions nor-
malized to DRAQ5 cell nuclei counter stain (blue). BrdU was
administered 6 hours prior to completion of 24 hour treatment.
Representative confocal images are shown above each bar, with
a global view of cushion contained in the inset. mean  SEM,
n = 12, *p< 0.0001, t-test
with Alk5 inhibition, as shown through the combined treatment of TGF3 +
5-HT + anti-Alk5 in Figure 3.10. This combined treatment generated a strain
energy density similar to the TGF3 + anti-Alk5 treatment (0.209  0.023 Pa vs
0.245 0.16 Pa, respectively), and further supported that the effects of 5-HT sig-
naling on AV valve remodeling is dependent on canonical TGF signaling. To-
gether, these findings suggest that exogenous 5-HT acts through the 5-HT2b re-
ceptor to augment or impair TGF3 induced cushion stiffening and compaction
in a dose dependent manner.
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Figure 3.9: 5-HT signaling modulates TGF3 induced AV cushion stiff-
ness. Physiological dosages of 5-HT (470 nM, 5-HT) exac-
erbated TGF3 stiffening, while elevated dosages (47 M, 5-
HT+) eliminated it. Molecular inhibition of the 5-HT2a recep-
tor (MDL100907 10 nM, anti-5-HT2a) and the serotonin trans-
porter (Fluoxetine 10 M, anti-SERT) did not affect TGF3 me-
diated biomechanical stiffening. Inhibition of the 5-HT2b re-
ceptor (SB204741 35 M, anti-5-HT2b) however eliminated the
stiffening effect of TGF3. mean  SEM, n  6, *p < 0.0001
t-test relative to control, # p < 0.05 2-way ANOVA with Tukey
post-hoc test.
5-HT modulates TGF3 regulation of AV cushion mesenchyme phenotype
Exogenous 5-HT administration potentiated remodeling relevant gene ex-
pression in organ cultured AV cushion mesenchyme. TGF3 mRNA transi-
tioned from 1.9  0.1 fold upregulation over controls at physiological 5-HT to
0.40 0.16 down regulation at high 5-HT dose (Figure 3.11A). The physiological
5-HT dose had no statistically significant effect on SMA, col12, cyclin b2, and
RhoA expression. In contrast, high 5-HT significantly decreased transcription
of SMA (0.18  0.09), collagen12 (0.22  0.07), and RhoA (0.46  0.11 Figure
3.11A). No effect on cyclin b2 expression was observed at either dose, suggest-
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Figure 3.10: TGF3 and 5-HT stiffness generation is dependent on Alk5
signaling pathway. Strain energy density (Pa) of cushions
treated with TGF3 (1ng/ml) only, TGF3 + Alk5 inhibitor
(SB431542, 2.6 M anti-Alk5), TGF3 + 5-HT (470 nM), and
TGF3 + 5-HT + anti-Alk5. mean  SEM, n  8, Different
letter pairings denotes statistically significant p <0.05, 2-way
ANOVA.
ing proliferation was not directly regulated by 5-HT. Physiological 5-HT did
not affect TGF3 induced gene expression (Figure 3.11B), but high dose 5-HT
markedly reduced gene expression of TGF3 (0.86  0.20 vs. 2.2  0.6), SMA
(1.4  0.4 vs. 5.3  0.4), collagen12 (1.3  0.3 vs. 3.8  0.9), and RhoA (1.3
 0.2 vs. 2.1  0.3) (Figure 3.11B). Proliferation related gene cyclin b2 was not
significantly affected by 5-HT in combination with TGF3. These results sug-
gest that exogenous 5-HT potentiates TGF3 more likely through interaction
with upstream activation points and/or TGF3 synthesis, rather than interact-
ing with TGF3 downstream targets, such as SMA, RhoA, or col1, directly.
We also analyzed the mRNA expression of intracellular 5-HT (i5-HT) related
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Figure 3.11: 5-HT treatment modulates TGF3 mediated gene expression.
A) TGF3 mRNA transcripts increase with physiological 5-
HT (470 nM, 5-HT), but decrease at high dose (47 M, 5-HT+).
SMA, RhoA, and col12, were not affected by physiological
5-HT dose, but were significantly down regulated with high
5-HT treatment. B) High 5-HT treatment mitigates exogenous
TGF3 induced contractile gene expression, while TGF3 in-
duced proliferation was independent of 5-HT dose. mean 
SEM, n = 3-5 pooled samples of 8-10 cushions, *p< 0.05 via
ANOVA comparisons with controls.
genes transglutanminase 2 (TGM2) and the serotonin transporter (SERT). i5-HT
transamidates small GTPases andmatrix proteins, in a process called ”serotony-
lation” [187]. Tranglutaminase 2 (TGM2) is a i5-HT binding partner which as-
sists transamidation of RhoA [70] and fibronectin [113], altering tissue mechan-
61
ics through GTPase activation and matrix protein cross-linking, respectively.
SERT mRNA expression was significantly increased with 5-HT treatment (1.5
0.2 fold, P<0.05), but was downregulated with the 5-HT+ dose (0.46 0.12 fold,
Figure 3.12). TGF3 treatment stimulated a 4.0  1.0 fold increase in TGM2,
but SERT transcription remained near control levels (0.70  0.11 Figure 3.12B).
Addition of 5-HT with TGF3 significantly decreased SERT and TGM2 mRNA,
regardless of 5-HT dose. Though TGF3 treatment did upregulate TGM2, the
down regulation of SERT by 5-HT treatment and the lack of mechanical changes
seen with the SERT inhibitor suggest that serotonylation is not a primary mech-
anism of stiffness increase in the ex vivo culture remodeling results.
Elevated 5-HT induces atrioventricular valvuloseptal defects in ovo
As the effects of TGF signaling on valve formation are well studied
[14, 11, 181], we here test whether exogenous 5-HT administration in ovo alters
valve morphogenesis. 5-HT administration in ovo at HH17 induced a spectrum
of cardiac defects by HH36 (Day 10) as summarized in Table 3.2. Temporal
and dosage dependant viability curves (Figure 3.13) showed that 0.7mg dose
was over 50% lethal at HH36, but administration of the same dose of 5-HT at
HH25 or HH31 did not result in further lethality or defect formation (data not
shown). The only gross malformations observed were localized to the heart and
chest wall. Approximately 42% (24/57) of affected embryos exhibited an ectopic
heart which protruded through an incomplete chest wall closure (Figure 3.13).
To confirm that interior defects resulted specifically from 5-HT exposure and
not secondarily from the ectopia, an experimental thoracotomy was performed
to model the ectopic condition. We found no statistically significant occurrence
of any cardiac defects with experimental ectopia, supporting that 5-HT was re-
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Figure 3.12: Intracellular 5-HT uptake is modulated by 5-HT dose. A) 5-
HT transporter (SERT) gene expression was downregulated
via high 5-HT (47 M, 5-HT+) dose, while transglutaminase
2 (TGM2) was not affected. Physiological dose of 5-HT (470
nM, 5-HT) had no effect on either SERT or TGM2 gene expres-
sion. B) TGF3 (1ng/ml) stimulated 4-fold increase in TGM2,
which was mitigated by either doses of 5-HT. TGF3 had no
effect on SERT expression. mean  SEM, n = 3-4, *p<0.05,
t-test.
sponsible for the cardiac defects observed. A ventricular septal defect (VSD or
SVSD) occurred in 42% (24/57) of the defective embryos. Approximately 18%
(10/57) of the embryos exhibited double outlet right ventricle (DORV) defects.
5-HT administration also resulted in significantly enlarged atria with thinned
walls in 35% (20/57) of the defective embryos (Table 3.2, Figure 3.15A). All of
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Table 3.2: Cardiac Defect Summary of in ovo 5-HT Administration
Control Serotonin Thoracotomy
# of embryos treated (HH17) 35 133 107
# of embryos survived (HH36) 34 60 49
# of defective embryos (HH36) 0 57* 27
Ectopic - 24* 25*
VSD - 5 -
SVSD - 19* 1
DILV - 3 -
DOLV - 1 -
DORV - 10* -
Enlarged Atria - 20* 3
the embryos with DORV also exhibited highly stenotic or atretic atrioventric-
ular (AV) valves (Figure 3.15B), with the normally muscular flap valve in the
right AV canal appearing thin and fibrous like the left AV valve. Regardless of
gross cardiac defect identified, the average (0.144  0.009 mm, mean  SEM)
and minimal (0.080  0.007 mm) thickness of the left AV septal leaflet was thin-
ner in 5-HT treated embryos than controls (0.191  0.009 and 0.165  0.023 mm
respectively, Figure 3.15C). No differences were found in mural leaflet thick-
ness, or in the length of either leaflet. The reduction in AV valve thickness with
5-HT treatment indicated an increase in tissue compaction, and may possibly be
a recapitulation of the migratory/contractile phenotype observed ex vivo.
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Figure 3.13: Plot of avian embryo viability as a function of time and 5-HT
dose. 5-HT administration to the surface of HH17 chick em-
bryos resulted in greater than 70% lethality at dosages above
0.75 mg. The majority of deaths occurred within 48 hours of
incubation. Doses of 0.5 mg and below were over 80% viable
with virtually no morphological defects. Doses administered
at later incubation times (Day 5, Day 7) did not result in lethal-
ity or defects by HH36 (data not shown). 5-HT administration
at the predicted 50% lethality dose (0.7 mg/100 l) resulted in
55% lethality by Day 10.
Exogenous 5-HT increases AV cushion stiffness through TGF signaling in
ovo
Systemic 5-HT treatment at HH17 resulted in a statistically significant 1.4 
0.2 fold increase in AV cushion stiffness over control at stage HH25 (strain en-
ergy density of 0.43  0.06 Pa vs. 0.31  0.03 Pa, *p<0.05, Figure 3.16). We next
analyzed the mesenchymal gene expression patterns in this in ovo system. 5-HT
significantly upregulated TGF3 (1.7 0.1), SMA (1.5 0.1), col12 (1.5 0.1),
cyclin b (1.6  0.2), and RhoA (1.7  0.2) (*p<0.05, Figure 3.17). Interestingly,
the TGF3 mRNA expression was comparable to that observed in the ex ovo or-
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Figure 3.14: Representative image of ectopic heart (arrow) and unclosed
chest (dashed line) observed with both 5-HT treatment and
thoracotomy sham controls.
gan culture treatment of TGF3 alone (2.2  0.6), 5-HT alone (1.9  0.1), and
TGF3 + 5-HT (2.0  0.3). SMA and col12 mRNA were also upregulated in
ovowith 5-HT, but less than with direct TGF3 administration in ex vivo culture
(SMA - 1.5 vs 5.7, RhoA - 1.7 vs 2.1). The similar mRNA profiles of the candi-
date genes in both models suggested that 5-HT also potentiates TGF signaling
in AV cushions in ovo. To confirm that the 5-HT treatment was indeed modulat-
ing TGF signaling activity in ovo, we quantified nuclear pSmad2/3 expression
in HH25 cushions with and without 5-HT treatment (Figure 3.18). 5-HT treat-
ment increased the number of cell nuclei with localized pSmad2/3 expression
2.6  0.8 fold over control embryos (0.28  0.04 vs. 0.11  0.03, p<0.01). To-
gether these results demonstrate that 5-HT potentiates TGF signaling in AV
cushions to control contractile differentiation, proliferation, and biomechanical
remodeling.
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Figure 3.15: 5-HT administration in ovo induces cardiac defects. A) Rep-
resentative virtual sections of control, 5-HT treated, and tho-
racotomy sham control hearts at HH36 via Endopainting and
confocal microscopy. B) Representative Movat’s pentachrome
stained sections of hearts with the same conditions. Promi-
nent cardiac defects, including enlarged atria (EA) and ven-
tricular septal defect (VSD), were associated with malformed
and malfunctioning AV valves (arrows). 25x, scale bar = 500
m. C) Left septal leaflet average thickness and minimum
thickness are both statistically thinner in 5-HT treated leaflets
than control. mean  SEM, n = 3-6 hearts per treatment,
*p<0.05, t-test.
3.4 Discussion
In this study we implemented a quantitative organ culture assay that simul-
taneously interrogated the contributions of cellular and molecular signaling to
drive cushion tissue-level remodeling and biomechanical strengthening. TGF3
stimulated a 2.5 fold increase in biomechanical stiffness (Figure 3.3), generated
in part by an increase in cell traction. This contractile phenotype is a common
outcome of TGF signaling in postnatal valve tissue. For instance, porcine aor-
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Figure 3.16: Exogenous 5-HT increases AV cushion stiffness. The strain
energy density (Pa) of HH25 cushions increased 1.4 fold with
systemic 5-HT treatment in ovo, mean  SEM, n = 8-10 cush-
ion, *p < 0.05, t-test.
tic valves express contractile marker SMA when stimulated by TGF1 in situ
[121]. Porcine aortic valve interstitial cells (VICs) embedded in collagen gels
expressed SMA in response to TGF1, and demonstrated significant gel com-
paction over untreated gels [185]. Similarly, TGF3 treated embryonic AV pro-
genitors compacted collagen gels to 10% of initial area [31]. Yet in contrast to
these reports, TGF3 induced contractility did not result in hyper-compacted
AV cushions (Figure 3.4), but instead compacted less than controls. A key dis-
tinction between these two assays is that in vitro collagen gel cultures havemuch
lower cell densities than our ex vivo system. The effect of proliferation on vol-
ume change is virtually undetectable in these gels, and cell traction dominates
the compaction behavior. In native tissues, especially in the embryo, changes
in cell proliferation and/or apoptosis have a significant impact on resulting tis-
sue volume and apparent compaction. Ex ovo culture of AV cushions enables
precise control of the biochemical environment while maintaining the natural
structural and cellular composition of the cushion. The lack of compaction with
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Figure 3.17: Exogenous 5-HT increases AV cushion TGF related remod-
eling genes in ovo. Gene expression levels of HH25 AV cush-
ions isolated from embryos treated with 5-HT at HH17 (48
hours). mean  SEM, n= 6-10 samples, each of 8-10 pooled
HH25 cushions, *p<0.05, t-test.
TGF3 treatment is therefore most likely due to a counterbalancing from in-
creases in cell proliferation and ECM synthesis. This supports a mechanism of
simultaneous tissue growth, matrix reorganization, and biomechanical stiffen-
ing during embryonic valve formation that is driven by a complex coordination
of cell tractions, matrix synthesis, and cell proliferation. These findings under-
score that embryonic valve tissue biomechanical remodeling, which is critical
for proper valve function, cannot be inferred strictly from isolated compaction,
proliferation, or matrix synthesis data, but is best measured directly from an
integrated system.
The interplay of TGF3 and 5-HT signaling was most notably seen through
the potentiation of TGF3 gene expression by 5-HT dose (Figure 3.7). The physi-
ological 5-HT concentration upregulated TGF3 expression, while the high con-
centration down regulated expression. Upregulation of TGF expression by
5-HT has been observed in several cardiac cells and tissues, though through
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Figure 3.18: 5-HT increases AV cushion pSmad2/3 expression in ovo Em-
bryos treated with systemic 5-HT at HH17 have increased pS-
mad2/3 expression at HH25 indicating elevated TGF signal-
ing. n=6, mean  SEM *p<0.01, t-test. Arrows denote repre-
sentative cells with pSmad2/3 nuclear staining. Cell nuclei -
blue, pSmad2/3 - red
which molecular pathways is still unclear. Adult aortic valve interstitial cells
treated with 5-HT have increased TGF1 activity, predominantly through the 5-
HT2a receptor [86, 189]. Neo-natal rat cardiac fibroblasts treated with 5-HT and
5-HT2a agonists upregulated SMA protein expression, a marker for fibroblast
differentiation and a gene induced by TGF signaling [190]. Similarly, TGF1
and SMA expression were elevated in SERT cre-lox KO mice hearts through
heightened 5-HT2a signaling in late embryonic stage mice, purportedly due to
excess 5-HT from SERT inhibition [139]. Other reports point to 5-HT2b as the
key mechanism. 5-HT administration in adult rats increased 5-HT2b mRNA
expression in both aortic and mitral valves, demonstrating a positive response
to 5-HT treatment[48]. SERT mRNA was down regulated in these valves de-
noting a negative response to elevated 5-HT, which our results also demon-
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strate (Figure 3.12B). The 5-HT2b receptor, TGF receptor type I and II, and the
TGF latent binding protein were all more expressed in canine myxomatous
mitral valves than normal valves, suggesting a coupling of these two pathways
through 5-HT2b [44]. Longterm 5-HT treatment of rats generated valve related
echocardiographic and histology defects [72], but these defects did not occur in
rats simultaneously treated with a 5-HT2b inhibitor [76]. This suggests that the
5-HT2b receptor may be a key pathway for cardiac and valve tissue remodeling.
Cardiac fibroblast studies indicate that the 5-HT upregulates TGF1 through a
mutual transactivation of the epidermal growth factor (EGF) and 5-HT2b path-
ways [84, 126]. Our results support a 5-HT2b dependant mechanism, as seen by
5-HT2b inhibition effectively blocking TGF?3 stiffening. The TGF stiffening ef-
fect was independent of 5-HT2a and SERT. Although TGF3 upregulated TGM2
expression, 5-HT treatment mitigated this expression, which suggests TGM2 ac-
tivity does not contribute to the enhanced stiffening of TGF/5-HT signaling.
High 5-HT also mitigated the TGF3 stiffening, though desensitization of the
5-HT2b receptor by a sustained high 5-HT dose may explain this effect. 5-HT
directly increased pSmad2/3 phosphorylation in cushion mesenchyme, and its
potentiating effect was abrogated through Alk5 blockade. This suggests that 5-
HT signaling through 5HT2b may interact with Smad2/3 signaling, but further
studies are warranted to clarify potential roles of other intermediate or down-
stream targets.
In our in ovo model, systemic 5-HT elevation induced severe heart defects,
including failure of the ventricular septum to close, ballooned atria, DORV, and
hyper-contracted AV valves. Variations of these defects have been observed in
other TGF and 5-HT related studies. VSDs are the most prevalent congenital
heart defects observed, occurring in approximately 50% of all clinical cardiac
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malformations [77, 151]. Selective serotonin uptake inhibitors (SSRI) taken dur-
ing the first trimester of pregnancy were associated with a statistical increase
in VSD prevalence in newborns [119]. Our data supports elevated extracellu-
lar 5-HT as a possible cause of this correlation. Removal of TGF secondary
messenger smad4 causes VSDs and other lethal congenital defects, which are
presumed to be consequence of decreased TGF signaling [146]. Yet removal
of TGF inhibitory messenger smad7 also generates VSDs [30], indicating that
exacerbated TGF signaling can also generate significant cardiac defects. The
dilated atria observed in our model are not explicitly reported in other 5-HT
studies, suggesting the defect may result from secondary effects, such as al-
tered hemodynamics from valve incompetence. For instance, enlarged atria de-
fects have been induced in zebrafish embryos through mechanical obstruction
of the AV canal [79]. Our avian model exhibited a small (18%), but statistically
significant, penetrance of DORV, which is a predominant congenital defect in
TGF2 KO mice (87% penetrance) [14]. Collectively these defects highlight the
morphogenetic potential of 5-HT in early cardiac development, and the similar
spectrum of defects generated across 5-HT and TGF related animal models.
An interaction of TGF and 5-HT signaling was observed in ovo through the
upregulation of TGF3 and contractile genes in the AV cushions (Figure 3.17),
the increase in pSmad2/3 expression (Figure 3.18), and the resulting thinned
valve morphology (Figure 3.15C). While the pSmad2/3 and mRNA expression
confirms that aspects of the ex vivo results occur in ovo, it is unclear whether
elevated TGF signaling at HH25 is solely responsible for the thinned valve
morphology observed at HH36. Hyperplastic and thickened AV valves occur in
TGF2 KO (31% penetrance) [14, 10], and TGF latent binding protein KO (81%
penetrance) [181] animals, which supports this hypothesis. However, adult rats
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treated with subcutaneous 5-HT injections for 7 days developed thickened AV
valves rich in GAGs [48], while 3 month treatment increased valve thickness,
but consisted primarily of collagen [72]. Thickened, collagen rich valves are
also reported in adult SERT KO mice [118], and at late embryonic stage SERT
KO pups [139]. Together these results indicate that elevated 5-HT signaling
can instigate valvular remodeling in vivo, but changes in valve microstructure
and morphology are clearly dependent on other factors such as treatment du-
ration, specimen age, or secondary effects from accompanying congenital mal-
formations. Altered hemodynamic loading can also generate defects, as evi-
denced through the serious malformations stimulated by mechanical pertur-
bation [192, 164]. Yet hemodynamic loading is simultaneously a consequence
and stimulant of molecular signaling, interacting in a cyclical rather than linear
cause-effect manner. This again emphasizes the importance of direct assess-
ment of mechanical stiffness, because it can distinguish the influence of these
microstructure and microenvironment variations on valve performance.
Embryonic valve formation and maturation utilizes multiple TGF isoforms
in spatially and temporally restricted ways that are also somewhat different
between species [29, 11]. We chose to focus on TGF3 over either TGF1 or
TGF2 because of its principal role in cell invasion during chick cushion EMT
[29], and confirmed increase in expression during post-EMT [31]. Our results
establish a molecular mechanism for short-term (24 hours) TGF3 stimulation
on AV cushion biomechanical remodeling, but the effects of prolonged signal-
ing on biomechanical and morphological changes remain unclear. This could
be addressed with a combined in vivo/in vitro experimentation over more time
points using a system like the approach presented here. The ex vivo culture sys-
tem contains both endocardial and mesenchymal cells, but lack of antibodies
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reactive in chick prohibited the determination of cell specific responses. Our
in ovo exogenous 5-HT administration model data complements existing data
on genetic mutant animal models of TGF and 5-HT related signaling in car-
diac development [14, 130]. Future studies will need to investigate whether the
serotonin effects of TGF3 change with TGF3 dose.
In conclusion, tissue mechanics, cell phenotype, and molecular signaling
all simultaneously direct and control tissue morphogenesis. Our results sug-
gest that TGF is a potent stimulator of cushion stiffening, and 5-HT is a key
regulator of this stimulating effect. Connecting signaling networks with cell
and tissue level responses will become increasingly important for understand-
ing post-EMT valve remodeling and potentially other embryonic remodeling
events. The quantitative experimental systems presented herein are an attrac-
tive approach for elucidating these multi-scale mechanisms and their down-
stream consequences.
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CHAPTER 4
AMODEL OF MECHANICALLY STIMULATED GROWTH AND SHAPE
CHANGE
4.1 Introduction
Embryonic development is characterized by rapid transitions in tissue size,
function, and morphology. Examples of this in heart development include the
folding of the heart tube into four chambers [115] and the elongation and con-
densation of the atrioventricular valve leaflets [94]. Experimental studies have
demonstrated that abnormal mechanical loading in the early heart can gener-
ate defects. As examples, the ligation of the left atrium of a chick embryo re-
sulted in reduced blood flow and a decrease in left ventricle volume [164], and
obstruction of blood flow in a zebrafish embryo generated enlarged atrias and
impaired valves [79]. Even in less mechanically robust environments, such as
neural tube formation [131] or torsion of the early cardiac tube [188], residual
stresses develop that are essential for proper formation. These examples em-
phasize the need for mathematical frameworks in which to connect mechanical
loading with changes in tissue size, shape, and function during embryogenesis.
Development of biological tissue may be divided into three categories:
mass addition (“growth”), material property change (“remodeling”), and shape
change (“morphogenesis”) [172]. Growth involves the cellular processes of
extra-cellular matrix production, cell proliferation, and cell enlargement. In
these processes, mass is converted and redistributed in and by the cells. Sources
of mass include soluble factors, such as those present in the blood stream or cell
culture media, or assembled protein structures, such as glycoaminoglycan or
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collagen networks from neighboring tissues. Growing systems are generally
modeled as open, at least with respect to mass, because the origin of the incom-
ing mass is external to the mechanical element(s) being modeled [114, 49, 62].
Remodeling broadly includes a change in material properties, such as stiffness,
anisotropy, constituent volume fractions, and/or chemical reactivity. Rarely
does remodeling occur in the absence of mass addition or shape change. We do
not consider remodeling in this study, but instead focus on growth and shape
change using a single constituent model.
Morphogenesis is the dynamic process in which embryonic tissues form,
change shape, and mature into functional organs. Kinematic descriptions of
morphogenesis as a mapping of material points have been considered in re-
search on plant growth [152, 166]. In the context of bone remodeling, Cowin
and Van Buskirk introduced a mechanically driven, small strain, surface growth
model that related the normal velocity of the bone surface to the difference in
current and referential strain experienced by the tissue [36]. Skalak and others
formalized finite strain growth using a velocity field description, and consider-
ated of both volumetric and surface additions [168]. Rodriguez and others [154]
extended this work with a multiplicative decomposition of the deformation gra-
dient into inelastic and elastic components, borrowing ideas frommetal plastic-
ity [101]. In their approach, tissue growth and shape change occurs through
a stress free evolution of the reference configuration, which is defined by the
inelastic deformation. With this decomposition, growth and shape change are
prescribed through evolution equations for the inelastic deformation. Here, we
use the multiplicative decomposition to derive evolution equations for growth
and shape change.
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The determination of the appropriate form of the evolution equations for
growth and shape change has been the focus of recent research [114, 49, 41,
6, 62]. With limited experimental data available, research has employed ther-
modynamic arguments from the entropy inequality or a dissipation principle to
motivate appropriate forms of the evolution equations. Regardless of the means
used to satisfy the inequality, such as the assumption of maximal dissipation
[148, 61], or the introduction of a quadratic form for the dissipative parts, it is
necessary to consider the influence mass addition has on the thermodynamics.
For example, does new mass enter with mechanical energy equal to the energy
at that material point, with no mechanical energy (stress-free), or with an in-
termediate, constituent-specific energy? External sources of mass or entropy
associated with the incoming mass are sometimes neglected [41, 64]. In this
paper, we evaluate how these different assumptions influence the evolution.
Various assumptions have been made regarding the mechanical stimuli of
growth and shape change, including strain [75, 36], stress [60, 154], and strain
energy [74]. Experimental evidence suggests that certain plants and embryos
maintain a target, or homeostatic, stress state [17, 15]. At the homeostatic stress
state, growth and shape change do not occur. Evidence for a homeostatic stress
is also seen in arteries, where the residual stress distribution promotes a uniform
stress field through the artery wall when fully loaded [33]. This uniformity
suggests the existence of an inherent mechanical loading preferred by the tissue.
We assume the existence of a homeostatic stress state and incorporate it into the
evolution equations through an expression for the balance of biochemical forces
[42, 41].
Shear forces are a significant part of the mechanical environment in cer-
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tain instances of development. In particular, blood flow through the primitive
heart generates significant wall shear stress on the valve and vascular struc-
tures [191, 18, 79]. Experiments suggest that these shear forces are important for
activating biochemical cascades within the cell that drive the production and
rearrangement of extra-cellular matrix proteins, proliferation, cell contraction,
and other mechanically relevant processes [69]. While previous growth mod-
els have the capacity to evolve in shear [150, 6], examples of growth and shape
change under shear loading are limited. We present some simple examples to
demonstrate the shearing behavior of the model tissue.
4.2 Kinematics
Consider a stress-free body in the reference configuration at t = 0, denoted as
the initial configuration 0 in Fig. 4.1. The body undergoes a combined elastic-
inelastic deformation from the initial to current configuration  defined by the
mapping x = x(X; t). The observable deformation,
F =
dx
dX
(4.2.1)
includes elastic and inelastic deformations. We assume F may be expressed
as a multiplicative decomposition (Eq. 5.2.1) of the elastic, f , and inelastic, F ,
deformation:
F = fF : (4.2.2)
The multiplicative decomposition was introduced in the study of biological
growth by Rodriguez et al [154]. The advantage of this decomposition is that
it provides access, at least mathematically, to the inelastic deformation. Growth
and shape change due to biological processes may be prescibed in terms of, F ,
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Figure 4.1: Multiplicative decomposition of the overall deformation into
inelastc and elastic components
or by defining the inelastic deformation rate,
L = _FF 1; (4.2.3)
where a dot denotes the derivative with respect to time, t, at a fixed point in the
initial configuration. Although the ultility of this decomposition is generally
accepted [5], there exist a few issues worth mentioning. First, the decompo-
sition is not unique [114]. Any rigid body rotation of the stress-free, relaxed
configuration is permissible, as this will not contribute any stress. To avoid this
issue, we assume the initial configuration is known, and we incrementally up-
date the relaxed configuration relative to it through integration of the inelastic
deformation rate. The rotational component of F is, therefore, always known
and is unique to the specific evolution being modeled. Second, material points
are being added and/or removed from the initial configuration throughout the
evolution. How does this mass enter? At what density should it be added?
Here, we assume that density is constant; in this case mass addition is equal
to volume change. Finally, it is not clear whether the multiplicative decom-
position accurately describes how elastic and inelastic deformations interact.
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Previous research has demonstrated the ability of the decomposition to cap-
ture the shape and volume change of developing tissues [154, 175, 150]. How-
ever,includingmore biological features could provide better mechanistic insight
into how growth occurs. We will explore ways to incorporate such details in the
inelastic deformation rate in Section 4.5.
Inhomogeneous growth can produce incompatibilities. Incompatibilities are
isolated elements of growth or shape change which do not fit together in a
stress-free configuration [169]. An example of this is differential expansion
between two elements. In this case, both elements occupy the same space in
the stress-free configuration, resulting in a displacement field from the original
configuration to the relaxed configuration that is no longer one-to-one. Con-
sequently, the elastic deformation is also incompatible in this case in order
to maintain the compatibility of the total deformation. This compensation by
the elastic deformation gives rise to growth-induced residual stresses. Residial
stresses occur in several developing tissues [188, 194].
In the special case when growth is compatible the inelastic deformation may
be defined as the gradient of a growth displacement, , with respect to the
initial position, specifically,
F = d
dX
; (4.2.4)
or, in indicial notation as
FA = ;A :
In this decomposition, the elastic deformation is influenced by two mecha-
nisms, 1) the total, observable deformation, F , and 2) the evolution of the refer-
ence configuration due to inelastic deformation, F . In a compatible growth sit-
uation, the primative quantities would be the observable displacement, xi, and
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the inelastic displacement, . However, in general the inelastic deformation,
not the displacement, will be the primitive quantity that defines the growth and
shape change of the tissue. This distinction will be important for the variational
calculation of Section 4.4.
From this decomposition, the deformation rates are related as follows,
Lik = lik + fiLf 1k ; (4.2.5)
where L = _FF 1, l = _ff 1, and L = _FF 1. The overall deformation rate, L
may be separated into the symmetric stretching tensor,
D = d+
1
2

fLf 1 + f TLTfT 
and the skew-symmetric spin tensor,
W = w +
1
2

fLf 1   f TLTfT  :
The varibles d and w are, similarly, the symmetric and skew-symmetric parts
of l. The product of the inelastic determinant, J = det(F), and the elastic
determinant, j = det(f) equals the overall volume change. That is,
det(F ) = det (f) det (F) ; (4.2.6)
or,
J = j J : (4.2.7)
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4.3 Field Equations
4.3.1 Conservation of Mass
In a growing system, the amount of mass present in the tissue depends on the
time of the evolution. The calculation of mass density is further dependent of
a choice of volume. Following the notation of Lubarda and Hoger [114], we
define three measures of density:
0 =
dm0
dV
; (4.3.1a)
 =
dm
dv
; (4.3.1b)
and,
g =
dm
dV
= J ; (4.3.1c)
where Eq. 4.3.1a gives the density of initial mass per initial volume, Eq. 4.3.1b
gives current mass per current volume, and Eq. 4.3.1c gives the current mass
per initial volume.
We express the mass balance in an integral form over the initial volume, V ,
d
dt
Z
V
g dV =
Z
V
J dV ; (4.3.2)
where  is the rate of mass addition per unit current mass. In local form, this
reduces to
_g = _(J) = J ;
which, upon carrying out the differentiation becomes,
_+ dkk + D =  ; (4.3.3)
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where d andD are the symmetric parts of the elastic and inelastic deformation
rates defined in Section 4.2. All mass enters through the inelastic deformation,
therefore, D = . This reduces the continuity equation to,
_+  dkk = 0 : (4.3.4)
We further assume that the elastic deformation is isochoric (j = 1 and dkk = 0),
which simplifies Eq. 4.3.4 to,
_ = 0 :
Hence, the ratio of current mass to current volume remains constant and equal
to the ratio of initial mass to initial volume. In this case,
 = 0  const ;
and the new mass enters the tissue with the same density as the original ma-
terial. Furthermore, with the elastic deformation incompressible, the total and
inelastic Jacobians are equal,
J = J ; ;
so
g = J = J : (4.3.5)
4.3.2 Conservation of Linear Momentum
The balance of linear momentum requires that the change in momemtum of a
body is equal the sum of external forces applied to it. In a growing system,
an additional external force term that balances the momentum of the incoming
mass is, in general, present. We express this balance law in an integral represen-
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tation over the initial configuration,
d
dt
Z
V
J _xi dV =
Z
V
J [bi +  _xi] dV +
Z
@V
TiANAdS0Z
V
J xi dV =
Z
V
TiA;A + J bi + J ( _xi   _xi)D dV ; (4.3.6)
where bi is the external body force per unit mass, TiA is the external surface
traction per unit area in the initial configuration,NA is the unit normal vector of
the reference configuration surface, xi is the displacement of the body,  is the
growth and remodeling displacement (see Section 4.2), and _xi is the velocity of
the incoming mass.
There is currently no experimental data on the velocity of the incomingmass.
To circumvent this, a common approach is to assume that the mass enters (or
leaves) with the same velocity of the body ( _xi = _xi) [114, 91]. Another approach
is to consider growth to be a quasi-static process; in this case, all of the dynamic
terms in the balance law are neglected [42]. These two approaches are effec-
tively equal. A third approach is to represent the momentum of the incoming
mass with a “reversible” and an “irreversible” term [49]. The reversible term
balances the momemtum of the new mass in the system, _xi = _xi as in the pre-
ceding approaches. The irreversible term is the momemtum associated with
other physical forces, potentially dissipative, involved in the growth process.
For example, if the velocity of the incoming mass differred from the current
velocity of the tissue, the momentum difference would be represented in this
irreversible term. Here, we assume that mass enters with the same velocity as
that of the body ( _xi = _xi). This is motivated by the difference in time scales be-
tween mechanical loading (seconds) and tissue growth (days), which suggests
that momentum due to growth does not significantly influence the balance of
linear momentum. In this way, the local form of Eq. 4.3.6 in the initial configu-
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ration reduces to
TiA;A + J bi = J xi : (4.3.7)
4.3.3 Conservation of Angular Momentum
Wenext evaluate the balance of angularmomentum. Aswith linearmomentum,
we introduce an external source of angular momentum to balance the change in
velocity of the mass entering the system. With this term, the balance law in
integral form over the initial volume becomes,
d
dt
Z
V
J ijk xj _xk dV =
Z
V
J ijk xj (bk +  _xk) dV +
Z
@V
ijk xj TkANAdS0 ;
(4.3.8)
where ijk is the permutation tensor. We again assume _x = _x. Appling the
divergence theorem to the surface terms,Z
V
J ijkxj

xk + _xk _D

dV =
Z
V
ijk xj (TkA;A + J bk +  _xk)+ijkxj;ATkA dV ;
and using Eq. 4.3.7, we arrive at the local form
ijkFjATkA = 0 : (4.3.9)
Eq. 4.3.9 requires that,
FjATkA = TkAFjA : (4.3.10)
4.3.4 Balance of Biochemical Forces
Themultiplicative decomposition of the deformation gradient facilitated the ex-
pression of growth and shape change as an inelastic deformation. Although the
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stress is not directly dependent on FA, this deformation represents the evolu-
tion of the reference for the elastic deformation, onwhich the stress does directly
depend. This evolution is fundamentally driven by the biochemical and/or cel-
lular forces of growth. Recently, Dicarlo and Quiligotti [42] proposed a bal-
ance of accretive forces to describe the relationship between these forces and
the tissue evolution. This provided a formal method in which to incorporate
biological details into the mechanics. Prior to this, Klisch et al. [91] equated the
stress-work of growth to the extra energy needed for growth using the energy
equation, but did not describe this relation as a balance law. Here, we include
the balance of biochemical forces as a balance law; and, then, demonstrate its
derivation from a variational principle.
We first state the balance of biochemical energy associatedwith the evolution
of the reference configuration in integral form over the initial configuration,Z
V
CL dV =
Z
V
BL dV ;
where we have borrowed the notation of Dicarlo and Quilligotti [42] for the in-
ternal growth and shape-change, symmetric couple, C , and the external bio-
chemical force couple, B . A consequence biochemical forces is homeostasis,
which is the propensity of a living system to maintain its physical environment.
For instance, when an artery is pressurized beyond the homeostatic pressure,
it will grow to mitigate the elevated loading [59]. Cells are responsible this
change in reference configuration, and their activity is regulated by biochemical
gradients. In the context of a growing tissue, a biological force could be the pro-
duction of extra-cellular matrix proteins. The synthesis of these proteins do not
elastically deform the tissue, but instead change the reference configuration of
the elastic deformation. Another example of a biochemical force is the inhibition
of actin polymerization through treatment with Cytochalasin D. Without actin,
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the cells can no longer exert forces on the extra-cellular matrix, which results
in its relaxation. Biochemical forces evolve the reference configuration, but do
not contribute momentum. We adopt a balance of biochemical forces in order to
include these biochemical effects [42, 41]. Assuming that Cauchy’s localization
principle applies to the biological process represented in the this balance law,
we arrive at the reference configuration local form
C   B = 0 : (4.3.11)
This algebraic formulation is identical with that employed by previous works
[42, 6, 41].
4.3.5 Balance of Energy
We now consider the balance of mechanical, thermal, and biochemical energy
for this system using a integral representation in the initial configuration. The
external work terms include work done by both the mechanical forces and bio-
chemical couples. As growth of a single phase is intrinsically an open system,
in that it is influenced by parts of the system that are not being modeled, the
energy balance includes the kinetic (1
2
_xi _xi) and internal energy (h) associated
with the mass entering the system:
d
dt
Z
V
J

1
2
_xi _xi + 

dV =
Z
V

J bi _xi + BL + r + J 

1
2
_xi _xi + h

dV
+
Z
@V
(TiA _xi   qA)NAdS0
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or, after applying the divergence theorem,Z
V
J

1
2
_xi _xi + 

D+J xi _xi + J _ dV =
Z
V
J bi _xi + BL + r   qA;A
+ J 

1
2
_xi _xi + h

+ (TiA _xi);A dV
=
Z
V
J bi _xi + BL + r   qA;A
+ J 

1
2
_xi _xi + h

+ TiA;A _xi + TiA _xi;A dV :
Upon grouping terms with corresponding velocities and assuming _xi = _xi, we
can solve for the internal energy rate:Z
V
J _ dV =
Z
V
TiA _xi;A + CL + JD + r   qA;A dV (4.3.12)
where we have used,
TiA;A + J bi   J xi = 0
C = B
D = k
and,
 = h    :
The local form of the rate of internal energy in reference configuration is, then,
J _ = TiA _xi;A + CL + JD + r   qA;A : (4.3.13)
In Eq.4.3.13, the current internal energy may differ from the internal energy
of the newly removed or deposited tissue ( 6= 0). This is motivated by
the extra-cellular matrix proteins, which are the predominant structural com-
ponents of tissue. Such proteins are initially secreted by cells as individual fiber
strands, which coil with other strands to form a mature collagen fiber. Even-
tually the protein is removed through an enzymatic degradation process. This
88
suggests that the internal energy from growth is unlikely to enter in with the
current energy. Also, by permitting different internal energies, we provide a
means to incorporate kinetic rates of turnover of newly acquired mass, such as
those proposed in mixture-theory approaches [82, 66].
4.4 Principle of Virtual Work
We now derive balances of linear momentum and biochemical forces through
the variation of the internal and external energy. Neglecting changes in thermal
energies, the first variation of the internal energy is,
Wint = 
Z
V
 J dV
=
Z
V
  J +  J dV ; (4.4.1)
where  =  is the free energy per unit current mass and V is the initial vol-
ume.
The variation of the total and inelastic deformation gradients are,
FiA = xi;A ; (4.4.2)
and,
FA = LFA : (4.4.3)
The external energy includes the work done by external forces on the ob-
servable displacements, xi and the external biochemical stress-work associated
with the evolution of the reference configuration, BL , where,
BL = BF 1AFA : (4.4.4)
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The variation of the external energy is,
Wext =
Z
V
Jbi xi + BF 1AFA dV +
Z
@V
TiA xiNA dS0 ; (4.4.5)
where bi is the body force per unit current mass, TiA is the physical stress applied
to the initial configuration surface, S0, which is defined by the normal vectorNA.
The variation of the internal energy is equivalent to the variation of the ex-
ternal energy.
Wint = Wext (4.4.6)
From incompressibility, the total and inelastic Jacobians are equal (J = J , Eq.
4.3.5), which requires that their variations are equivalent:
J = J ;
JF 1iA xi;A = JF 1A FA ;
and,
Jxi;i = JF 1AFA : (4.4.7)
The variation of the current density, , is zero. The variation of the internal
energy,  , is
  =   (fi)
=
@  
@fi

@fi
@FjA
xj;A +
@fi
@FA FA

=
@  
@FiA
xi;A +
@  
@FA FA : (4.4.8)
Using the above relations, we may now evaluate the internal and external vari-
ations. Note that we have replaced the total Jacobian with the inelastic Jacobian.Z
V
J @
 
@FiA
xi;A + J @
 
@FA FA +
 JF 1A FA dV
=
Z
V
Jbi xi + BF 1AFA dV +
Z
@V
TiA xiNA dS0 (4.4.9)
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The following identity facilitates the use of the divergence theorem.
@ 
@FiA
xi;A =

@ 
@FiA
xi

;A
 

@ 
@FiA

;A
xi (4.4.10)
We employ Eq. 4.4.10 in the internal energy variation on the left side of Eq. 4.4.9
and apply the divergence theorem.
Wint =
Z
V
 J

@  
@FiA

;A
xi + J @
 
@FA FA +
 JF 1A FA dV
+
Z
@V
J @
 
@FiA
xiNA dS0 (4.4.11)
Upon combining Eq. 4.4.11 and 4.4.9 and grouping terms associated with their
respective virtual displacments yields the balance laws and boundary condi-
tions as coefficients of the variations in the integrands:
0 =
Z
V
 J
"
@  
@FiA

;A
+ bi
#
xi dV (4.4.12)
+
Z
V

J @
 
@FB FB +
 J    B

FAF 1A dV (4.4.13)
+
Z
@V

J @
 
@FiA
  TiA

NA xi dS0 (4.4.14)
The first condition, Eq. 4.4.12, is the balance of momentum expressed in the
initial configuration, 
@  
@FiA

;A
+ bi = 0 : (4.4.15)
The second balance law, Eq. 4.4.13, is similar in form to the conservation of mo-
mentum, but, instead, represents the balance of biochemical forces associated
with the evolution of the relaxed configuration (Section 4.3.4),
J @
 
@FB FB +
 J    B = 0 (4.4.16)
Comparing Eq. 4.4.16 to the proposed biochemical balance law, Eq. 4.3.11, we
infer that in equilibrium,
C = J @
 
@FB FB +
 J  : (4.4.17)
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Evaluating the surface integrals in Eq. 4.4.14 results in:
TiA = J @
 
@FiA
: (4.4.18)
4.5 Entropy Inequality
We now consider the entropy inequality to determine an evolution equation for
the inelastic deformation. We recall that
 =    (4.5.1)
where  is the Helmholtz energy per unit mass,  is the internal energy per
unit mass,  is the absolute temperature, and  the entropy per unit mass. The
Helmholtz energy is a thermodynamic potential representing the extractable
work from a system. Taking the time derivative of Eq. 4.5.1 and solving for the
entropy rate yields Eq. 4.5.2.
_ =   _  1 + _ 1   _ 1 (4.5.2)
We now assume the Helmholtz free energy is a function of the constituitive
variables FiA;FA; ; ;A and D . ;A is the temperature gradient in the initial
configuration. D is the sym (L) = sym

_FAF 1A

which is an objective
quantity. The time derivative of  yields,
_ =
d
dt
[ (FiA;FA; ; ;A;D)]
=
@ 
@FiA
_xi;A +
@ 
@FA
_FA + @ 
@
_ +
@ 
@;A
_;A +
@ 
@D
_D (4.5.3)
The Clausius-Duhem entropy inequality in integral form is as follows,
d
dt
Z
V
J  dV  
Z
V
 1 r + J  h dV +
Z
@V
 1qANAdS0  0 ;
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or, after applying the divergence theorem,Z
V
J _   J _FAF 1A    1 r +
 
 1qA

;A
dV  0 :
where we have used,
 = h    (4.5.4)
We have added a source of entropy, h, which is associtated with the change of
mass in the system. In local form, the inequality reduces to,
J
h
_   _FAF 1A
i
   1 r +  1qA;A    2;A qA  0 (4.5.5)
where r and qA are volume and surface heat sources, respectively. We now insert
Eq. 4.3.13 into Eq. 4.5.5 and expand yielding,
J
h
  _ + _  _
i
  J  _FAF 1A + qA;A    1;AqA   r  0
 J _ + TiA _xi;A + C _FAF 1A + J  _FAF 1A   J _    1;AqA  0
where we have used,
 =    : (4.5.6)
Upon insertion of and Eq. 4.5.3 and grouping like terms, we arrive at the fol-
lowing:
 J @ 
@FiA
+ TiA

_xi;A +

CF 1A   J
@ 
@FA + J  F
 1
A

_FA
 J

@ 
@
+ 

_   J @ 
@;A
_;A   J @ 
@D
_D    1;AqA  0
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To ensure this inequality holds for all possible _xi;A; _; _;A and _D , we require
that,
J @ 
@FiA
= TiA ; (4.5.7)
@ 
@
=  ; (4.5.8)
@ 
@;A
= 0 ; (4.5.9)
@ 
@D = 0 : (4.5.10)
With these requirements, the remainder of the inequality,  , is,
  =

CF 1A   J
@ 
@FA + J  F
 1
A

_FA    1;AqA  0 : (4.5.11)
Notice that the difference in current and incoming Helmholtz free energy,  ,
appears in the remainder. We now phrase the entropy inequality in terms of the
elastic deformation constituitive variables using the following definitions.
 =  Pi =
@  
@fi
ij = Pifj 
@ 
@FA =  Pj fjF
 1
A
With these identities, the entropy remainder can alternatively be expressed as,
  =

CF 1A   J
@  
@FA + J  F
 1
A

_FA    1;AqA  0
[C + J fiPi + J  ]F 1A _FA    1;AqA  0
C + J fiijf 1j + J  
L    1;AqA  0
where L is the deformation rate of F as defined in Section 4.2. At thermody-
namic equilibrium   = 0, and the first partial derivatives of   also equal zero.
We define equilibrium as,
L = 0
;A = 0
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and evaluate thier first partial derivatives equal zero. First, the partial with
respect to the deformation rate, which yields:
@ 
@L

0
= 0
C0 + J fiijf 1j + J  = 0
C0 =  J
 
  + fiijf
 1
j

: (4.5.12)
Note that this is equivalent to the equilibrium result from the variational calcu-
lation when  h = 0 (see Eq. 4.4.17).
Then, taking the partial derivative with respect to the temperature gradient,
@ 
@;A

0
= 0
  1 q0A = 0
q0A = 0 : (4.5.13)
We now assume that C can be represented as the sum of its equilibrium, C0 ,
and dissipative parts, C0 ,
C = C0 + C
0
 (4.5.14)
We further assume a form of the dissipative stress to be
C0 = aL (4.5.15)
where a  0 and may depend on the independent constitutive variables. From
this we can now define an evolution equation for L through the balance of
biochemical forces (Eq. 4.3.11),
C   B = 0 (4.5.16)
Inserting Eq. 4.5.12 and Eq. 4.5.15 into Eq. 4.5.16, we determine a relation for
L .
 J    + fiijf 1j + aL + B = 0
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L = 1
a
J  fiijf 1j +    B (4.5.17)
We now define the homeostatic state as an external biochemical force,
B = J fiijf 1j
where ij is the homeostatic Cauchy stress in the current configuration. With
this assumed form, L reduces to a linear function that depends on the differ-
ence between current and homeostatic stress states.
L = 1
a
J fi  ij   ij f 1j +   (4.5.18)
The evolution equation proposed in Eq (4.5.18) represents a hybrid between
two accountings of the energy entering or leaving the system via mass addition
or subtraction. The incoming mass is often assumed to enter with the free en-
ergy of the current body, namely,  h =  [49, 114, 92]. This results in  = 0
in the Eq. (4.5.18) leaving only the Cauchy stress difference as the mechanism
of growth and shape change. Alternatively, others have not included an exter-
nal source term ( h = 0) [6, 42]. This assumes that the creation of new mass
reduces the rate of internal energy production by consuming energy from other
external sources, specifically the biochemical stress-work, C L . This results
in evolution equations that contain an Eshelby stress term (see Section 4.7),
E :=  I   fT 0 : (4.5.19)
The external biochemical force is then assumed to be a homeostatic Eshelby
tensor, E0 = B, creating a set of evolution equations which are driven by the
difference of two Eshelby tensors. The homeostatic Eshelby tensor, E0, is related
to the homeostatic Cauchy stress through the following relation,
E0 =     fiijf 1j (4.5.20)
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where   is the homeostatic free energy. We now evaluate the physical signifi-
cance of  6= 0 through a series of numerical examples.
4.6 Numerical Examples of Evolution Equations
To demonstrate the behavior of the model, we first analyze a set of homogenous
deformations applied to a solid, incompressible, hyperelastic cube. We use a
Neo-Hookean material with free energy potential,
 =  (Ib   3) ; (4.6.1)
where  is the shear modulus and Ib = tr(b) is the first invariant of the left
Cauchy-Green tensor of the elastic deformation. From the hyperelastic poten-
tial, we obtain the Cauchy stress as
ij = 2

bij   1
3
bkkij

  p ij ; (4.6.2)
where the first term is the deviatoric part of the stress and p is the hydrostratic
pressure associated with incompressibility. The value and form of the homeo-
static stress, ij , will be defined as needed. Using this material law, the evolution
equation (Eq. 4.5.18) is,
L = 2J
a

fi

bij   1
3
bkkij   p
2
ij  
ij
2

f 1j +
  
2


=
2J
a

fififjf
 1
j  

1
3
bkk + 

 +
1
2
 
     fiijf 1j

=
2J
a

c  

1
3
bkk + 

 +
1
2
 
     fiijf 1j

: (4.6.3)
In this, we have rephrased the hydrostatic pressure as a strain,  = p=(2). Note
that because the Cauchy stress of a Neo-Hookean material is linear in bik, the
evolution equation becomes a function of the right Cauchy Green tensor, c .
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Figure 4.2: Non-zero   results in isotropic volume addition or subtrac-
tion depending on its value. A) Plot of the axial inelastic com-
ponent versus normalized evolution time. B) Plot of non-axial
normal components versus normalized time.  = 1:1,  = 10,
a = 10
4.6.1 Fixed Stress
Consider now the situation where the elastic stretch ratios are held fixed, f =
const. As a consequence of this, the stress is fixed, and we expect continuous
growth of the inelastic components. We first consider the stress state associated
with uniaxial elongation,
f = diag
 
;  1=2;  1=2

and
b = diag
 
2;  1;  1

;
with the initial conditions
F (X; 0) = f and F(X; 0) = I :
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Figure 4.3: Inelastic Jacobian J affects qualitative behavior of growth un-
der compressionA) Plot of the axial inelastic component versus
normalized evolution time. B) Plot of non-axial normal compo-
nents versus normalized time.  = 0:9,  = 10, a = 10
The hydrostatic pressure is determined by assuming the stress in the x3 direction
is zero, resulting in
p = 2
 
2    1 :
For this problem, we assume that the homeostatic stress is zero,  = 0, and,
instead, focus on   . We employ two different levels of incoming free energy,
  =    no incoming energy ;
and
  = 0 equal incoming energy :
These are the two extremes currently discussed in the literature. It is unlikely
that new tissue enters the body with a free energy exceeding the current free
energy, > 0. We then solve for the components ofF over time by integrating
Eq. 4.6.3 using the Matlab function ode45.
A fixed uniaxial stress state associated with  = 1:1 causes the cube to elon-
gate indefinitely in the direction of loading (Figure 4.2). When   = 0, no in-
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elastic deformation occurs in the stress-free directions (x2 and x3). In constrast,
when no incoming energy is included, these directions slightly retract (dashed
line Figure 4.2B). The rate of axial elongation is also reduced by the  term.
Similar behavior was observed under uniaxial compression ( = 0:9, Figure
4.3), except that the growth rate was further reduced by the diminishing inelas-
tic Jacobian. This limited the divergence between the F11 curves for   = 0
and   =    , compared to the elongation case. The Jacobian is also respon-
sible for the difference in concavity of the evolution of F22 between tensile and
compressive loading.
The effect of   is similar in a homogeneous shear deformation,
f =
266664
1 k 0
0 1 0
0 0 1
377775 and b =
266664
1 + k2 k 0
k 1 0
0 0 1
377775 ;
in which k is a constant shear deformation and p = (2=3) k2. The growth rate
of the normal components decreased when  =  W , including the stress-free
x3 direction. The shear components were affected by   (Figure 5.23A). This is
a consequence of the Jacobian in Eq. 4.6.3, which relates the volume change due
to normal component growth to the remodeling rate of the shear component.
4.6.2 Fixed Displacement
We now investigate a situation in which the total deformation is fixed. Consider
the shear deformation,
F =
266664
1 k 0
0 1 0
0 0 1
377775 ;
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Figure 4.4: Fixed Shear Stress A) Inelastic shear deformation over time B)
Evolution of inelastic shear component, F12 = F21. C) F11 com-
ponent D) F22 component. k = 0:3,  = 10, a = 10
where at time equal zero,
f(X; 0) = F and F(X; 0) = I :
Because F is fixed, the deformation rate of the total deformation is zero. Using
a kinematic relation (Eq. 4.2.5) we see that,
lik + fiLf 1k = 0 ; (4.6.4)
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which describes how the elastic and inelastic deformations will trade-off as
the evolution occurs. The incompressibility assumption requires that lkk = 0,
which, from Eq. 4.6.4, implies that L = 0. Therefore, shape change occurs
without growth. As a consequence of this condition, the hydrostatic pressure
becomes,
L = 0 = 2J
a

c  

1
3
bkk + 

 +
1
2
  

0 =
2J
a

c   bkk   3 + 3
2
  

0 =   + 1
2
  :
The hydrostatic pressure is, therefore, equal to the free energy difference:
p =   : (4.6.5)
The evolution of the inelastic deformation is unaffected by the choice  in this
fixed displacement situation. However, because of Eq. 4.6.5, the stress state
evolution is affected. In Figure 4.5F we see that the negative incoming free en-
ergy induces a negative hydrostatic pressure; that is, the tissue is under tension.
All of the normal stress components are shifted by this pressure. The tissue is
attempting to retract, which requires a tensile restoring force to maintain the
position of the surface. Interestingly, the nature of 22 and 33 is exchanged be-
tween the two   cases. For instance, notice that when   = 0, the approach
to equilibrium is shallow for 22 and steep for 33. The opposite is true when
  =    . This case study demonstrates how shape change can relieve stress in
displacement-constrained situations.
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Figure 4.5: Stress relaxes under fixed shear deformation. A) The shear
stress evolution was unaffected by the choice of free energy
term. Interesting nonlinear effects occur in B) 22 C) 11 and D)
33 components. The negative free energy essential inverts the
evolution of these two components. The negative hydrostatic
pressure F) initially increases the 11 stress. E) Schematic of the
initial and equilibrium states of the inelastic deformation. Note
that the elastic deformation contains rotation. k = 0:3,  = 10,
a = 10
4.7 Discussion
Computational and experimental approaches to understanding tissue growth
have significantly expanded in recent years. With the increase of investigators
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in this area, the perspectives on growth and remodeling mechanisms have be-
come increasingly diverse [5]. Debated entities range from whether the mul-
tiplicative decomposition adequately captures growth behavior to what is the
fundamental mechanical measure of homeostasis. In this paper, we analyzed
how the thermodynamic assumptions regarding the incoming mass affect the
evolution of tissue shape and volume. We included the potential for growth in
shear and evaluated the consequence of this through some numerical examples.
These results provide a possible mechanism for how tissue growth and shape
change may be directed by mechanical loading.
Although some have adopted the “accretive force balance” approach to de-
rive specific constitutive relationships for the inelastic evolution [6, 137], the
formulation has yet to acquire broad acceptance. The necessity of this “configu-
rational” force balance has been questioned by Ganghoffer et al [62], who sug-
gest instead that the intermediate configurational forces naturally arise from the
change in integration domains and from defining stress in terms of the free en-
ergy per unit initial volume,  0 = 0 . In a strictlymechanical theory this is true,
but in our view, a biochemical and/or biomolecular forces must be postulated
[41]. The biochemical force balance provides a natural means to incorporate
bio-related forces and their conseqeunces, such as the homeostatic stress state
implemented in this work and others [175, 150]. A form of this balance law has
also been used to relate the growth rate to the concentration of nutrients, which
introduces a more concrete example of a bio-chemical force [7] Future imple-
mentations of this balance law with mechanistic biological data will determine
whether this construction is physically justified.
The occurrence of an Eshelby-like tensor in the evolution equations for the
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inelastic deformation has been the focus of recent discussion in growth mechan-
ics [117, 49, 42]. Originally derived to determine the energy change associated
with the translocation of a material inhomogeneity [50, 51], the Eshelby stress
tensor is considered the key driving force of elastoplasticity [34], crack propa-
gation [52], and volumetric growth [49, 62]. In our formulation, the presence
of an Eshelby-like term depends on whether or not a source of free energy was
included in the energy balance. If no external energy source was included the
evolution equation included an isotropic free energy term. If the external en-
ergy source was equal to the current internal free energy, only the physical and
biochemical stress-work terms and thermal terms would remain in the entropy
inequality. The numerical examples demonstrated that the free energy source
primarily affected the amount of volume change. This was particularly clear
in the case of uniaxial loading with no source term, in which the directions or-
thogonal to the loaded axis retracted, even though they were stress free (Figure
4.2B).
The magnitude of the free energy of newly created tissue is still an open
question. Newly synthesized fibronectin, a key extra-cellular matrix protein,
must be stretched in order expose sites for binding to other matrix proteins
[170, 104, 95]. This supports the inclusion of a non-zero free energy source. In
the assembly of collagen, a ubiquitous and critical extra-cellular matrix protein,
applied stretch increases the density and organization of fibers which resulted
in increased mechanical stiffness [142]. This suggests that the magnitude of the
incoming free energy may depend on the current stretch. In a homogeneous,
single constituent model, spatially varying amounts of incoming free energy
translates into spatially-dependent volume change. Although a limitation of
the current model, the single constituent formulation made the physical signifi-
105
cance of the free energy source term clear.
The biomechanical loads that regulate the homeostasis are still debated [5].
Stress, strain, and strain energy criteria have been proposed [135, 36], but have
been difficult to experimentally distinguish. Evidence from artery mechan-
ics, plant remodeling, and embryonic development point to stress as the re-
sponse stimulus [33, 15, 16], however several in vitro studies show elevated
cellular activity under strain [71]. In this work, we employ a homeostatic
Cauchy stress state, which has been implemented in several previous works
[154, 173, 175]. This is distinct from an Eshelby homoestatic stress proposed in
recent works [6, 7]. In the Eshelby formulation the homeostatic Cauchy stress
and the isotropic free energy term are related by evaluating the free energy at
the same deformation. Our formulation allows the homeostatic Cauchy stress
and the homeostatic free energy to vary independently, allowing for both a cell
specific stress response and an extra-cellular matrix protien specific entrance of
free energy.
Inelastic shear deformations have been underrepresented in examples em-
ployed to illustrate growth and shape change. Examples of growth often con-
strain it to material principal axes, which is justified by either the symmetry
of the loading conditions or by the underlying microstructure [150, 6, 4]. It is
important to consider shear deformations in high shear environments, such as
fluid flow in the developing heart and vascular structures [124, 191]. A recent
growth model of avian valve development showed a decrease in valve elonga-
tion and condensation when inelastic shear deformation was not included [23]
(see chapter 5). Inelastic shear deformations may also be involved in the tor-
sion seen in blastomeres of cleaving Xenopus zygotes [38] and the looping of
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the primitive heart tube [177]. Furthermore, there is increasing evidence that
cells can sense shear stresses [69], suggesting that growth models should have
the capacity to evolve into a sheared configuration in response to this stimulus.
In conclusion, we have presented a self-contained derivation of a finite
elastic-inelastic model of growth. In doing this, we have engaged the current
question of the need for a biochemical force balance and the question of how the
free energy of the incoming mass affects the evolution of the tissue. A limitation
of our study is the implementation of a single constituent theory, which does
explicitly treat interactions between difference constituents. An incompressible,
single constituent theory also requires a spatially constant density, which is un-
realistic for some tissues. Our examples includes inelastic shear deformations,
that involve shape changes but not growth. Future variants growth models
with more biological detail, including multiple constituents, molecularly based
remodeling forces, and variable growth rates are needed to better capture mech-
anisms of growth and shape change observed in embryonic development.
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CHAPTER 5
COMPUTATIONAL SIMULATION OF HEMODYNAMIC DRIVEN
GROWTH AND REMODELING OF EMBRYONIC ATRIOVENTRICULAR
VALVES
Embryonic heart valves develop under continuous and demanding hemo-
dynamic loading. The particular contributions of fluid pressure and shear trac-
tions in valve morphogenesis are difficult to decipher due to an inability to de-
couple them experimentally. In this study, we present a computational model
of HH27 atrioventricular (AV) embryonic valve (cushion) growth and remod-
eling, incorporating experimentally derived physiological hemodynamic and
tissue mechanics inputs. Fluid loads on an axisymmetric AV cushion/myocar-
dial section were derived through a semi-iterative scheme of fluid simulation,
followed by evolution of the cushion, and then an update of fluid forces in re-
sponse to the new geometry. We demonstrate that the hemodynamic loads place
the AV cushion in a compressive stress state. We assumed the cushions pos-
sessed an intrinsic homeostatic stress state that was isotropic, homogeneous,
and compressive. Simulations determined that the homeostatic stress magni-
tude modulated the rate of volume addition during the evolution, but not the
re-shaping of the cushion. We found that the pressure distribution on the AV
cushionwas sufficient to generate the elongated and condensed leaflet-likemor-
phology through inducing tissue resorption on the inflow side of cushion and
expansion on the outflow side. Conversely, shear tractions minimally altered
tissue volume, but regulated the remodeling of tissue near the cushion surface,
particular at the leading edge. Significant shear and circumferential residual
stresses developed as the cushion evolved in shape. This model provides in-
sight into how natural and perturbed mechanical environments may direct AV
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valvulogenesis, and suggests mechanobiological mechanisms for valve growth,
remodeling, and malformation.
5.1 Introduction
Atrioventricular valve formation is thought to be regulated by dynamic interac-
tions between molecular and mechanical signaling. The primitive valves (cush-
ions) initiate as gelatinous masses of hyluronan from the myocardial wall of the
heart tube. A layer of endothelial cells line the inner surface of the heart tube,
with the outer wall consisting of cardiomyocytes [67]. The endocardial cells
lining the cushion invade the underlying matrix and acquire a mesenchymal
phenotype through a process called the endocardial to mesenchymal transfor-
mation (EMT) (see illustrated reviews [140, 163, 27]). As the cushion matures,
these mesenchymal cells remodel the matrix directing a transition from hyluro-
nan to collagen based matrix, and a transition from globular to planar mor-
phology [94, 88]. Significant advances have been made in identifying the key
molecular signals needed for this initiation and maturation [27, 46, 140], yet lit-
tle is known about the role of mechanical signaling in cushion development.
The hemodynamic environment of the embryonic cushion rapidly increases in
pressure over development, resulting in an exponential increase in cardiac out-
put and heightened wall shear stresses [80, 191]. Concomitant with this increase
in mechanical load, the AV cushions elongate to form thin, fibrous leaflets with
increased extracellular matrix (ECM) proteins and greater mechanical stiffness
[25, 28, 94].
These findings motivate the hypothesis that hemodynamic forces direct
valve morphology and stimulate the turnover and remodeling of the internal
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valve constituents. Surgical manipulations of heart development have demon-
strated that altered hemodynamic flows result in defective cardiac morphology
[78, 182]. The perturbed mechanical loads have included differences in local
shear stress [79, 69], pressure [164], andmyocardial activity [13]. The differential
roles of pressure gradients or wall shear stress in directing AV valve morpho-
genesis are unknown. By understanding their specific roles, we could identify
loading profiles that are defective, and/or determine whichmechano-sensors to
target in order to block the effect of the defective mechanical loading. However,
uncoupling the effects of pressure and shear tractions is difficult to do experi-
mentally.
Computational approaches to the study of the mechanical regulation of mor-
phogenesis are an attractive alternative to address these issues of coupled load-
ing and predictability. Numerical models have provided insights into the fluid
dynamics of the embryonic heart, such as the transition of peristaltic to pulsatile
flow [178] and the distribution of normal and shear forces in AV canal [18, 124].
Recent gains in fluorescent and ultrasound imaging have enhanced these com-
putational studies by providing critical information on the magnitude and tem-
poral nature of in vivo hemodynamic loads [55, 79, 191]. Previous stress-driven
growth models have qualitatively captured the morphology of several develop-
mental phenomenona such as invagination [127], gastrulation [173, 174], cardiac
looping [149], and ventricle growth [108]. Stress-based growth laws assume that
tissue morphology is a direct response to the current stress state, or to the dif-
ference in current stress from a homeostatic stress state. This is in contrast to
growth models phrased in terms of strain or strain energy, with corresponding
homeostatic states assumed as functions of these quantities [36]. Experimen-
tal evidence in plants and embryos supports stress as the mechanical criterion
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to which living organisms respond [16, 15]. Stress-based evolution equations
for growth also arise naturally when the entropy inequality is employed [7, 63],
further supporting this form of growth law.
The objective of this study was to develop and implement a computational
framework incorporating both fluid-structure interaction and growth mechan-
ics to identify mechanical mechanisms sufficient to reproduce valve-like mor-
phology. Physiological fluid flow parameters and cushion material properties
were utilized. The results indicate that fluid pressure directs spatially depen-
dant volume addition and removal resulting in valve elongation. Shear trac-
tions do not significantly alter volume, but instead stimulate tissue distortion,
particularly near the cushion surface. Growth and remodeling induces residual
stresses which may significantly alter (or guide) cushion formation over time.
This model provides an initial framework of mechanically induced valve devel-
opment on which further biological detail may be incorporated.
5.2 Methods
5.2.1 Kinematics
Consider a stress-free body in the reference configuration at t = 0, denoted as
the initial configuration 0 in Fig. 5.1. The body undergoes a combined elastic-
inelastic deformation from the initial to current configuration  defined by the
mapping x = x(X; t). The observable, total deformation, F = dx
dX
, includes
components of growth, remodeling and elastic deformation. We assume F can
be expressed as a multiplicative decomposition of the elastic components and
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Figure 5.1: Multiplicative decomposition of the deformation gradient. The
observable deformation, F , is decomposed into an elastic, f ,
and inelastic, F , deformation. All volume change occurs
through F as the elastic deformation is assumed to be iso-
choric, det(f ) = 1. All growth and remodeling is described by
the inelastic deformation. The initial, relaxed, and current bod-
ies are referred to as 0, R, and , respectively.
growth and remodeling (inelastic) components as done in several preceding
works [154, 114, 150]. The total deformation is thereby defined as the product
of the inelastic, F , and the elastic, f , deformations.
F = fF (5.2.1)
The elastic deformation is considered nearly incompressible, det(f)  1, and
is the deformation used to calculate the elastic stress. The inelastic deformation
comprises both volumetric changes representative of growth and shape changes
representative of remodeling. This deformation will be prescribed through
a constituitive relation. Although the inelastic deformation does not directly
contribute to the elastic stress, the geometric incompatibilities from differen-
tial growth and remodeling induce elastic residual stresses required to maintain
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material continuity.
5.2.2 Material Law
The material properties of the avian AV cushions have previously been charac-
terized by fitting an isotropic, exponential hyperelastic material law (Eq. 5:2:2)
to experimental data [25].
W =
C
2
fexp ( [I1   3])  1g+ 1
D
(J   1)2 (5.2.2)
Parameters C and  are the linear and nonlinear material constants, respec-
tively, of the material law, while D is inversely related to the bulk modulus
which enforces the incompressibility constraint. I1 is the first invariant of the
left Cauchy-Green stretch tensor b = ffT , and J = det(f) is the Jacobian of
the elastic deformation. From the strain energy function (Eq. 5.2.2), the Cauchy
stress is derived as
 =
1
J
@W
@f
fT (5.2.3)
=
C
J
exp [ (I1   3)] b+ 2
D
(J   1) I: (5.2.4)
Using the pipette aspiration technique, Buskohl et al [25] quantified the stiffness
of HH25, HH29 and HH34 AV cushion and presented the data in terms of strain
energy density. The strain energy density was defined as the area under the
stress-stretch ratio curve of a uni-axial loaded bar from  = [1; 2], with closed
form expression shown in Eq. 5.2.5.
W12 =
C
2
[exp (2)  1] (5.2.5)
Buskohl et al [25] reported significantly stiffer material properties in the plane
of the tissue versus that in the trans-planar direction at HH36, indicating the
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Table 5.1: Fluid/Solid Material Parameters
Item Value Units
Density 1060 kg
m3
Viscosity 0.003 [Pa  s]
R 0.5 mm
Re 5 –
 0.3 –
C 100 Pa
D 2 E-03 Pa 1
W12 41 Pa
a0 1 E-02

1
Pa t

development of material aniostropy (see chapter 2). As the pipette data for the
HH29 cushion was likely underestimating the cushion stiffness, we attempted
to compensate for this by increasing the linear parameter, C, from C = 2 Pa to C
= 100 Pa. This increased the strain energy density of the tissue fromWavg = 0:84
Pa to Wavg = 41 Pa. We chose C = 100 Pa because it approximately halved the
four orders of magnitude difference between the in-plane and trans-planar stiff-
ness measurements. The nonlinear parameter,  = 0:3, at HH29 was retained
(Table 5:1).
5.2.3 Growth Law
In this growth model, the Cauchy stress is assumed to the key driver the growth
and remodeling processes. The deformation rate of the inelastic tensor, F , is
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prescribed through the constituitive relation,
L = _FF 1 = a(r)fT (   )f T (5.2.6)
where  is the homeostatic stress state and a is the radially dependent growth
rate parameter. The concept of a homeostatic, or target stress, has been em-
ployed in several other growth models [154, 82, 150]. The homeostatic stress
provides a non-zero stress state at which no growth occurs. In light of lim-
ited experimental data, we assumed the homeostatic stress to be a homogenous,
isotropic compressive stress of magnitude p, (Eq. 5:2:7).
 =  pI (5.2.7)
A compressive homeostatic state was chosen because the hemodynamic loads
on the AV cushion are compressive in this simulation. We emphasize that this
simulation models the average flow through the AV canal over one cardiac cy-
cle. At specific times of the cardiac cycle, blood flow may produce regions of
negative pressure on the cushion surface. These negative pressures have been
observed in peak-flow simulations of avian AV canal [18], and in in vivo imaging
of zebrafish heart tubes [55]. However, we hypothesize that growth and shape
change are a result of the average mechanical loading because they occur on a
much longer time scale than the peak loads of the cardiac cycle. An isotropic
stress state was chosen to avoid any directional bias that distortional compo-
nents would have introduced. The growth rate parameter was assumed to vary
linearly in the radial direction of AV canal, promoting more growth near the
surface of the cushion. This was motivated by the increased cell density near
the cushion surface observed from hematoxylin stained histology sections of
HH27 AV valves (Fig. 5.2). The exact formulation used in finite element (FE)
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Figure 5.2: Increased cell density near the valve surface supports a gra-
dient in the growth rate parameter, a(r). Representative histol-
ogy image of HH27 left AV valves stained withWeigerts hema-
toxylin. Magnification: 94x, 150x
implementation was
a(r) =
8><>: a0
 
1  r
R

: r  R
0 : r > R
where R is the radius of the AV canal (R=0.5 mm), and r the radial position from
the axis of symmetry. A colormap of the growth rate parameter is presented in
Fig.5.3B.
5.2.4 FE Implementation of the Fluid/Solid Model
The mechanical environment of the AV cushion is primarily defined by the
hemodynamic forces generated through the pump action of the embryonic
heart. To approximate these fluid loads, the AV canal and cushion were mod-
eled together through an idealized axisymmetric geometry (Figure 5.3A). A
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Figure 5.3: AV canal model geometry and growth rate gradient. a) Cross-
section of the AV canal model geometry with AV cushions
(AVC) shown inside. Red lines indicated blood flood from
the atrium to ventricle. Gray band denotes myocardial wall.
b) Colormap of growth rate parameter a(r) over the 2D AVC
cross-section. R is the radias of the AV canal and r is the ra-
dial coordinate as referenced from the axis of symmetry. The
dashed red line from A to B denotes the cushion surface nor-
malized from 0 to 1 in future figures. The AVC cross-sectional
area is the area bounded by the red and white dashed lines. a0
= 0.01 [1=(Pa t)]
cylindrical coordinate system was defined with the axial direction, y, oriented
in the direction of flow and the radial direction, r, orthogonal to the axis of sym-
metry (Figure 5.3). The length to diameter ratio of the AV canal was 4 mm to 1
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mm and the cushion was a near semi-circular cap of radius 0.25 mm. These di-
mension are supported by micro-CT images of AV canals [191] and a previously
implemented computational model of AV canal blood flow [18]. The surface of
the cushion and myocardial wall interface was smoothed to mitigate potential
stress concentrations. The blood was simulated as an incompressible, Newto-
nian fluid, with density and viscosity of 1060 kg/m3 and 0.003 Pa-s, respectively.
Although blood is non-Newtonian, the viscosity is nearly constant in the range
of shear rates used in our simulation [2].
The pressure and velocity profiles were determined using the axisymmetric
Navier Stokes equations for the conservation of momentum and the continuity
equation. All interior surfaces of the canal, including the cushions, had no slip
boundary conditions (Figure 5.4 Step 1). The inflow and outflow pressures were
selected to match experimental data of the time averaged velocity through the
AV orifice (3.08 cm/s  0.99 cm/s , Yalcin et al [191]). The time averaged ve-
locity was calculated by averaging AV orifice velocities over one cardiac cycle,
or heartbeat. This is the mean loading velocity experienced by the cushion, and
was considered a reasonable approximation of the loading range which directs
cushion growth.
The peak velocity blood flowwas simulated to compare the AV orifice veloc-
ities profiles from the experimental data and our model. This comparison was
only used to validate our idealized geometry for the AV canal and cushion. The
pressure drop across the AV canal necessary to match the AV orifice velocity for
the average and peak flow conditions was 62 and 1200 dynes/cm2, respectively.
Reynolds numbers for each condition were Re = 5 and Re = 65 using the AV
orifice diameter (0.5 mm) as the characteristic length. Both Reynolds numbers
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Figure 5.4: Schematic of fluid/solid interaction algorithm and boundary
conditions(BC). Each iteration followed this process, Step 1:
Simulate the fluid flow in the AV canal with no slip velocity
BCs along the fluid/solid interface and a pressure drop, P =
Pin - Pout, across the canal. Step 2: Transfer the pressure and
wall shear stress loads from the fluid model to the cushion sur-
face using the 1D surface elements (black dashed line). Apply
displacement BCs to myocardium as shown. Step 3: Calcu-
late the elastic stress and inelastic deformation for a set time
of growth and remodeling, and then remove load. Step 4: Up-
date the fluid mesh using the new relaxed cushion geometry.
Repeat Steps 1-4.
are within the laminar range for flow in round tube (ReL < 2100) [128]. The
entrance length, le for fully developed flow in a tube with laminar flow is,
le
D
= 0:06Re : (5.2.8)
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In the peak flow condition, the minimum entrance length needed is le = 1:95
mm. The entrance length used in the simulation was le = 2mm.
The fluid/solid model was decoupled in the FE implementation, and solved
through a semi-iterative approach. First the pressure and velocity profiles were
determined from the fluid problem. The flow induced pressure and shear trac-
tions on the AV cushion surface were then transferred to the solid model to
simulate the elastic and inelastic deformations. After a set time of inelastic de-
formation, the fluid simulation was rerun with the evolved geometry, and the
fluid forces were updated (see Figure 5.4).
The FE simulations were computed in ANSYS v12.1 using four-node quadri-
lateral elements in both the fluid and solid domains (meshes are shown in Fig-
ure 5.4). A series of two-node surface elements were used to transfer the normal
and shear components of the fluid load onto the solid model (black dashed line
in Figure 5.4, step 2). A total of 3400 fluid elements and 2400 solid elements
were used in the simulations. The exponential material law and the growth law
were implemented through the USERMAT subroutine (see Appendix C.2). At
every integration point, the USERMAT subroutine would determine the elas-
tic deformation gradient (f = FF 1) and calculate the Cauchy stress and the
spatial elasticity tensor. The growth tensor would also be updated through the
following explicit integration scheme,
Fij (t+t) = Fij (t) + Lim(t)Fmj(t)t: (5.2.9)
To assess the importance of the shear deformations in capturing the valve mor-
phology, a simulation was performed in which the shear components ofF were
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not allowed to evolve. In this case, the update of the growth tensor was
Fij (t+t) =
8><>: Fij (t) + Lim(t)Fmj(t)t : i = j0 : i 6= j
Computations were performed until 0:6  det(F)  2:6. Outside this range
convergence difficulties occurred due to the accumulation of large inelastic de-
formations or large gradients of inelastic deformation. Simulation results were
compared by using cross-sectional area, orientation angle, and color maps of
computed mechanical outputs. The orientation angle was defined as the angle
between the myocardial wall and the line that connects the bottom center of the
cushion to the displaced position of the top-center point on the cushion surface
(see Figure 5.17D).
5.2.5 Mesh Sensitivity
Some modifications were made to the cushion geometry to improve conver-
gence. First, the intersection between the cushion and myocardial regions was
filleted. This interface orginally formed a right angle, as highlighted by the red
circles in Figure 5.5. The fillets reduced the stress concentrations in these re-
gions. Secondly, the growth rate parameter, a(r), was linearly varied, from zero
at the myocardial wall, to unity at the axis of symmetry. While this was moti-
vated by the heightened cell density near the cushion surface, as explained ear-
lier, this also benefited the computation by reducing the jump between growth
and no growth conditions at the myocardium interface. These two changes led
to the final geometry used in the simulation.
A mesh sensitivity test was performed to determine if there were mesh de-
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Figure 5.5: Early version of AV cushion geometry and mesh. Undeformed
configuration is denoted by the dashed outline. The red circles
highlight the initial sharp corners between the cushion andmy-
ocardium wall.
pendent effects. We varied the element density of the mesh relative to the mesh
used for the simulation (MD=1). We evaluated a two-fold increase (MD=2) and
a four-fold decrease (MD=0.25) in mesh density. The fluid and solid meshes for
each mesh density are shown in Figure 5.6 and Figure 5.7, respectively.
Effect of mesh density on fluid results
We compared the initial fluid force profiles between the different meshes.
The pressure profile did not differ significantly between any of the meshes
(Figure 5.8). In contrast, the wall shear stress differed significantly between
MD=0.25 and MD=2. The MD=0.25 shear stress profile lacked the symmetry
present in the other curves (Figure 5.9). The MD=2 shear stress differed from
MD=1 only at the center of the cushion surface, where the shear stress is maxi-
mal. The shear stress is more sensitive to the mesh density because it is deter-
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Figure 5.6: Fluid domain meshes used in the sensitivity analysis.
mined from a spatial derivative, specifically,
WSS = 

@u
@y

y=0
; (5.2.10)
where  is the dynamic viscosity, u is the fluid velocity parallel to wall surface,
and y is the distance perpendicular to thewall. The approximation of this spatial
derivative is less accurate with a coarse mesh than a fine mesh. The agreement
between the MD=1 and MD=2 meshes suggested that the MD=1 mesh was suf-
ficient for our analysis.
Effect of mesh density on solid results
We evaluated the effect of mesh density on the solid model through two
metrics: 1) comparing the evolution of the cushion cross-sectional area with
time, and, 2) comparing of the residual stress fields. The cross-sectional area
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Figure 5.7: Solid domain meshes used in the sensitivity analysis.
evolutions for MD=0.25, MD=1, and MD=2 are shown in Figure 5.10. Mesh re-
finement beyond MD=1 did not alter cushion evolution. The evolution of the
coarser mesh (MD=0.25) did not agree with the other mesh densities. However,
the trend of the evolution agrees, as evidenced by the increasing area due to
growth. Also, the evolved shape of the MD=0.25 is similar to the evolved shape
of the MD=1 and MD=2 cushions shown in the Figure 5.11. The residual stress
fields between MD=1 and MD=2 at time, t = 1, were minimally different. The
higher resolution of the refined mesh resulted in slightly smoother contours.
The coarser mesh inadequately approximated the residual stress, especially in
the stress concentration regions at the cushion/myocardial interface. The con-
sistency between the residual stress fields of the MD=1 and MD=2 meshes indi-
cated that mesh refinement beyond MD=1 was not necessary.
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Figure 5.8: Initial fluid pressure profiles were minimally affected by vari-
ations in mesh density. Cushion surface normalized as shown
in Figure 5.3
As mentioned at the end of Section 5.2.4, all simulations had convergence
difficulties as the inelastic deformation evolved. Convergence predominantly
failed on the exit flow surface in the region where the inelastic Jacobian reached
a minimum. In this region, the Newton-Raphson residuals did not satisfy the
convergence tolerance within the maximum number of Newton-Raphson iter-
ations allowed (50) (Figure 5.12). The coarse mesh displayed a larger region of
unconvergent NR residuals, but this region still coincided with the NR residual
regions of the other meshes. This suggests that the cause of the convergence
difficulties is similar for all the meshes.
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Figure 5.9: Wall shear stress distribution is sensitive to mesh density.
Cushion surface normalized as shown in Figure 5.3
5.3 Results
Fluid forces apply compressive load to AV cushion
In our simulations, the pressure drop across the AV canal was adjusted to
match the experimental average velocity at the AV orifice (3.08  0.99 cm/s)
[191]. A pressure drop of 62 dynes/cm2 (0.046 mmHg) generated a parabolic
velocity flow profile through the AV orifice with an average velocity of 3.07
cm/s (Figure 5.13). The Reynolds number through the AV orifice was Re=5
which can be considered laminar for tube flow. The flow profile in the AV
orifice during peak velocity was previously calculated by using actual HH27
AV canal geometries (36.6 cm/s, Yalcin et al. [191]). To validate our idealized
geometry, we simulated peak flow through the orifice (P = 1200 dynes/cm2,
Vavg = 36 cm/s, Figure 5.13B). The velocity profile resembled a plug flow, and
agreed well with the prior study. This indicated that the axisymmetric AV canal
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Figure 5.10: Evolution of cushion cross-sectional area with time for vary-
ing mesh densities. MD=1 and MD=2 are consistent, but
MD=0.25 does not agree.
and semi-circular cushion geometries were adequate approximations. The AV
canal pressure rapidly dropped from 52 dynes/ cm2 on flow entrance surface
to 7 dynes/cm2 on the flow exit surface of the cushion, mainly due to the nar-
rowing of the valve orifice. The shear tractions were oriented in the direction of
flow, and their magnitude was symmetrically distributed about the cushion sur-
face (solid, Figure 5:14B). As the cushion evolved, the fluid loads would change
based on the evolved cushion geometry. Expansion of the cushion increased the
pressure drop across the cushion surface, while retraction decreased the pres-
sure drop (dash and dash-dot respectively, Figure 5:14A). A similar trend was
seen in the shear traction, with the magnitude of maximum shear increasing
with cushion expansion and decreasing with retraction (Figure 5:14B). The sym-
metry of the shear traction profile declined as the initial geometric symmetry of
the cushions degenerated. Together, the average hemodynamic loads put the
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Figure 5.11: Circumferentual residual stress at time, t = 1, for varying
mesh densities.
AV cushion in a compressive and sheared state throughout the cardiac cycle.
While clearly the geometry of the cushions affects the fluid force profile, the
high to low pressure drop across the AV cushion should still occur even with
irregularly shaped valves. However, the effect of irregular cushion geometry or
cushion asymmetry was not analyzed in this study.
AV cushion volume change rate is negative under fluid loading
The time derivative of the inelastic jacobian (J = det(F)), or dilatation rate
(Eq. 5:3:1), determines the rate at which material is introduced or removed dur-
ing the inelastic deformation.
_J = tr (L)J (5.3.1)
Included in Eq. 5:3:1 is the growth rate parameter a(r)which varies in the radial
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Figure 5.12: Newton-Raphson (NR) residuals were localized to the
high resorption region on the flow exit surface. The non-
convergent area increased with reduced mesh density (MD).
direction from a value of zero at the cushion/myocardium interface to a value
of one on the axis of symmetry. The initial dilatation rate of the entire cushion
under only the pressure load is negative, with the highest resorption rate at the
top of the entrance surface (arrow 1, Figure 5:15A). The shear tractions induced
a positive dilatation rate on the inflow side and a negative on the exit, but the
rate is an order of magnitude less than the pressure induced dilatation rate. The
difference in magnitude of the rates is due to 1) the difference in applied load
magnitude, and 2) the nature of shear deformations to intrinsically drive dis-
tortion and not dilatation. This is seen in the case of a pure shear deformation,
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Figure 5.13: Average velocity over the cardiac cycle generates low
Reynolds flow (Re = 5). A) Parabolic velocity profile at AV
orifice under average flow condition, with approximated 3.07
cm/s spatial average. B) Plug flow velocity profile across the
AV orifice when experimental peak velocity used in simula-
tion. Plug flow agrees with calculated velocity profile using
innate AV orifice geometry [191]. This indicates that the ide-
alized initial geometry of this model is an appropriate approx-
imation. (Re=65)
k, which contributes k2 terms to the diagonal components of the stress, where
typically k < 1. Though the pressure is the dominant load on the entrance side
of the cushion, it is of the same order of magnitude as the shear tractions on the
exit side of cushion near the top (Figure 5:14). It is in this region that the shear
tractions modulate the inelastic dilatation rate, by increasing the resportion rate
near the myocardial interface on flow exit side of the cushion (arrows 2a-b, Fig-
ure 5:15 A,C). The hemodynamic loads initially place the cushions into a state
of resorption, which is only exacerbated by cushion expansion (dash-dot Figure
5:14).
We propose the tissue responds to this compressive load by acquiring a pref-
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Figure 5.14: Valve-like morphology generates fluid force profiles that pro-
mote further valve elongation and condensation. A)Plot of
pressure distribution on the AV cushions at initial loading
(solid) and after evolution with  = 0 (dash-dot) and  =
 P
2
I (dash). B) The shear traction distribution becomes less
symmetric as the cushion evolves asymmetrically. The maxi-
mal shear stress occurs at the leading edge of cushion. Nor-
malized cushion surface denoted by red dashed line between
point A and B in Figure 5.3B
erential, homeostatic, compressive stress state. With limited data on the mag-
nitude and spatial distribution of the homeostatic stress, we assume a homoge-
nous, isotropic stress state with a magnitude proportional to the pressure drop
across the AV canal (P). As this pressure largely determines the stress state of
the AV cushions, it is plausible that the homeostatic stress state would be sen-
sitive to this load. With the incorporation of this homeostatic stress state, the
initial dilatation rate uniformly increases in the cushion, resulting in volumet-
ric expansion on the flow exit side of cushion, while maintaining resorption on
flow entrance side (Figure 5:15D). The combination of the fluid forces with ho-
moestatic stress provides an initial rate of dilatation conducive to generate AV
cushion morphology.
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Figure 5.15: Compressive fluid loads stimulate negative dilation of AV
cushion. Color maps of _J = JL after initial loading with
A) pressure load only, B) shear tractions only, C) all applied
loads, and D) all loads with homogenous homeostatic stress
 =  P
2
I . The resorption rate was highest at leading of in-
flow cushion surface (arrow 1). The shear tractions increase
the rate of resorption on the back side of the cushion at the
interface with the myocardium (arrow 2a-b). Compressive
homeostatic stress shifts dilatation rate into a positive growth
range. Color map in units of [1=t].
Valve-like morphology generated with time averaged fluid forces and
isotropic homoestatic stress conditions
The evolution of the AV cushion under different load conditions was ana-
132
lyzed through comparison of cross-sectional area and the migration of the top-
center point of the cushion surface. As anticipated, without a homestatic stress
the AV cushion volume contracted (Figure 5:16A), but in a spatially dependant
manner. More volume was removed on inflow side of cushion than outflow,
and the cushion even expanded in a small region on the inflow side at the cush-
ion/myocardial interface (Figure 5:16C). The area ratio increased as the mag-
nitude of the compressive homeostatic stress increased. A net increase in area
was seen at magnitudes of  P=2 and P, while  P=4 was still a net de-
crease. These area changes are evident from the evolved configurations shown
in Figure 5:16B (t=0.6).
With  =  P=2 I and no fluid load applied (NL), the AV cushion bal-
looned into the AV canal (Figure 5:16B). The cross-sectional area increased sig-
nificantly, while maintaining a constant orientation angle of =2. This deter-
mined that an isotropic homeostatic stress contributes directly to the volume
change of the evolved cushion, and not the orientation. All loaded simulations
had the same initial rate of change of the orientation angle, regardless of home-
ostatic tissue stress value. This indicated that the hemodynamic forces, not the
homeostatic stress, directed the cushion shape change. The orientation angle be-
gan to diverge between the simulations after t=0.5, with large homeostatic stress
magnitudes generating smaller angles (Figure 5:16D). This is a consequence of
the elevated hemodynamic loads experienced by cushions with net volume ad-
dition.
The combination of the fluid forces with  =  P=2 I resulted in increased
cushion volume and elongated morhophology, similar to that of later stage
valves. The other homeostatic stress magnitudes tested resulted in either de-
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Figure 5.16: Fluid force distribution and homeostatic stress state generate
valve-like morphology. A) Plot of AV cushion cross-sectional
area normalized to initial area versus evolution time. Several
compressive, isotropic, homeostatic stress states are shown.
Note that a non-zero homeostat will stimulate remodeling
when no load (NL) is applied. B) Plots of evolved configu-
rations after removal of load for all scenarios. C) Colormap
of the inelastic jacobian, J = det(F), which details the spa-
tial distribution of cushion expansion or resorption. D) The
top center cushion surface evolves in the direction of flow as
seen by the decrease in orientation angle over time. The ori-
entation angle is defined as the angle between the y-axis and
the line connecting the bottom center of the cushion with the
deformed position of the top center cushion surface.
ficient or excessive in volume addition, creating retracted or thickened cushions
(Figure 5:16B). New tissue was primarily introduced at the cushion tip, with
tissue resorption occurring on the inflow cushion surface (Figure 5:16C). The
evolved cushion geometry increases the fluid pressure on inflow surface and
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reduces the pressure on the exit surface of the cushion (Figure 5:14A), encour-
aging this elongated shape. This suggests that cushion growth and remodeling
is supported by a positive feedback process, whereby hemodynamic forces cre-
ated by the asymmetric fin shape promote further condensation and elongation
of the cushion.
Differential roles of pressure and shear traction in cushion formation
The hemodynamic loads on the AV cushion are sufficient to remodel a cush-
ion with  =  P=2 I into a valve-like shape. Thiselongated and condensed
shape is primarily a consequence of the fluid pressure, as evidenced by the pres-
sure only simulations (Figure 5.17). As seen in the dilatation rates (Figure 5.15),
the pressure stimulates tissue removal on the flow entrance side of cushion,
and expansion on the flow exit side. The pressure significantly decreased the
rate of volume increase compared to the no load evolution (Figure 5.17A). The
shear tractions had little effect on cushion volume, although a slight increase
was observed at the leading edge of the cushion in the full load model versus
the pressure only model (Figure 5.17B). The magnitude of the shear tractions
are maximal in this region, and promote distortion and thinning of the cushion
leading edge.
The fluid pressure had little effect on orientation angle, while the shear trac-
tions were the dominant stimuli of this metric (Figure 5.17C). The pressure di-
rected the valve-like morphology, but did so without significant displacement
of the top center cushion surface (Figure 5.17D). In this way, volume was selec-
tively removed or added about the center line of the cushion. The top center
point significantly migrated under shear loading. This may indicate that shear
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tractions are still important for the remodeling of the AV cushion surface, even
if not important for overall cushion volume change.
Figure 5.17: Pressure modulates volume change while shear directs sur-
face remodeling. A) Area ratio plot for simulations with pres-
sure only, shear tractions only, no load, and full load. B) De-
formed configuration of each load scenario. The difference
between full load and pressure only is shown in enlarged im-
age of cushion leading edge. C) The shear traction directed
migration of top center point. The pressure remodeled the
cushion by removing and adding volume about the centerline
of the cushion, displacing the center point very little. D) Vec-
tor plots depicting the displacement of cushion surface nodes
and the orientation angle, . Vector length and color indicate
displacement magnitude (kx   Xk). Note that the isotropic
growth due to the homoestatic stress does not affect the ori-
entation angle.
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Growth and remodeling induces residual stress
Radial and axial stress concentrations develop during the evolution at the
cushion/myocardium interface on the flow exit cushion surface (arrows Figure
5.18 & 5.19). Both the pressure and shear tractions contribute to the location and
intensity of this stress. After removal of the fluid load, the cushion relaxes to the
evolved configuration, which is not stress free. The stresses in this configura-
tion, termed residual stresses, are introduced by differential tissue growth and
remodeling during the evolution. The cushion/myocardium interface develops
residual stresses because of the difference in growth rate across that boundary,
as the myocardium does not grow in this simulation. Even in the loaded state,
Figure 5.18: Radial residual stress. The residual stress in this direction is
minor when compared to the applied stress state values. Sig-
nificant compressive radial stress occurs at the cushion/my-
ocardial interface on the flow exit side (arrow).
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Figure 5.19: Axial residual stress. Residual stress is insignificant when
compared to the applied stress, but stress concentrations do
exist along the cushion/myocardium interface (arrow).
the continuity of the stress field is disrupted along this interface by prior inelas-
tic deformations. The radial and axial residual stresses are small relative to their
counterparts in the loaded configuration (Figure 5.18 & 5.19). In contrast, the
circumferential residual stresses are of the same sign and order of magnitude of
the loaded stress state (Figure 5.20). The compressive residual stress is due to 1)
growth in the radial direction placing tissue closer to the axis of symmetry un-
der higher compressive stress, and 2) the homeostatic stress tempering the nega-
tive growth rate induced by the compressive hemodynamic load which in effect
stimulates growth where retraction would have happened without the homeo-
static stress. The converse is true in the simulation with no homeostat, where a
tensile residual stress accrues in the circumferential direction. The magnitude
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and sign of the circumferential residual stress appears to be predominantly a
consequence of the cushion growing in a tube.
Figure 5.20: Growth and remodeling induces residual stress. Circumeren-
tial residual stress is influenced by growth in the radial-axial
plane. The residual stress is maximal at the cushion leading
edge, where the radial position in the AV canal is shortest (ar-
row 1). It is compressive because 1) circumferential stress is
higher than the homeostatic stress which stimulates growth,
and 2) the circumferential retractions are insufficient to match
the reduced space due to radial growth toward axis of sym-
metry. With  = 0, the applied compressive load stimulated
circumferential resorption which resulted in a tensile residual
stress (arrow 2).
The residual shear stress in r-y direction is also of similar magnitude to the
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Figure 5.21: Residual shear stress. The residual shear stress is mainly local-
ized to the cushion/myocardium interface on the inflow sur-
face (arrows 1a-b). The negative applied shear stress results
in a positive residual stress due to the accruement of inelastic
shear deformation in that region.
loaded shear stress near the cushion/myocardium interface on the inflow side
of cushion (arrow, Figure 5.21). The applied load induces a negative shear stress
in that region, which results in an inelastic shear deformation. When the load
is removed, the tissue attempts to return to its original configuration, which
creates a positive shear stress in this remodeled region. In this stress-based
growth model, the residual stress does influence the evolution of the cushion.
Relaxation of the residual stress was investigated by incrementally updating
the stress-free reference configuration to the unloaded evolved configuration.
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The residual stresses were then disregarded at each update. In this relaxed
model, the cross-sectional area and cushion morphology began to diverge from
the non-relaxed model (Figure 5.22). Though the differences were small for the
evolution times investigated, these results support the possibility that residual
stresses may induce distinct and functional differences at longer times.
Figure 5.22: Residual stress alters AV cushion evolution. A) Plot of nor-
malized cushion area vs. normalized simulation time. Ar-
rows denote the reset of the stress-free reference configuration
to the unloaded evolved state, which in effect eliminates the
residual stresses. The relaxed residual model increased the
cross-sectional area at a faster rate than the simulation with
residual stress maintained. B) Reduced residual stress stimu-
lated evolution of more tissue in the direction of blood flow.
Simulation details: Full Load,  = P=2I
Inelastic shear deformations are important for driving valve-likemorphogen-
esis
The morphogenesis of the AV cushion includes not only an increase in tissue
volume at this stage, but also significant change in shape. The inelastic shear
deformations play a pivotal role in reproducing shape change in this growth
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model. The shear components of the growth and remodeling tensor are max-
imal at the tip of the AV cushion (Figure 5.23C). The fluid shear tractions and
tissue growth rate are also maximal in this region. A simulation was run in
which the shear components did not evolve. In this situation the cushion grew
in the direction of flow, but did not remodel as efficiently into the elongated and
condensed valve shape (Figure 5.23B). The cross-sectional area also increased
at a slower rate in this simulation (Figure 5.23A). This is most likely due to the
difference in applied fluid forces between the two remodeled geometries. These
results suggest that shear deformations, or shear remodeling, may be important
in controlling valve morphology.
5.4 Discussion
The hemodynamic environment of the embryonic heart applies morphologi-
cally significant mechanical loads to the developing AV valves (review [159]).
Experimental studies both support and contest shear stress as a mechanical
stimulus of cushion development. The reduced shear tractions due to occluded
blood flow in zebrafish resulted in defective cardiac looping, bulbus formation,
and inflow/outflow tract fusion, which occur in hearts without AV cushions
[79]. Another study suggested that shear tractions are secondary effects com-
pared to myocardial function [13]. Myocardial force was reduced through my-
ofibrillar ATPase inhibition to the point of stagnant blood flow, but the AV cush-
ions still developed. Our computational model indicated that fluid shear trac-
tions do not significantly change cushion volume, but are instead responsible
for cushion surface remodeling. Maximum shear tractions, and consequently
inelastic shear deformation, were localized to the leading edge of the cushion
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Figure 5.23: Inelastic shear deformations are key to recapitulating valve
morphology. A) Removal of the inelastic shear components
results in reduced cross-sectional area growth compared to
the full growth law. B)Without shear components the cushion
does evolve in the direction of flow (dash-blue), but has lim-
ited shape change. C) Color maps of the Fry and Fyr display
the large inelastic shear deformations throughout the cushion.
(Figure 5.14B,5.23C). The fluid pressure predominantly directed the valve-like
morphology through selective removal and addition of volume, in conjunction
with a compressive, homeostatic stress state. Interestingly, the pressure had lit-
tle effect on the evolution of the top center region of the cushion, while the shear
tractions significantly elongated this region (Figure 5.17D). Although the fluid
shear tractions did not significantly alter cushion volume, their role in stimulat-
ing cellular and molecular signaling may be instrumental to the growth process
[69], but this is not represented in the current model.
Homeostatic reference states, defined in terms of both stress and strain, have
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become common features of tissue growth models [82, 154, 173]. Evidence of a
homeostatic stress state has been previously investigated in arteries [33, 82, 176].
Opening angles of excised arteries show a non-homogenous residual stress dis-
tribution, which promotes a uniform circumferential and axial stress when the
artery is loaded [33]. This suggested the existence of a uniform, preferential
stress state maintained by the tissue. Although there is no data on the homeo-
static stress state for AV cushions, the compressive fluid forces and the need of
a directionally unbiased model motivated the use of a homogenous, isotropic,
compressive stress state. This homeostatic stress was essential in generating a
net increase in cushion volume needed to reproduce the growth of the cushion.
In the present model, cessation of growth or remodeling would occur only if the
internal and external pressure of the AV canal were constant and equal to the
homeostatic stress of the AV cushion. The loading conditions for this growth
equilibrium state are incompatible with fluid flow, indicating that at least re-
modeling, if not growth, is persistently active. Continuous growth and remod-
eling would not be appropriate for modeling homeostatis of an adult valve, but
is a plausible feature of a morphogenesis model.
The isotropic homeostatic stress functionally represented an active growth
process in the AV cushion, which was modulated by the distribution of the
stress from the fluid loads. Where the applied stress was less than the home-
ostatic stress, the tissue retracted; where it was higher, volume was added. This
type of response is observed in left atrial ligation studies, where the left AV
valve thickens due to a decrease in blood inflow and AV canal pressure [164].
In our model this is seen in the ballooning of the cushion that occurs when no
loads are applied, but the homeostatic stress is non-zero (Figure 5.16). Thick-
ened valves are a common phenotype seen in gene knockout (KO) mice, such as
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TGF2 [14], periostin [171], and collagen 111 [110]. While it is possible that ge-
netic aberrations may perhaps modulate the homeostatic stress, resulting in in-
correct cushion volume, no method to measure the homeostatic stress in valves
is currently known. It may be possible to infer cushion residual stresses, and
then relate to the homeostatic stress, through incision methods similar to those
used to study arteries. At the same time, it is important to note that the biolog-
ical rational of stress-based growth and consequently a stress-based homeostat
is still a subject of debate in the morphomechanics community [5]. Different me-
chanical or molecular criteria may better define the nature of the tissue homeo-
static state.
Several biological details were incorporated in the growth model. Fluid
loads were determined from in vivo velocity measurement acquired from ul-
trasound imaging. The material law parameters were acquired from previous
mechanical testing. The model also included a gradient in growth rate, which
was motivated by cell distributions seen from AV cushion histology sections.
More experimental work is needed to verify whether mass addition and ECM
production is spatially dependant in this way. Although significant experimen-
tal data was incorporated in the model, additional biological features would
enhance the predictability and insight of the simulation. Inclusion of multiple
constituents through mixture theory is a step in this direction. Mixture the-
ory approaches have successfully modeled constituent turnover and mechani-
cal feedback responses in models of arteries [82, 147]. Incorporating molecular
details into future growth and remodeling similations is essential for defining
the relationships between cellular and tissue scale events. This is particular rel-
evant for valve development as there are several gene specific defective valve
phenotypes with both physiologic and clinical significance.
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In this study, we have correlated the distribution of the fluid loads and an
isotropic homeostatic stress state with valve-like morphology of the AV cush-
ions. Pressure appears to be the key load responsible for cushion growth and
remodeling, but shear tractions may serve an important role in surface remod-
eling. Inelastic shear deformations were shown to be important for acquiring
the valve-like evolved configuration. The model also indicated that the me-
chanical aspects of valvulogenesis may be self-propagating, as the elongated
valve shape generated fluid force profiles which promoted further cushion elon-
gation. While this elongated morphology is appropriate for modeling the AV
cushion, it may not accurately portray growth and remodeling in other valves
of the heart [40, 109]. Additional refinements, such as increasing the degree of
freedom of the cushion material at myocardium interface and including growth
of the AV canal, may be necessary to reproduce themorphology of other leaflets.
Novel in vitro and in vivo experiments are needed to establish the nature of the
homeostatic state, which could be analyzed with this growth law. This model
may also inform researchers on the optimal location or magnitude of mechani-
cal perturbation needed to generate disease state animal models. For instance,
the shear stress could be modulated by using blood viscosity modifiers, or the
AV canal pressure drop increased through left atrial ligation. In all, our growth
model provides a useful framework on which to investigate morphological as-
pects of valve development, and motivates further experimental studies toward
understanding mechanical signaling in vivo.
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CHAPTER 6
EDUCATIONAL OUTREACH AND BROADER IMPACTS
6.1 Introduction
Early connections to and appreciation for physical processes in biology are key
motivators for students to pursue biomedical engineering careers. Yet encour-
aging this science passion among students is difficult, and requires techniques
to assist students in identifying themselves as science learners. As a NSF GK-12
fellow, I had the unique privilege of addressing these issues as a mentor and
“resident scientist” for at-risk middle school students. I was paired with a mid-
dle school teacher for one year, and high school teacher for a second year at
Elmcrest Children’s Center in Syracuse, NY. Focusing primarily on my research
area of heart valve development, I engaged the students through interactive lec-
tures, extensive Q & A sessions, and a hands-on curriculum involving data sets
frommywork. The curriculummodule has culminated in amanuscript submis-
sion to the American Biology Teacher (see Sec. 6.4), which is a practitioner journal
focused toward life science teachers. This outreach experience demonstrated
that embryonic development can effectively connect students to biology, and
instill wonder as students realize that they themselves were formed through a
similar process.
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6.2 Ask a Scientist
Questions are an important instrument students utilize to broaden their under-
standing of the world. Students are naturally interested in knowing the answer
to their own questions, and hence question formation engages students in sci-
ence. To encourage scientific thinking and question asking, our teaching team
constructed an “Ask a Scientist” box for student submitted questions. The box
allowed questioned to be asked with anonymity, removing the sometimes in-
timidating situation of asking a question in the classroom. More often than not
though, students signed their questions and wanted others to know what they
had asked. Questions ranged from simple and silly to more technical and com-
plex. Others were more reflective, with students asking me personal questions
about why I chose to be a scientist and what I liked about science. Though not
comprehensive, below is a list of questions submitted to the “Ask a Scientist”
box which gives a snapshot into the thoughts of the science students.
 Do you have any experiments with explosions? Have you made explo-
sives?
 Howdo you know that the chick’s heart starts the sameway that themam-
malian heart?
 Can you dissect a frog for us?
 What tools do you need to dissect a chicken?
 How can people live so long? Who was the first person who was on the
earth?
 If an elevator was coming down the shaft and broke and you jump right
before the elevator hits the floor, assuming the elevator doesn’t crush like
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a can, could you still not get hurt?
 Mr. B, how is penicillin made?
 How many beats does a chicken heart have in a second? Why do people
research on chick hearts and what’s so important about chick hearts?
 Why do you like science? Do you like the field of work you do?
 Why are you so happy with your job? What’s so special about it?
6.3 Informal Lectures
In a more traditional teaching approach, I also gave short talks on a variety of
topics throughout the year. Students were free to ask questions at any point
during the talk, which consequently morphed the talk into an interactive Q&A
session. Corralling the sometimes scattered and unrelated question back to the
discussion was a recurring challenge, yet was also great practice for me in man-
aging conversations. Some representative lectures are presented below.
Collaboration in Science
Science is becoming an increasingly more fluid and networked career area.
Disciplines which had little to no crossover 50 years ago, now find that their
interface is on the cutting edge of current research trends. Heart disease is an
example of a research problem which requires a collaboration of many differ-
ent fields in both the pure and applied sciences, as seen in Figure 6.1. Biology
and biochemistry investigate the initiation of valve calcification, while clinicians
and pharmacologists seek therapies to reverse its progression. Biophysicists and
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Figure 6.1: Schematic of scientific collaboration which emphasises the in-
terdisciplinary nature of science. Heart disease is presented as
an example of a scientific problem.
mechanical engineers study the role of the mechanical environment in exacer-
bating disease states, and provide models which computational biology scien-
tists can simulate numerically. The exciting thing about such collaborations is
that solutions to difficult problems are systematically discovered by utilizing
the strengths of every participant.
Importance of Animal Models
Biological systems share common life sustaining processes. The study of one
species can provide general insights into many others. In the context of under-
standing and preserving human life, animal models are of prime value. Without
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these models, we would not have the medical advances taken for granted today.
For example, genetic alterations in mice have uncovered the necessity, function,
and significance of a plethora of proteins leading to our knowledge of heredi-
tary diseases and direction towards effective treatments in humans. Likewise,
animal research benefits veterinary science in treatment of animal diseases with
applications in animal population control and domestic animal care. For stu-
dents, however, animal research is often a difficult topic because the study of
vital organ systems or development necessitates the ultimate death of the ani-
mal studied. The discussion moves quickly from matters of scientific interest to
one of ethical and moral dilemma. It was my observation that teachers, admin-
istrators, and students are hesitant to engage in dialogue over these issues. This
hesitancy to broach the ethical dilemma in fact prevented my bringing one of
the more hands-on portions of my research to the classroom.
The topic of animal models provides an opportunity for students to wrestle
with their understanding of the world and their value systems. A more for-
mal discussion would reveal the unconscious double standard among most stu-
dents, namely that scientific research on animals is wrong, yet consumption of
animals for food and comfort is completely appropriate. In the discussions I did
have in the classroom regarding animal research, I emphasized that the scientific
community has established strict standards for humanely treating animals, and
how the results of this research have benefited animal medicine, as well as hu-
man medicine. Unjustified animal cruelty was condemned, and I affirmed the
professional and respectful nature scientists are called to exercise when dealing
with animal specimens. The approach the teacher and I took in handling these
discussions with our students was a good start. In future classes, a more for-
mal and intentional treatment of the topic would, in my mind, better serve the
151
students.
Relating to the Microscale
Much of life science research works around the 1-100 micron length scale,
which is a nebulous unit of measurement for students who relate best to every-
day length scales of inches and meters. To assist the students in relating to the
size of a micron, I constructed a slideshow of images of the back of a penny
taken at different magnifications. Starting at the highest magnification, I had
the student guess what the object was, reminding them to consider the scale
bar. After revealing the penny’s identity, the student now had a reference point
for the micron scale, namely: Abraham Lincoln’s thumbnail is approximately
200 m long.
Modeling Projectile Motion
Mathematical modeling of physical phenomena is an important tool in sci-
entific research. To practice this skill, the students and I teamed up to model
projectile motion. Due to the student’s lack of calculus background, the discus-
sion focused on specifying the governing laws involved, appropriate assump-
tions about the projectiles properties, and nature of the forces acting on the pro-
jectile. Table 6.1 summarizes the key components of the modeling discussion.
Without the knowledge of integration, the students predicted the trajectory of
two different objects. The first was a wad of notebook paper, whose behavior
is dominated by the gravitational force, and the other a slightly compacted tis-
sue, which has resistive air forces on the order of the gravitational force when
launched with a high initial velocity (see Figure 6.3). Of course, testing the
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Table 6.1: Key Consideration in Modeling of Projectile Motion
 Governing Laws: Newton’s Laws of Motion
– Objects in motion stay in motion unless acted upon by an external
force
– The change in momentum is proportional to the motive force
F =
d
dt
(mv)
– For every action there is an equal and opposite reaction
 Forces Involved: gravity and air resistance
 Relevant Physical Properties
– Shape: affects air resistance and center of mass location
– Density: mass distribution affects center of mass
– Surface Area: affects the air resistance
 Assumptions:
– Object is not magnetic
– Color or chemical composition of object does not affect trajectory
153
(a) (b)
(c) (d)
Figure 6.2: Progression of magnified images of the Abraham Lincoln
penny. This established a reference point of the microscale for
the students.
hypothesis was the most interesting part of the exercise as selected students
were allowed to launch the wad of pad and the wad of tissue and compare the
trajectories. In the gravity-dominant case, the projectile’s trajectory follows a
parabolic path as expected. Interestingly, the wad of tissue had a triangular tra-
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Figure 6.3: Schematic of projectile motion models and resulting trajecto-
ries
jectory, which was a consequence of the air resistance. This modeling exercise
strengthened the students’ intuition for knowing what is necessary to consider
when describing a system. Projectile motion proved to be a great case study
as all students had previous experience with flying objects and were naturally
interested.
Biomedical Engineering Imaging Tools
Advancements in imaging technology have led to breakthroughs in the
biomedical sciences. Two imaging techniques used in the Cardiovascular En-
gineering lab at Cornell University are ultrasound and micro-computed tomog-
raphy (micro-CT). Possessing the ability to non-invasively probe inside spec-
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imens, these tools are ideal for continuation studies of living systems, such
as the study of embryonic heart development. Ultrasound technology defines
the spatial boundaries between acoustically different media in the specimen by
interpreting the scattering of high frequency sound waves of a source probe.
Micro-CT is a high- resolution (25 m x 25 m) x-ray machine which maps the
specimen’s 3D geometry by interpreting the diffraction pattern of radioactive
particles colliding with the specimen.
6.4 Retinoic Acid and Embryonic Development Curriculum
As required by the NSF GK-12 Fellowship program, I developed a curriculum
module related to my area of research. The aim of this work was not only to
communicate important scientific concepts, but also to instill a sense of discov-
ery and excitement in my students. The ex ovo culture system was an ideal ap-
proach to achieve both of these goals. The following article was a collaborative
effort amoung Russell Gould, Susan Curran, Shivaun Archer, Jonathan Butcher
and myself. The article has been submitted to the The American Biology Teacher,
which is a practitioner’s journal for primary and secondary teachers in the life
sciences.
Multidisciplinary inquiry-based learning using an ex ovo chicken culture
platform - Role of vitamin A on embryonic morphogenesis
Embryonic development offers a unique perspective on the function ofmany
biological processes and their heightened sensitivity to environmental factors.
This hands-on lesson investigates the effects of elevated vitamin A on the mor-
phogenesis of chicken embryos. The active form of vitamin A (retinoic acid)
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is applied to shell-less (ex ovo) cultured chick embryos, which are highly ac-
cessible and intrinsically spawn inquiry. The student activities mirror the sci-
entific research process, including review of the scientific literature, hypothesis
formation, experimental design, interpretation of data, and re-evaluation of ini-
tial hypothesis. This exercise supports instruction on developmental biology,
biophysics, animal research, and experimental design, and is motivated by a
clinically relevant health issue.
6.4.1 Introduction
Major congenital defects occur in 2.5% of all near or full-term babies [45]. These
malformations affect multiple body systems, and are caused by both genetic
and environmental factors. Chromosomal rearrangements or local mutations
within the genome can disrupt normal development, such as with Down and
Patau syndromes. Environmental factors are chemical, molecular, and mechan-
ical stimuli which can guide or misdirect embryonic development. Common
negative environmental factors include maternal substance abuse, pollutants,
nutritional deficiencies, and/or medications. In this exercise, we investigate the
role of a nutritional environmental factor (vitamin A metabolite), in directing
embryonic chicken development.
Retinoic Acid (RA) is the active form of vitamin A and has been correlated
with severe congenital defects at both surplus and deficient levels of mater-
nal consumption [1, 197]. RA regulates cell differentiation, proliferation, and
development-related gene expression through interactions with retinoic acid re-
ceptors located on the DNA [97]. The specific RA signaling mechanisms for tis-
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sue morphogenesis are still an active area of research. Excessive consumption
of vitamin A supplements has been correlated with increased risk of congenital
defects of newborns [157]. Furthermore, the increased use of RA for medicinal
purposes, such as treatment of acne (tretinoin) underscores the importance of
clarifying the role of RA in birth defect formation.
The chick embryo is an excellent animal model in which to study human
morphogenesis of the heart, limbs, and eyes [39]. Advantages of using the chick
embryo for research include short development times, no maternal sacrifice,
and ease of access for observation and treatment administration. Shell-less (ex
ovo) chick culture furthers this access by allowing real-time observation of the
whole chick and its complement of extraembryonic vasculature. Ex ovo culture
is an intrinsically inquiry-based classroom activity as the natural response of
students is to ask, “How can a chick embryo develop without a shell?” The high
school lesson engages this enthusiasm by exploring the role of vitamin A in de-
velopment, and the negative consequences of vitaminA excess. The teaching ac-
tivities include an interactive background of RA scientific literature, hypothesis-
driven experiments, hands-on ex-ovo culture with RA treated embryos, system-
atic measurement of growth, and interpretation of data in the context of the re-
viewed literature. This exercise supports instruction in developmental biology,
molecular signaling, animal research, experimental design, and is motivated by
a clinically relevant health issue using current scientific research.
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6.4.2 Preparing for the Study
Materials and Methods:
 Fertilized white Leghorn chicken eggs (local poultry farm)
 Egg Incubator & Rocker (HovaBator, GQF Mfg. $60- $100)
 Cling Wrap
 70% ethanol
 Rubber bands (#16, 2.5 in)
 Rubber gloves & Safety Glasses
 9 oz plastic cups (Dia. 3in)
 100 mm diameter Petri dish
 Whatman Filter Paper Size 3
 1.5 ml centrifuge tubes (optional)
 Forceps
 All-trans-Retinoic Acid (Sigma-Aldrich R2625 $30)
 Dimethyl Sulfoxide (DMSO, <10ml)
 USB Microscope Veho VMS-100 ( $70) or alternative large working dis-
tance scope
 Bleach
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Preparation of Incubator and Chick Embryos
Fertilized white Leghorn chicken eggs should be obtained from your local
poultry farms. These fertilized embryos can be stored in a cooler maintained at
13 C (55 F) for up to 3-4 days until ready for use. Prior to the start of your ac-
tivity, clean out incubator with soap and water to remove contaminates. Dilute
bleach or 70% ethanol may be used to sterilize incubator. Line base of incubator
with aluminum foil for easy clean up and place thermometer inside. Pre-heat
incubator to 37 C (99 F), and let stand 1 hour to confirm constancy of temper-
ature. Place eggs blunt side up in incubator and turn on rocker to start chick
incubation (day 0). Include a 3
4
filled 9 oz cup of water inside incubator to main-
tain humidity.
Ex ovo Culture of Chick Embryos
After 72 hours (day 3), prepare hammocks for ex-ovo culture (Figure 6.4).
Fill the 9 oz plastic cups 3
4
full with warm water. Cut about 20 x 20 cm (8 x 8 in)
square of cling wrap and place loosely inside the cups. Cling wrap should be in
contact with water and form loose hammock. Secure cling wrap to cup with a
rubber band (Figure 6.4A). Spray the plastic wrap with 70% ethanol to prevent
contamination. Remove eggs from incubator after 72 hours of incubation. Ster-
ilize eggs by spraying surface with 70% ethanol. Lay the eggs horizontally on
egg carton for 1-2 minutes to allow the embryo to rotate (Figure 6.4B). Using a
sharp edge (like the edge of a metal bucket or a glass beaker), tap the egg gently
until there is a small dent on the underside of the egg (Figure 6.4C). Put thumbs
in opposite sides of the dent and open the shell directly above hammock (Fig-
ure 6.4D). The entire yolk, egg white, and embryo should fall into the hammock
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softly (Figure 6.4E). If the embryo is not on the top side of yolk, gently rotate
egg yolk with fingers (using gloves). Place a 100 mm diameter Petri dish on top
of the cup to seal the embryo. Transfer the embryo back into the incubator set
at 37 C with water cup to maintain humidity (Figure 6.4F). Observe embryos
as long as you would like or directed by the activity. We recommend that the
students perform the ex ovo culture under close supervision of an instructor or
teaching aide.
Figure 6.4: Step-by-step ex-ovo culture technique. A) Prepare hammocks
in plastic cups; B) Lay eggs on side to prep for cracking; C) Use
sharp edge to create narrow crack on center of egg; D) Care-
fully open egg shell directly above hammock and cup; E) Ro-
tate embryo to top side of egg yolk, F) Place in incubator at to
37 C (99 F)
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Motivate Study and Discuss Background
Before investigating the effect of vitamin A on the embryonic chick, it is im-
portant to motivate this study. Using the information outlined in the introduc-
tion, attempt to connect the overuse of vitamins and/or congenital birth defects
with the students’ experience with or perceptions of either issue. We found
this was best done through a brief, but interactive large group discussion. In
addition, we recommend discussing normal embryonic development, particu-
larly pertaining to chick development (Hamburger and Hamilton embryo atlas
images provided in the supplement and/or online at www.butcherlab.com).
Sufficient background information is needed to further place excess vitamin
A exposure in context and facilitate the students’ hypothesis formation. The stu-
dents were given excerpts from introduction sections of scientific and medical
journal articles to analyze. Field-specific literature was paraphrased to increase
the readability of the excerpts. With each excerpt we included a series of ques-
tions which assessed reading comprehension and the acquisition of scientific
concepts. Though reading technical literature can be difficult for students, com-
pletion of the exercise empowered the students and broke down the false notion
that scientific research can only be understood by scientists. The exercise is sim-
ilar to scientific reading comprehension questions on many standardized tests.
It may also be used as a graded activity, which provides early feedback for both
student and teacher on the progress of the project. We recommend small groups
of two or three students, preferably with a range of ability, for this exercise. An
initial read-through as a large group can remove any class-wide gaps in under-
standing. An example excerpt and questions are shown below, and additional
excerpts can be found online: http://climb.bme.cornell.edu/embryo.php
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Background Information Excerpt Example
Read the following excerpt from Ritchie et al [153] and answer the questions.
“Vitamin A is an essential nutrient required for normal embryonic devel-
opment. Both an excess and deficiency during gestation will result in abnor-
malities. Vitamin A (in its more common metabolic form, retinoic acid [RA]) is
teratogenic when orally administered to pregnant rats, mice, hamsters, guinea
pigs, rabbits and dogs. The induced malformations occur in all body systems
including the central nervous system (CNS), the face, the cardiovascular sys-
tem (ventricular septal defect, aortic arch anomalies), the limbs, the urogenital
system, the respiratory system, and the gastrointestinal system. [...] The ques-
tion then arises, would similar malformations be induced in humans exposed
to RA? Teratogenic outcomes have reportedly been associated with exposures
>40,000 IU [IU - international unit of biological activity] or >10,000 IU. Equally
reports have also suggested that supplemental RA intakes of <10,000 IU have
no increased risk of major malformation. This contradictory data in humans
highlights the importance of laboratory animal data in risk estimation.”
Background Questions to Help with Hypothesis Generation
 Q#1) List the stages of chick embryonic development and illustrate normal
morphology.
 Q#2) List the reported body systems that are affected by vitamin A excess
during development.
 Q#3) What does this excerpt indicate about the role of vitamin A in devel-
opment?
 Q#4) The authors indicate there is a “contradiction” in the human data.
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What is the contrary/conflicting data?
 Q#5) Why is the contradiction important to settle?
 Q#6)What are the animal models for vitamin A researchmentioned in this
excerpt?
 Q#7) Why are animal models important for this research?
 Q#8) Why are different animal species important for this research?
Experimental Design
After reading the background material and discussing it as a class, divide
the students into groups of 3-4 to prepare for experiment. Ask each group to
formulate and record a hypothesis on what will happen when RA is applied to
the vasculature network of the ex-ovo cultured embryo as compared to a nor-
mal embryo. Remind the students to develop a testable hypothesis, considering
ahead of time which metrics they will use to evaluate the hypothesis. In this
module, embryo “tip-to-tail” length and eye diameter were the two morpho-
logical parameters used to compare between treatments. “Tip-to-tail” length is
defined as the longest straight line drawn between a point on the head and a
point on the tail of the embryo (Figure 6.5). Other measurement ideas include
wing bud length, limb bud length, embryo area, heart rate, and vasculature
branching.
Example Hypothesis & Proposed Metrics
We hypothesize that excess vitamin A administered to the embryo vascula-
ture will affect the entire embryo and will result in stunted growth and reduced
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eye size. We will use “tip-to-tail” length as a metric of embryo growth and di-
rectly measure eye diameter. Control experiments are an essential component
Figure 6.5: Image of chick embryo in ex-ovo culture at 4.5 days of incuba-
tion. Annotations: 1) Eye; 2) Heart; 3L) Left vitelline arterty;
3R) Right vitelline artery; 4) Chorioallantoic membrane; 5A)
Anterior vitellene vein; 5P) Posterior vitellene vein; 6) Tip-to-
tail length; 7) RA filter paper
to any well-designed scientific study. Spend a brief, but thorough time explain-
ing the types and purpose of controls with the students. Solicit their assistance
in identifying the most appropriate controls for this study. We recommend two
controls: an untreated group (standard control), and a filter paper with DMSO
only (sham control). The standard control will provide the benchmark of nor-
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mal development to compare with RA treated, and the sham control to verify
that the effects observed are not due to the filter paper or the RA solvent, DMSO.
6.4.3 Conducting the Investigation
Environment Perturbation Study: Addition of Vitamin A (Retinoic Acid)
From previous dose-dependent and temporal responses, we have deter-
mined that a RA concentration of 1mg/ml applied at day 4 of incubation in-
duces morphological changes by day 7 of incubation. We recommend that the
teacher mix and administer the RA treatment to the embryo. RA and DMSO
should be handled with gloves and safety glasses. Cut the Whatman filter pa-
per into 2-5 mm diameter circles or strips. Dilute 1mg of RA in 1ml of DMSO
in a 1.5ml tube. Place the filter paper sections in the 1.5ml tube and let soak
for 10-15 minutes. Using forceps, remove filter paper from RA solution and
place on the ex-ovo culture. We suggest placement of the filter paper on the
right side of the embryo, within the vasculature (Figure 6.5). Capture images of
the embryo and vasculature sequentially at day 4, day 5, day 6, and day 7 us-
ing the USB-microscope (Veho VMS-100, Figure 6.6 and 6.7). Measure the cho-
sen metrics of tip-to-tail length and eye diameter from these images using open
source software ImageJ (NIH, http://rsbweb.nih.gov/ij/). Simple instructions
for ImageJ are available at http://climb.bme.cornell.edu/embryo.php. Hand
measurement using a caliper or ruler is a viable alternative. Finally, record the
measurements in tables for each metric (Figure 6.8).
166
Figure 6.6: Experimental design consists of soaking filter paper in differ-
ent concentrations of retinoic acid (RA) and placing it on the
embryonic vasculature. Following several days of incubation,
a USB-microscope can capture the downstream effects on de-
velopment.
Analysis & Interpretation of RA Treatment Results
An essential part of the scientific process, and often the most challenging,
is to quantitatively analyze and correctly interpret the data. To assist with this
task, we recommend that the students plot the data, either digitally or by hand,
for each output measured (Figure 6.7). Instruct the students to use the data to
confirm or deny their initial hypothesis. If the hypothesis is confirmed, the stu-
dents must prepare a series of arguments from the data to support their claim.
If the hypothesis fails, the students must generate a new hypothesis based on
the results of the study. It is also important to consider the implications of these
results in a broader context. For instance, ask the students how these results
might relate to human development, or how the other unmeasured features of
the embryo, such as the internal organs, might be affected by the treatment.
Example Data Analysis & Interpretation Worksheet
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Figure 6.7: Retinoic Acid Perturbation Study Data Set. Array of ex-ovo
chick images across treatment and over time. RA treatment
stunted embryo development and even resulted in embryo
lethality at higher dosages
Using the generated tables, line graphs, and previous understanding of em-
bryonic development and RA, work through the following questions as you
analyze the data (Figure 6.8).
 Q#1) Compare the “tip-to-tail” length and eye diameter between the con-
trol and RA treatments. Did addition of retinoic acid stimulate or stunt
growth?
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– While the control and treated embryos had roughly the same start-
ing tip-to-tail length, by day 7 the control tip-to-tail length was 25%
greater than the embryos with 1mg/ml RA treatment. The 2mg/ml
RA treatment embryo died before day 7. These results suggest that
RA stunted and/or terminated the growth of the embryo.
 Q#2) Are the sham results different from the control? What do the sham
results indicate about our method of treatment?
– The sham results do not appear to be significantly different from the
control. This indicates that the defects were not induced by the filter
paper or DMSO, but instead can be wholly attributed to the addition
of retinoic acid.
 Q#3) Approximate the growth rate of each treatment by determining the
slope of the “tip-to-tail” curves. Which condition had the fastest growth
rate? Which was the slowest?
– Control - 0.39 mm/day, Sham - 0.34 mm/day, RA 1mg/ml - 0.25
mm/day, RA 2mg/ml - 0.2 mm/day. The control embryo had the
fastest growth rate and the 2mg/ml RA treatment had the slowest.
The control growth rate was roughly twice as fast as the 2mg/ml RA
treatment. This result agrees with the conclusion in question #1, that
RA stunted the embryo’s growth.
 Q#4) From our data, we see that RA treatment affected the global devel-
opment of the embryo, yet the treatment was applied locally. Why do you
think this is?
– Even though the retinoic acid is applied over a small area away from
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the embryo, it was placed on a blood vessel of the vasculature net-
work. This particular placement on a vessel facilitated the spread,
and uptake, of RA in the embryo body. This emphasizes the sub-
stantial role the circulatory system plays in nutrient consumption and
trafficking, demonstrating how high local concentrations of harmful
agents can have global consequences due to rapid transport through-
out the developing embryo.
 Q#5) Explain how an optimum (not too high and not too low) human ex-
posure to vitamin A measurement could be determined from similar ex-
periments.
– The upper-bound dosages for human embryos could be approxi-
mated from this studies data by scaling according to body weight
or blood volume.
6.4.4 Discussion
The embryo chick provides a unique lens through which to study general (cell
activity, organ systems) and development-specific (cell differentiation, morpho-
genesis) processes in biology and physics. Watching the embryo induces funda-
mental questioning of why some structures develop first vs. later on, how the
embryo is feeding itself, and how processes change with growth. The effects
of physics such as diffusion, transport, and mechanical forces can be incorpo-
rated into our lesson framework. Instructional versatility enables the breadth of
content to be appropriately scaled to student ability or knowledge base. For in-
stance, observation, measurement, and prediction of normal development may
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Figure 6.8: Quantification of Eye diameter and Tip-to-Tail length for RA
perturbation study using open source software (ImageJ) pro-
vided by the NIH.
be sufficient for middle school biology students, while the RA perturbation
model may be more appropriate for upper level high school students. In the
following, we present further background information and ethical issues with
animal research to extend the applicability of this lesson (Figure 6.9).
Metabolic and Molecular Aspects of Study - Mechanism of Action
Vitamin A is broken down into all-trans-RA and 9-cis-RA which is then
transported to the nucleus of the cell. Within the nucleus, all-trans-RA binds
to retinoic acid receptors (RAR) and 9-cis-RA binds to retinoid receptors (RXR).
RAR and RXR form RAR/RXR heterodimers, which bind to regulatory regions
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Figure 6.9: Engagement of students during the ex-ovo chick culture and
analysis of experimental results.
of the chromosome called retinoic acid response elements (RARE). Binding of
all-trans-RA and 9-cis-RA to RAR and RXR respectively allows the complex
to regulate the rate of gene transcription. In the case of all-trans-RA applied
systemically to a developing chick embryo, complexity arises since cells/tis-
sues will respond to the retinoic acid differently. For example, in the devel-
oping limb bud, tissue regression has been largely associated with the molec-
ular control of self-induced cell death (apoptosis). Brain defects have been
largely associated with the molecular control of cell migration. Therefore, we
suggest a generalized mechanism of action be used for explanation. Upon
excess RA administration, stunted growth may be the result of abnormal cell
migration or apoptosis which is regulated directly by the transcriptional com-
plex (all-trans-RA and 9-cis-RA to RAR and RXR) (Figure 6.10, adapted from
http://lpi.oregonstate.edu/infocenter/vitamins).
Bioethics of Animal Research
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Figure 6.10: Metabolic and molecular pathway of RA (advanced student
classrooms) describing the mechanism through which RA
regulates gene expression.
Using live embryos within the classroom will inevitably spark a conversa-
tion about humane treatment and ethics. We feel this is an extremely important
aspect, and should not be overlooked. From a purely regulatory standpoint, all
use of vertebrate animals in research, teaching and testing is regulated by the In-
stitutional Animal Care and Use Committee (IACUC, http://www.iacuc.org/).
Chick embryos younger than embryonic day 15 (E15) are assumed to be unable
to experience pain, because of limited neural development. It is recommended
that E14 or younger embryos be euthanized by hypothermia, typically by plac-
ing the eggs in a 20 C freezer. Chick embryos from E15 to pre-hatching should
be euthanized by decapitation, anesthetic agents, or another rapid and humane
method. Studies using embryos within three days of hatching or hatchlings
must be reviewed by the normal IACUC procedure for vertebrate animals. In
our experiments, embryos will be euthanized at day 7, which is only 1/3 of
173
the way through its 3 week hatching cycle. Therefore, the embryos cannot ex-
perience pain and are exempt from any IACUC protocols. This however, will
not limit conversation about the ethics of animal research within the classroom.
We encourage teachers to lead a classroom discussion on the role of animals
in scientific research, and use this time effectively to discuss humane treatment
and ethics. From our experience, the level of concern and opinions will vary
from class to class. It is imperative to guage student sensitivity in a considerate
and objective manner before conducting the experiments. Resources for animal
research ethics can be found on the web: www.ethics.org.
6.5 GK-12 Experience Summary
The GK-12 program has been asmuch a learning experience for me as a teaching
one. Students face social and family difficulties that supersede their academic
challenges, something I didn’t fully appreciate before the GK-12 program. The
baggage from broken homes and relationships makes its way into the class-
room, disrupting the students’ focus and confidence. The GK-12 fellowship
is not designed to address these family issues, however, by sharing positive,
affirming, and educational moments with students, we create a safe place for
students to think and achieve. In all, I think the approach our teacher-fellow
team took to engage students, through open Q & A sessions, informal lectures,
and a unique curriculum module, was successful. Support for this statement
comes from student comments about our curriculum:“This is awesome! I want
to know everything about the body!” and “I like science now!”. Another indica-
tor of program success was that four students asked me for information about
attending Cornell, and others started thinking about college, quite possibly for
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the first time. Though intangible, it is these student interactions that I will re-
member, and I know that the GK-12 program benefited everyone involved.
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CHAPTER 7
CONCLUSION
The formation of the embryonic heart is truly a complex and fascinating pro-
cess regulated by mechanical and molecular feedback. In this study, we have
identified some specific mechanisms of mechano-molecular feedback, devel-
oped tools to measure mechanical properties, and implemented a computa-
tional framework of growth and remodeling on which to further explore valve
development. We now summarize the conclusions and contributions of this re-
search. Remaining research questions and future directions are discussed.
Quantification of avian embryonic AV valves
The mechanical properties of post-EMT valves were previously not charac-
terized. Through this work, we have quantified how valve stiffness increases
and how the valve transitions from a globular to a planar geometry during
this period of valvulogenesis. We developed a new method for interpreting
the pipette aspiration experiment for soft, nonlinear materials using an analytic
expression. This extends the use of the method beyond the linear elastic range
and eliminates the need for computational simulations to evaluate each data set.
Our exponential material law sufficiently captures the nonlinearity observed in
early stage embryonic valve tissues. The deformable post technique was also
implemented to test the planar valve at the later stages of development. We
anticipate that these techniques may be of use to development biology labs in-
terested in measuring mechanical properties.
This study demonstrated a significant level of anisotropy present in the valve
by stage HH36 (Day 10). The origin of this anisotropy is an important follow-up
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research question. The role of molecular and/or mechanical signals in stimulat-
ing these microstructural changes is still unknown, although the valve commu-
nity does know some of the ECM proteins involved [88, 94]. Preliminary data
from the lab suggests that increases in ECM fiber density and orientation are
primarily responsible for the anisotropy (see Appendix A Figure A.1), but these
features have not been quantified. Mechanical aspiration with a circular pipette
is an isotropic technique. We hypothesize that a rectangular pipette may be able
to distinguish effects of tissue anisotropy. FE simulation is needed to validate
this hypothesis. Developing a constitutive lawwith ECMfiber details is another
direction for this work
Biomechanical Remodeling by TGF3 and 5-HT in post-EMT Valves
The biomechanical remodeling capacity of two key signaling pathways was
identified through this study. TGF3 stimulated 2-fold increases in tissue stiff-
ness and proliferation rates in AV cushion hanging drops. 5-HT potentiated
the effect of TGF3 through the 5-HT2b receptor, but may also act through
other downstream interactions. We identified an interesting dynamic between
the remodeling processes of cell contraction, proliferation, and ECM synthe-
sis. TGF3 treatment increased cell contractile behavior, but the AV cushion ap-
peared less compacted than the control because proliferation and ECM synthe-
sis compensated for the volume change due to compaction. The interaction of
5-HT and TGF3 was further demonstrated in vivo through system 5-HT treat-
ment of avian embryos. These results provide a specific molecular mechanism
for stiffness generation, and may have implications for the how the anisotropy
discussed in the previous section occurs.
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Two different lines of research are motivated by this study. First, we have
established a novel in vitro culture system which can be used to investigate the
effect of other molecular signals on AV cushion mechanics. A natural follow-
up study would be to investigate downstream points of interaction between
TGF and 5-HT signaling. Alternatively, the system could be used to study
non-molecular stimuli such as osmotic pressure changes.
Second, having established that TGF is important in the biomechanical re-
modeling process, it would be interesting to see the effect of removing TGF.
We have begun to investigate this question using a TGF2 KO mouse model.
The TGF2 isoformwas chosen for the mouse because it appears to perform the
same function as TGF3 does in the chick during EMT [29]. TGF2 KO valves
have an odd morphology, characterized by an increased, ”butterfly-shaped”
volume (see Appendix A Figure A.2) [14]. This morphology is hypothesized to
be the continuation of EMT into what are normally considered post-EMT stages
[11]. Our preliminary data shows that the KO valves are stiffer than WT valves
(see Appendix A Figure A.3). This neither agrees with the avian cushion re-
modeling data, nor with the histology results of other groups that show the KO
valves have increased glycoaminoglycan content, which is a structurally weak
constituent [11, 10]. Although hard to interpret, the stiffness result does confirm
that TGF regulates valve mechanics, but not in a binary way. More research is
needed to reconcile these differences.
AModel of Mechanically Stimulated Growth and Remodeling
The role of mechanical stimulation in tissue growth and remodeling will
increasingly be a focus of research in the developmental biology and biome-
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chanics communities. We have derived an evolution equation for tissue growth
and shape change using the conservation laws of continuummechanics and the
entropy inequality. Our formulation includes a remodeling force balance law,
which was previously proposed in a different form [42]. We introduce a home-
ostatic stress state, which is the stress at which growth ceases, as a biological
force through this balance law. The mechanical energy of newly created tissue
is still an open question in the growth mechanics field. We propose that the
free energy of this new tissue is non-zero, but not necessarily equal to the cur-
rent free energy of the body. Our numerical examples indicated that varying
the free energy term adjusts the rate of isotropic volume growth or modulates
the hydrostatic pressure, depending on whether problem is stress-controlled or
displacement-controlled.
Future work on this growth model should include both theoretical and ex-
perimental components. The model currently assumes that the tissue is a single
constituent, but in reality tissues consist of several constituents. Although the
single constituent theory adequately models the bulk mechanical behavior, the
microstructural details, such as a shift in constituent volume fractions, are ab-
sent from the model. Histology data from our lab indicates that the shift from
GAGs to collagen during valvulogenesis is significant [94, 28]. Incorporating
these details would increase the biological relevance of the growth model. The
mechanical nature of homeostasis is an important and largely open question.
Novel experiments are needed to characterize the homeostatic mechanical stim-
ulus to which cells respond and attempt to mitigate. Molecular signaling may
also affect biomechanics, either through direct activation of remodeling pro-
cesses or indirectly by reprogramming the preferred homeostatic mechanical
state. Experimental insights of this nature are needed in order for the concept
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of a homeostat to move from a descriptive to a mechanistic feature of growth
models.
Computational Model of AV Valvulogenesis
We then applied our growth theory to the specific application of modeling
the development of AV valves. We showed that the distribution of fluid pressure
and shear tractions was sufficient to generate a valve-like shape. This required
the assumption of a compressive, isotropic, homeostatic state, which was justi-
fied by the compressive loading the valve experiences during these stages. As
the valve remodeled, the fluid forces on the new shape promoted further elon-
gation and condensation of the leaflet. This suggested that fluid-driven valve
growth may be a positive feedback system. Residual stress developed at the
valve/myocardial interface due to the discontinuity in growth rate across that
line. Significant circumferential residual stress developed at the leading edge
of the cushion due to radial growth toward the axis of symmetry. Residual
shear stress was localized to the inflow and outflow valve surfaces near the my-
ocardium. We also demonstrated the importance of inelastic shear deformation
in generating the leaflet-like shape. These simulations support the hypothesis
that mechanical forces are key drivers of valve morphogenesis.
Our focus was on modeling normal valve development, but this computa-
tional framework could naturally be extended to understanding defect forma-
tion. Future work for this project is to use fluid loading profiles from flow per-
turbation studies to model the defective morphology seen in experiments. The
significance of the homeostatic state can also be investigated with this model.
For example, the enlarged ”butterfly-shaped” valves observed in the TGF2 KO
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mouse can be generated by adjusting the spatial distribution of the homeostatic
stress (see Appendix A Figure A.4). Simulations of this nature may provide
insight into where, or what, to look for when trying to identify what defines
homeostasis. More biological details could also be incorporated into the model.
For example, in vivo AV canal geometries quantified using micro-CT could be
imported into ANSYS. Similarly, the 3D geometry of defective AV canals could
also be simulated in this way. This would evaluate the dependence of valve
growth on initial geometry, and potentially provide some clinically relevant in-
sights.
Conclusion
The mechanical and molecular signaling results of this work have implica-
tions for congenital heart defects (CHDs). We have characterized the normal
mechanical properties of AV valves, which can now be used to identify defective
valves. Our results establish the efficacy of TGF3 and 5-HT to regulate tissue
mechanics, which motivates including these genes in future studies of specific
CHDs. Then through a theoretical growth law, we demonstrated the potential
capacity of mechanical signaling to direct normal valve formation. Our compu-
tational growth model can be extended to analyze experimental models of CHD
formation. In all, this dissertation contributes to the current understanding of
heart valve mechanics and molecular signaling, and provides new directions
for future research.
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APPENDIX A
APPENDIX A - FUTURE WORK/PRELIMINARY DATA
Formation of ECM Anisotropy in AV Valve
Figure A.1: AV cushion transitions from an isotropic ECM at day 5 to sig-
nificantly anisotropic ECM by day 12. Left AV leaflets at 10x
and 40x maginication. Leaflets stained with general amino
acid stain 5-(4,6-dichlorotriazinyl)aminofluorescein (5-DTAF),
50 M for 30 min
Defective valve morphology in TGF2 KO mice
TGF2 deficient AV valves were larger than WT valves with approximately
a 3.6 fold increase in cross-sectional area. KO valves were irregularly shaped
and demonstrated delayed formation of the fibrous ventricular septum. Cell
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count was 3-fold higher in KO valves, but no statistical difference in cell density
was observed.
Figure A.2: TGF2 KO Morphology A) Massons trichrome stain of E14.5
wildtype (WT) and knockout (KO) whole hearts (70x scale bar
= 200 m) and AV valves(150x scale = 100 m) B) Significant
increase in valve cell number in KO overWT. mean SD, *p<
0.05 t-test, n = 3 C) Cell density was not statistically different
between WT and KO. mean  SD, t-test, n = 3, density units
cells(104 m2) n = 3, mean  SD, *p<0.05 t-test
TGF2 KO mice have stiffer AV valves at stages E12.5 & E14.5
Pipette aspiration demonstrated that post-EMTAV valve stiffness is elevated
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over WT and HET embryos. KO strain energy density was approximately 1.3
fold over WT at E12.5 and 1.5 fold at E14.5.
Figure A.3: Valve stiffness is elevated in TGF2 KO A) Representative
P vs  curves for E14.5 WT and KO embryos. B) Calcu-
lated strain energy densities of WT, HET, and KO genotypes
at stages E12.5 and E14.5. mean  SD, n = 6, *p < 0.01 wrt to
WT and HET, 1-way ANOVA wrt genotype
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TGF2 KO morphology can be modeled by varying the homeostatic stress
Figure A.4: “Butterfly” morphology of TGF2 KO can be simulated by
having a more compressive homeostatic stress () on the in-
flow (top) side relative to the outflow (bot) A) Color map of the
dilatation rate after initial loading B) Inelastic Jacobian which
represents the change in volume
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APPENDIX B
APPENDIX B - MATLAB FILES
Appendix B contains the key Matlab files that were used to either generate nu-
merical data presented in the thesis, or to aid my understanding of how the
FE algorithms worked. All supporting function files are in the Matlab folder
attached with the thesis. All executable files have the word “Run” in the file-
name.
B.1 Fixed Stress Growth
Purpose: Determine the evolution of the inelastic deformation under a fixed
elastic stress, f = const, with a homeostatic stress, and two possible incoming
free energies,   = 0 or   =    . Results are presented in Chapter 5.
B.1.1 Fixed Stress Run
1 %Fixed Elastic Stress PB 5.21.12
2 clear;clc;close all
3
4 %Assume components of b = f*f’ are constant
5 %with respect to time. Therefore the elastic
6 %stretches and the stress are constant in time.
7 %This code looks at the evolution of the growth
8 %tensor G under such a loading. Hydrostatic strain
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9 %theta determined using S33=0 BC
10
11 %Homeostatic Stress can be changed in the ode file
12
13 %Evaluate 2 Incoming Free Energies
14 %1) Wh = 0 --> dW=-W
15 %2) Wh = W --> dW=0
16
17 %Parameters
18 mu = 10; %Shear Modulus
19 a = 0.01; %Integration Factor
20 L1 = 1; %Axial Stretch Ration
21 k = 0.3; %Shear Parameter
22 %f0 = [cos(phi) sin(phi) 0; -sin(phi) cos(phi) 0; 0 0 1];
23 f0 = [L1 k 0; 0 1/sqrt(L1) 0; 0 0 1/sqrt(L1)];
24 b0 = f0*f0’;
25
26 IC = [1,1,1,0,0,0,0,0,0];
27 tspan = [0,1];
28 for j = 1:2
29 IC = [1,1,1,0,0,0,0,0,0];
30 theta = b0(3,3);
31 MAT = [mu,a,j];
32 [t,f] = ode45(@remod_shear_traction_ode2b,...
33 tspan,IC,[],f0,MAT,theta);
34 if j==1 %dW = -W
35 f1 = f;
36 t1 = t;
37 % [theta1,TRb1] = back_solve(t,f,F0,MAT);
38 elseif j==2 %dW = 0
39 f2 = f;
40 t2 = t;
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41 % [theta2,TRb2] = back_solve(t,f,F0,MAT);
42 end
43 end
44 %Plot Results
45 det1 = f1(:,1).*f1(:,2).*f1(:,3) - f1(:,4).*f1(:,5).*f1(:,3);
46 det2 = f2(:,1).*f2(:,2).*f2(:,3) - f2(:,4).*f2(:,5).*f2(:,3);
47 fixed_f_G_stretch2(t,[f1(:,1),f2(:,1)]) %G11
48 fixed_f_G_stretch2(t,[f1(:,2),f2(:,2)]) %G22
49 fixed_f_G_stretch2(t,[f1(:,4),f2(:,4)]) %G12
50 fixed_f_G_stretch2(t,[det1,det2]) %det(G)
B.1.2 Fixed Stress ode
1 function [dydt] = remod_shear_traction_ode2b(t,y,f0,MAT,theta)
2
3 mu = MAT(1); a = MAT(2); j = MAT(3);
4 %Solve for Growth Tensor
5 G11 = y(1);G22 = y(2);G33 = y(3);
6 G12 = y(4);G21 = y(5);G13 = y(6);
7 G31 = y(7);G23 = y(8);G32 = y(9);
8
9 G = [G11 G12 G13; G21 G22 G23; G31 G32 G33];
10 f = f0; %Elastic Deformation
11 %--------------------------------------------------
12 %Homeostatic Stress - Sigma_33 = 0
13 Lh = 1;
14 fh = diag([Lh,1/sqrt(Lh),1/sqrt(Lh)]);
15 %--------------------------------------------------
16 %Elastic Stress - Sigma_33 = 0
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17 Lab = Elsheby(f,fh,mu,j,theta);
18 Gdot = a*det(G)*Lab*G;
19 dydt = [Gdot(1,1);
20 Gdot(2,2);
21 Gdot(3,3);
22 Gdot(1,2);
23 Gdot(2,1);
24 Gdot(1,3);
25 Gdot(2,3);
26 Gdot(3,1);
27 Gdot(3,2)];
28
29 function Lab = Elsheby(f,fh,mu,j,theta)
30 b = f*f’;
31 bh = fh*fh’;
32 W = mu*(trace(b)-3);
33 if j==1
34 Wh = 0;
35 elseif j==2
36 Wh = W;
37 end
38 sig = 2*mu*(b - theta*eye(3));
39 sigh = 2*mu*(bh - bh(3,3)*eye(3));
40 Lab = f’*(sig-sigh)/f’ +(Wh-W)*eye(3);
B.2 Fixed Displacement Remodeling
Purpose: Determine the evolution of the inelastic deformation under a fixed
displacement, F = const, with a homeostatic stress, and two possible incom-
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ing free energies,   = 0 or   =    . At t = 0, an incompressible, purely
elastic deformation is applied to a solid cube and held. The inelastic deforma-
tion evolves to return the current stress to the homeostatic level. Results are
presented in Chapter 5.
B.2.1 Fixed Displacment Run
1 %Remodeling in Shear PB 6.03.12
2 clear;clc;close all
3
4 %Assume a fixed shear deformation and simulate
5 %tissue remodeling.
6 %Evaluate 2 Incoming Free Energies
7 %1) Wh = 0 --> dW=-W
8 %2) Wh = W --> dW=0
9
10 %Homeostatic stress can be adjusted within
11 %the ode file
12
13
14 %Parameters
15 k = 0.5; %Shear Parameter
16 mu = 10; %Shear Modulus
17 a = 0.1; %Integration Factor
18 L2=1; %Axial Stretch Ration
19 F0 = [L2 k 0;0 1/sqrt(L2) 0; 0 0 1/sqrt(L2)];
20 %F0 = [1 0 0; k 1 0; 0 0 1];
21
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22 %IC = [G11, G22, G33, G12, G21]
23 IC = [1,1,1,0,0,0,0,0,0];
24 tf = 1;
25 tspan = [0 tf];
26 %W Loop - Free Energy
27 for j = 1:2
28 MAT = [mu,a,j];
29 [t,f] = ode45(@remod_shear_ode,tspan,IC,[],F0,MAT);
30
31 if j==1
32 f1 = f;
33 G11 = f(:,1);
34 G22 = f(:,2);
35 G12 = f(:,4);
36 t1 = t;
37 [theta1,TRb1,S1] = back_solve(t,f,F0,MAT);
38 elseif j==2
39 f2 = f;
40 G11_2 = f(:,1);
41 G22_2 = f(:,2);
42 G12_2 = f(:,4);
43 t2 = t;
44 [theta2,TRb2,S2] = back_solve(t,f,F0,MAT);
45 end
46 end
47
48 %Hydrostatic Pressure w/ Zero Homeostatic stress
49 W = mu*(TRb1-3);
50 frac = [0,1,2];
51 THETA = zeros(length(W),length(frac));
52 for k = 1:length(frac)
53 THETA(:,k) = 1/3*TRb1 + W*(frac(k)-1)/(2*mu);
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54 end
55
56 fixed_f_G_stretch2(t1,[S1(:,1),S2(:,1)]/(2*mu));
57 fixed_f_G_stretch2(t1,[S1(:,2),S2(:,2)]/(2*mu));
58 fixed_f_G_stretch2(t1,[S1(:,3),S2(:,3)]/(2*mu));
59 fixed_f_G_stretch2(t1,[S1(:,4),S2(:,4)]/(2*mu));
60 fixed_f_G_stretch2(t1,[theta1,theta2]);
61
62 figure
63 plot(t1,THETA,t1,theta1,t2,theta2,’o’)
64 xlabel(’Time’); ylabel(’P/(2 \mu)’);
65 legend(’\Delta W = -W’,’\Delta W = 0’,’\Delta W = W’)
66
67 %Initialize Structures
68 Lt = length(t);
69 b11 = zeros(Lt,1);b22 = zeros(Lt,1);
70 b12 = zeros(Lt,1);b33 = zeros(Lt,1);
71 GG11 = zeros(Lt,1);GG22 = zeros(Lt,1);
72 GG12=zeros(Lt,1);GG33=zeros(Lt,1);
73 Sig11=zeros(Lt,1);Sig22=zeros(Lt,1);
74 Sig12=zeros(Lt,1);Sig33=zeros(Lt,1);
75 JG = zeros(Lt,1);Jb = zeros(Lt,1);
76
77
78 %Generate Movie of Deformation
79 for i=1:length(t)-10
80 G11 = f(i,1);G22 = f(i,2);G33 = f(i,3);
81 G12 = f(i,4);G21 = f(i,5);G13 = f(i,6);
82 G31 = f(i,7);G23 = f(i,8);G32 = f(i,9);
83 G = [G11 G12 G13; G21 G22 G23; G31 G32 G33];
84 GG = G*G’;
85
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86 ff = F0/G; %Elastic Deformation
87 b = ff*ff’; %Left-Cauchy Green
88
89 b11(i) = b(1,1);
90 b22(i) = b(2,2);
91 b33(i) = b(3,3);
92 b12(i) = b(1,2);
93 Jb(i) = det(b);
94
95 SX1 = G*[1,0,0]’; %Line 1-2
96 SY1 = G*[0,1,0]’; %Line 1-4
97 S13 = G*[1,1,0]’; %Line 1-3
98
99 x1 = F0*[1,0,0]’;
100 y1 = F0*[0,1,0]’;
101 x13 = F0*[1,1,0]’;
102
103 LX1x = [0,SX1(1)]; LX1y = [0,SX1(2)];
104 LY1x = [0,SY1(1)]; LY1y = [0,SY1(2)];
105 LXY1x = [SX1(1),S13(1)]; LXY1y = [SX1(2),S13(2)];
106 LYX1x = [SY1(1),S13(1)]; LYX1y = [SY1(2),S13(2)];
107
108
109 Lx1x = [0,x1(1)]; Lx1y = [0,x1(2)];
110 Ly1x = [0,y1(1)]; Ly1y = [0,y1(2)];
111 Lxy1x = [x1(1),x13(1)]; Lxy1y = [x1(2),x13(2)];
112 Lyx1x = [y1(1),x13(1)]; Lyx1y = [y1(2),x13(2)];
113
114 clf
115
116 line(Lxy1x,Lxy1y,’Color’,’b’,’LineWidth’,2,’LineStyle’,’--’)
117 line(LX1x,LX1y,’Color’,’g’,’LineWidth’,2) %Growth deformation
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118 line(LY1x,LY1y,’Color’,’g’,’LineWidth’,2)
119 line(LXY1x,LXY1y,’Color’,’g’,’LineWidth’,2)
120 line(LYX1x,LYX1y,’Color’,’g’,’LineWidth’,2)
121 line(Lx1x,Lx1y,’Color’,’b’,’LineWidth’,2,’LineStyle’,’--’)
122 line(Ly1x,Ly1y,’Color’,’b’,’LineWidth’,2,’LineStyle’,’--’)
123 line(Lyx1x,Lyx1y,’Color’,’b’,’LineWidth’,2,’LineStyle’,’--’)
124 xlabel(’X’,’FontSize’,20)
125 ylabel(’Y’,’FontSize’,20)
126 axis([0 2 0 2])
127 axis square
128
129 h = legend(’$F$’,’$\mathcal{F}$’);
130 set(h,’Interpreter’,’Latex’,’FontSize’,16,...
131 ’YColor’,[1 1 1],’XColor’,[1 1 1])
132
133 text(0.1,1.75,’$f \,=$’,’Interpreter’,’Latex’,’FontSize’,18)
134 text(0.25,1.75,num2str(ff(1:2,1:2),2),’FontSize’,18)
135
136 M(:,i) = getframe;
137 %Store Inelastic Deformation
138 GG11(i) = GG(1,1);
139 GG22(i) = GG(2,2);
140 GG33(i) = GG(3,3);
141 GG12(i) = GG(1,2);
142 JG(i) = det(G);
143
144 %Store Cauchy Stress
145 Sig = 2*mu*(b - 1/3*trace(b)*eye(3));
146 Sig11(i) = Sig(1,1);
147 Sig22(i) = Sig(2,2);
148 Sig33(i) = Sig(3,3);
149 Sig12(i) = Sig(1,2);
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150 end
B.2.2 Fixed Displacement ode
1 function [dydt] = remod_shear_ode(t,y,F0,MAT)
2
3 mu = MAT(1); a = MAT(2); j = MAT(3);
4
5 %Solve for Growth Tensor
6 G11 = y(1);G22 = y(2);G33 = y(3);
7 G12 = y(4);G21 = y(5);G13 = y(6);
8 G31 = y(7);G23 = y(8);G32 = y(9);
9
10 G = [G11 G12 G13; G21 G22 G23; G31 G32 G33];
11
12 f = F0/G;
13
14 %Homeostatic State
15 Lh = 1; kh = 0;
16 fh = [Lh kh 0;0 1/sqrt(Lh) 0; 0 0 1/sqrt(Lh)];
17
18 Lab = Elsheby(f,fh,mu,j);
19 Gdot =a*det(G)*Lab*G;
20 dydt = [Gdot(1,1);
21 Gdot(2,2);
22 Gdot(3,3);
23 Gdot(1,2);
24 Gdot(2,1);
25 Gdot(1,3);
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26 Gdot(2,3);
27 Gdot(3,1);
28 Gdot(3,2)];
29
30 function Lab = Elsheby(f,fh,mu,j)
31 b = f*f’; c = f’*f;
32 bh = fh*fh’;
33 W = mu*(trace(b)-3);
34 if j==1
35 Wh = 0;
36 elseif j==2
37 Wh = W;
38 elseif j==3
39 Lh = 1;
40 fh = diag([Lh,1/sqrt(Lh),1/sqrt(Lh)]);
41 bh = fh*fh’;
42 Wh = mu*(trace(bh)-3);
43 bh = diag([1 1 1]);
44 end
45 dW = Wh-W;
46 theta = 1/3*trace(c) + dW/(2*mu);
47 sig = 2*mu*(b - theta*eye(3));
48 sigh = 2*mu*(bh - trace(bh)/3*eye(3));
49 Lab = f’*(sig-sigh)/f’ +(Wh-W)*eye(3);
B.2.3 Fixed Displacement backsolve
Calculates the hydrostatic pressure neccesary to ensure the evolution is volume
preserving, L = 0.
1 function [Theta,TRb,S] = back_solve(t,f,F0,MAT)
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2 %Solve for the Cauchy stresses and
3 %hydrostatic pressure using the inelastic
4 %deformation results from the ode solver
5
6 Lt = length(t); mu = MAT(1); j = MAT(3);
7 WW = zeros(Lt,1);
8 TRb = zeros(Lt,1); Theta= zeros(Lt,1);
9 S = zeros(Lt,4);
10 for i=1:Lt
11 G11 = f(i,1);G22 = f(i,2);G33 = f(i,3);
12 G12 = f(i,4);G21 = f(i,5);G13 = f(i,6);
13 G31 = f(i,7);G23 = f(i,8);G32 = f(i,9);
14 G = [G11 G12 G13; G21 G22 G23; G31 G32 G33];
15 ff = F0/G;
16 b = ff*ff’;
17 WW(i) = mu*(trace(b)-3);
18 if j==1
19 dW=-WW(i);
20 elseif j==2
21 dW = 0;
22 end
23 TRb(i) = trace(b);
24 Theta(i) = 1/3*TRb(i) + dW/(2*mu);
25 sig = 2*mu*(b - Theta(i)*eye(3));
26 Theta(i) = dW/(2*mu);
27 S(i,1) = sig(1,1); S(i,2) = sig(2,2); S(i,3) = sig(3,3);
28 S(i,4) = sig(1,2);
29 end
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B.3 3D Single Element FE Model
Purpose: Implement a nonlinear FE model of a single element to, 1) validate
constitutive-relation derivations, 2) to better understand the construction of the
tangent elasticity matrix, and 3) see how the Newton Raphson iteration is im-
plemented in ANSYS. The model consists of a single, 4-node cube element with
four Gauss integration points in each dimension. This is a Lagrangian formu-
lation. The cube is under a uni-axial load in the x-direction which is initially
ramped with no growth, and then held with growth active. The inelastic de-
formation is stored using a Matlab <struct>, similar to the user state variables
in ANSYS. A pseudo-code of the Newton Raphson method in the context of
Figure B.1: Pseudo-code of nonlinear FEs using the Newton Raphson al-
gorithm
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nonlinear FEs is presented in Figure B.1. The “run” file plots a 3D image of a
growing cube in real time during the simulation (Figure B.2). Only key Matlab
files for the algorithm are presented. Supporting files, such as shape functions
and storage routines, are included in the attached folder.
Figure B.2: Pseudo-code of nonlinear FEs using the Newton Raphson al-
gorithm
B.3.1 3D Cube Nonlinear FE Run
1 %3D Stress-based Growth Element 10/17/11
2 clear; clc; close all; tic
199
34 %3D FEM algorithm for a stress based growth
5 %law using a Neo-hookean material. Algorithm
6 %details a single element only. Lagrangian
7 %implementation, hence 2nd PK stress calculated.
8
9 %Uniaxial Loading
10
11 %-----------------------------------------------
12 %Initial Element Nodes & Material Parameters
13 mu = 20; %Initial Shear Modulus
14 D1 = 0.002; %Inverse Bulk Modulus
15 a = 0.05; %Numerical Integration Factor
16 MAT = [mu,D1,a];
17 %Initial Node Coordinates (cube [0,1])
18 [XYo,XY] = init_node_coords();
19 xy_n = XY;
20 %Initial Growth Tensor & Displacement Profile
21 [G,F0] = init_G(); ue=zeros(24,1); %tou=[0;0;0];
22 %-------------------------------------------------
23 %Figure Setup
24 scrsz = get(0,’ScreenSize’);
25 h1 = figure(’Position’,...
26 [200 300 scrsz(4)/2 scrsz(4)/2]);
27 h2 = figure(’Position’,...
28 [700 300 scrsz(4)/1.5 scrsz(4)/2]);
29 %-------------------------------------------------
30 [z,w] = gauss4(); %Gauss Nodes & Wieghts
31 %-------------------------------------------------
32 n = 20; %total # time steps
33 t = 0; %Start time
34 T = 1; %End time
200
35 del_t = T/n; %Step Size
36 T_load = 1; %Load Time Final
37 mm = 5; %# of load steps
38 tou = 0; touf = 5/4; %Inital & Final Load
39 del_tou = (touf-tou)/mm; %Load Ramp
40 %-------------------------------------------------
41 %Initialize Storage Structures
42 u2x = zeros(n,1); C11 = zeros(n,1);
43 Time = zeros(n,1); Sigxx = zeros(n,1);
44 Sigyy = zeros(n,1); Sigzz = zeros(n,1);
45 Sigxz = zeros(n,1); Sigxx_F = zeros(n,1);
46 B11 = zeros(n,1); e11 = zeros(n,1);
47 ux_n4=zeros(n,1);Cse = zeros(6,6);
48 P = zeros(24,1); KK = zeros(n,1);
49 B11_F = zeros(n,1); Sigxx_all = zeros(n,1);
50 JL=1; iii=1;
51 %Time Loop
52 for jj=1:n
53 %Apply Load Increment
54 if jj < mm
55 tou = tou + del_tou;
56 else
57 tou = tou;
58 end
59 t = t + del_t;
60 %-----------------------------------------------
61 %Newton-Rhaphson Loop
62 tol=10ˆ-5; maxiter=200; del=3;kk=1;
63 while kk< maxiter && del>tol
64 %Load Vector - no load increment
65 %x-axis normal load
66
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67 P(1)= tou/JL; P(4)=tou/JL;
68 P(7)=tou/JL; P(10)=tou/JL;
69 %x face,y-direction
70 %P(3)= tou; P(6)=tou; P(9)=tou; P(12)=tou;
71 %------------------------------------------------
72 %Loop over Elements (just one in this case)
73 xyV = XYo’ + ue; %Current Node Locations
74 xy = Voight_Trans(xyV);
75 %------------------------------------------------
76 %Gauss Integration
77 I=zeros(24,1); Kmat=zeros(24,24);
78 Kgeom=zeros(24,24);
79 Sb = zeros(9,9); P1 = zeros(24,1);
80 for i=1:4 %x coordinate loop
81 I1 = zeros(24,1);
82 Kmat1 = zeros(24,24);
83 Kgeom1 = zeros(24,24);
84
85 for l=1:4 %z coordinate loop
86 Ie=zeros(24,1);
87 K1=zeros(24,24);
88 K2=zeros(24,24);
89
90 for j=1:4 %y coordinate loop
91 %Volume Integral
92 Be=quadB3(z(i),z(j),z(l)); %dN/de
93 N=quadNV3(z(i),z(j),z(l)); %Voight N
94 Fex=Be*xy; %dx/de
95 Feo=Be*XY; %dX/de
96 Jeo=det(Feo); %Jacobian-Undeformed to Parent
97 F = Feo\Fex; %dx/dX - Deformation Gradient
98 B = Feo\Be; %dN/dX
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99 Bo=quadBo3(F,B); %Total Lagrangian Diff Operator
100 Bgeom=quadBgeom3(B);%Undeformed Gradient Operator
101 JL = F(2,2)*F(3,3);
102
103 %Inner Loop Stress Update
104 [S,Sb,Cse,G,F0] =...
105 Stress_Calc_NeoHookean_Calg(F,G,F0,MAT,i,l,j,t,Cse,kk);
106
107 %Internal Force Stiffness
108 Ie=Ie+w(j)*Bo’*S*Jeo;
109 %Material Stiffness
110 K1=K1+w(j)*Bo’*Cse*Bo*Jeo;
111 %Geometric Stiffness
112 K2=K2+w(j)*Bgeom’*Sb*Bgeom*Jeo;
113 end
114 I1=I1+w(l)*Ie; Kmat1=Kmat1+w(l)*K1; Kgeom1=Kgeom1+w(l)*K2;
115 end
116 I=I+w(i)*I1; Kmat=Kmat+w(i)*Kmat1; Kgeom=Kgeom+w(i)*Kgeom1;
117 end
118 %--------------------------------------------------------------
119 %Tangent Stiffness Assembly
120 Kt=Kmat+Kgeom; %Tangent Stiffness, Kt
121 R=I-P; %Residual = Internal - Applied
122 %--------------------------------------------------------------
123 if kk<2 %Store Initial Residual
124 Ro=R;
125 end
126 %--------------------------------------------------------------
127 %Apply Boundary Conditions
128
129 %Uniaxial load of cube element with displacements of
130 %side opposing the loaded surface fixed
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131 % %Apply BCs - Fixed yz face @ x=0, Nodes 5-8 Fixed
132 % R(13:24)=0; %Node 5-8
133 % Kt(:,13:24)=0; Kt(13:24,:)=0;
134 %Kt(13:24,13:24)=diag(ones(12,1));
135
136 %Apply BCs - Fixed yz face @ x=0, Nodes 5,8 Fixed
137 R(13:16)=0; %Node 5 Fixed, 6 ux=0
138 Kt(:,13:16)=0; Kt(13:16,:)=0;
139 Kt(13:16,13:16)=diag(ones(4,1));
140 R(22)=0; R(19)=0; %Node 7,8 ux=0
141 Kt(:,22)=0; Kt(22,:)=0; Kt(22,22)=1;
142 Kt(:,19)=0; Kt(19,:)=0; Kt(19,19)=1;
143
144 R(18)=0; R(23)=0; %Node 6 uz=0 Node 8 uy=0
145 Kt(:,23)=0; Kt(23,:)=0; Kt(23,23)=1;
146 Kt(:,18)=0; Kt(18,:)=0; Kt(18,18)=1;
147
148 R(3)=0; R(11)=0; %Node 1 uz=0 Node 4 uy=0
149 Kt(:,3)=0; Kt(3,:)=0; Kt(3,3)=1;
150 Kt(:,11)=0; Kt(11,:)=0; Kt(11,11)=1;
151
152 R(6)=0; %Node 2 uz
153 Kt(:,6)=0; Kt(6,:)=0; Kt(6,6)=1;
154 R(2)=0; Kt(:,2)=0; Kt(2,:)=0; Kt(2,2)=1;
155
156 % %Shear BCs
157 % R(13:24)=0; %Node 5-8
158 % Kt(:,13:24)=0; Kt(13:24,:)=0;
159 %Kt(13:24,13:24)=diag(ones(12,1));
160 %----------------------------------------------------------
161 %Plot Results before new F,
162 %evaluated at gauss node (3,3,3)
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163 drawnow
164 [Sig,B,F,Fg,Sig_F,u2] = Neo_output(G,xy,XY,ue,MAT,3,3,3);
165 xyp = [xy(1:4,:);xy([1,5:8,5,8,4,3,7,6,2],:)];
166 XYp = [XY(1:4,:);XY([1,5:8,5,8,4,3,7,6,2],:)];
167
168 C = F’*F; B_F = F*F’;
169 u2x(jj) = u2(1);
170 ux_n4(jj) = ue(10);
171 C11(jj) = C(1,1);
172 Time(jj) = t;
173 Sigxx_all(iii) = Sig(1,1);
174 Sigxx(jj) = Sig(1,1);
175 Sigyy(jj) = Sig(2,2);
176 Sigzz(jj) = Sig(3,3);
177 Sigxz(jj) = Sig(1,3);
178 Sigxx_F(jj) = Sig_F(1,1);
179 B11(jj) = B(1,1);
180 e11(jj) = 1/2*(B(1,1)-1);
181 B11_F(jj) = B_F(1,1);
182
183 set(0,’CurrentFigure’,h1)
184 plot3(xyp(:,1),xyp(:,2),xyp(:,3),XYp(:,1),...
185 XYp(:,2),XYp(:,3),’--’);
186 view([1,1,1])
187 axis([-1 2 -1 2 -1 2])
188 xlabel(’x’); ylabel(’y’); zlabel(’z’);
189 title(’NeoHookean Cube Element under surface traction’)
190 legend(’Deformed’,’Undeformed’,’Location’,’Southeast’)
191
192 set(0,’CurrentFigure’,h2)
193 subplot(1,2,1)
194 plot(u2x(1:jj),Sigxx(1:jj)/mu,u2x(1:jj),Sigxz(1:jj)/mu)
205
195 xlabel(’Time’)
196 ylabel(’Cauchy Stress, $T_{xx}$’,’Interpreter’,’latex’)
197 axis([0 0.25 -.2 1])
198 % h2 = legend(’$\sigma_{xx}(F)$’,’$\sigma_{xy}(f)$’);
199 % set(h2,’Interpreter’,’latex’)
200
201 subplot(1,2,2)
202 plot(sqrt(B11_F(1:jj)),Sigxx_F(1:jj)/mu,...
203 sqrt(B11(1:jj)),Sigxx(1:jj)/mu,...
204 sqrt(B11_F(1:jj)),Sigxx(1:jj)/mu)
205 xlabel(’Stretch Ratio’)
206 ylabel(’Cauchy Stress, $T_{xx}$’,’Interpreter’,’latex’)
207 axis([1 1.3 0 1])
208 h3 = legend(’$\lambda_{total} \sigma_{total}$’,...
209 ’$\lambda_{elastic} \sigma_{elastic}$’,...
210 ’$\lambda_{total} \sigma_{elastic}$’);
211 set(h3,’Interpreter’,’latex’)
212
213 %--------------------------------------------------------------
214 %Solve delT
215 delu=Kt\(-R); %Delta ug
216 ue=ue+delu; %Update Displacement
217 del=norm(R)/norm(Ro);
218 kk=kk+1;
219 iii = iii+1;
220 cond(Kt); %Condition of Tangent Stiffness Matrix
221 %-------------------------------------------------------------
222 end
223 kk;
224 KK(jj) = kk;
225 if jj > mm
226 G = growth_update(G,xy,XY,MAT,del_t);
206
227 else
228 G=G;
229 end
230 xy_n = xy; %Node Locations at tn
231 end
232 toc
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B.3.2 3D Cube Nonlinear FE Stress Calc
1 function [S,Sb,Cab,G,F0,JL] = Stress_Calc_NeoHookean_Calg(F...
2 ,G,F0,MAT,i,l,j,t,Cab,kk)
3
4 %Update 2nd PK stress tensor, and build tangent
5 %elasticity tensor. NeoHookean Material w/
6 %Bulk Modulus Parameter
7 %----------------------------------------------------------
8 %Initialize Subroutine Structures
9 Sb = zeros(9,9);
10 %Material Parameters
11 mu = MAT(1); %Shear Modulus
12 D1 = MAT(2); %Inverse Bulk Modulus
13 %-----------------------------------------------------------
14 %Decompose Growth and Elastic Deformation Components
15 Fg = growth_call(G,i,l,j); %Call current integration pt Fg
16 Fe = F/Fg; %Elastic Deformation Gradient
17 %----------------------------------------------------------
18 %Kinematics
19 Je = det(Fe); %Jacbian Elastic
20 Ce = Fe’*Fe; %Right Cauchy Green(RCG) Tensor
21 I = eye(3); %Identity Tensor
22 Cinv = I/Ce; %Inverse RCG
23 I_c = Jeˆ(-2/3)*trace(Ce); %1st Invariant
24 Cinv_b = Cinv*Jeˆ(2/3); %Deviatoric Cˆ{-1}
25 %----------------------------------------------------------
26 %NeoHookean Material Law: W = (mu/2)(I_c -3)+(1/D1)(J-1)ˆ2
27 Sm = mu*(Jeˆ(-2/3)*I-1/3*I_c*Cinv’)...
28 + 2/D1*Je*(Je-1)*Cinv’; %Second P-K Stress
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29 S=[Sm(1,1);Sm(2,2);Sm(3,3);Sm(2,3);...
30 Sm(1,3);Sm(1,2)]; %Voight Notation
31 %Stress for Geometric Stiffness Tensor
32 Sb(1:3,1:3) = Sm; Sb(4:6,4:6) = Sm; Sb(7:9,7:9) = Sm;
33 %-----------------------------------------------------
34 %Build Elasticity Tensor
35 Cab = Elast_tensor_NeoHookean_Calg(Fe,MAT);
36 %Material Subroutine Complete - Return to FEM Loop
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B.3.3 3D Cube Nonlinear FE Elasticity Tensor
1 function Cab = Elast_tensor_NeoHookean_Calg(F,MAT)
2 %Calculate Material Elasticity Tensor dS/dE
3 %Represent in 6x6 tensor using symmetry
4 % 1 2 3 4 5 6
5 %1 C1111 C1122 C1133 C1123 C1113 C1112
6 %2 C2211 C2222 C2233 C2223 C2213 C2212
7 %3 C3311 C3311 C3333 C3323 C3313 C3312
8 %4 C2311 C2322 C2333 C2323 C2313 C2312
9 %5 C1311 C1322 C1333 C1323 C1313 C1312
10 %6 C1211 C1222 C1233 C1223 C1213 C1212
11
12
13 %--------------------------------------------------------
14 %Initialize Subroutine Structures
15 Cab = zeros(6,6); Cab2 = zeros(6,6);
16
17
18 mu = MAT(1); D1 = MAT(2); %Material Parameters
19 C = F’*F; Cinv = C\eye(3); %RCG Stretch Tensor & Inverse
20 J = det(F); I_c = Jˆ(-2/3)*trace(C);
21 Ic = trace(C);
22 JJ = Jˆ(-2/3);
23 %---------------------------------------------------------
24 %Elasticity Coefficients
25 a5 = -(1/3)*mu*Jˆ(-2/3);
26 a7 = -(1/18)*mu*I_c + 1/(2*D1)*J*(2*J-1);
27 a8 = (1/6)*mu*I_c - (1/D1)*J*(J-1);
28
29 %Voight Notation
30 Cvi = [Cinv(1,1);Cinv(2,2);Cinv(3,3);...
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31 Cinv(2,3);Cinv(1,3);Cinv(1,2)];
32 Iv = [1;1;1;0;0;0];
33 for a = 1:6
34 for b = 1:6
35 %[i,j,l,m] = index(a,b);
36 % Cab2(a,b) = -(2/3)*mu*JJ*Cvi(b)*Iv(a) + ...
37 % (2/9)*mu*I_c*Cvi(b)*Cvi(a)- (2/3)*mu*JJ*Iv(b)*Cvi(a)...
38 % + (1/3)*mu*I_c*(Cinv(i,l)*Cinv(j,m)+Cinv(i,m)*Cinv(j,l))...
39 % + (2/D1)*J*(J-1)*Cvi(b)*Cvi(a) + (2/D1)*Jˆ2*Cvi(b)*Cvi(a)...
40 % - (4/D1)*J*(J-1)*Cinv(j,l)*Cinv(m,i);
41 [i,j,k,l] = index(a,b);
42 Cab(a,b) = -2/3*mu*JJ*(Iv(a)*Cvi(b) + Cvi(a)*Iv(b)...
43 -1/3*Ic*Cinv(j,i)*Cinv(l,k) - Ic*Cinv(j,l)*Cinv(k,i))...
44 +2/D1*J*(2*J-1)*Cinv(l,k)*Cinv(j,i)...
45 -4/D1*J*(J-1)*Cinv(j,l)*Cinv(k,i);
46
47 end
48 end
49
50 %Index between Vioght and Full Notation
51 function [i,j,k,l] = index(a,b)
52 if a==1
53 i=1; j=1;
54 elseif a==2
55 i=2; j=2;
56 elseif a==3
57 i=3; j=3;
58 elseif a==4
59 i=2; j=3;
60 elseif a==5
61 i=1; j=3;
62 elseif a==6
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63 i=1; j=2;
64 end
65 if b==1
66 k=1; l=1;
67 elseif b==2
68 k=2; l=2;
69 elseif b==3
70 k=3; l=3;
71 elseif b==4
72 k=2; l=3;
73 elseif b==5
74 k=1; l=3;
75 elseif b==6
76 k=1; l=2;
77 end
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B.3.4 3D Cube Nonlinear FE Growth
1 function G = Stress_Calc_NeoHookean_Growth(F,G,MAT,i,l,j,del_t)
2 %Update Growth Deformation
3 %NeoHookean Material w/ Bulk Modulus Parameter
4 % (i,l,j) -> (x,z,y)
5 %---------------------------------------------------
6 %Initialize Subroutine Structures
7 Sb = zeros(9,9);
8 %Material Parameters
9 mu = MAT(1); %Shear Modulus
10 D1 = MAT(2); %Bulk Modulus
11 a = MAT(3); %Numerical Integration Factor
12 %----------------------------------------------------
13 %Decompose Growth and Elastic Deformation Components
14 Fg = growth_call(G,i,l,j);
15 Fe = F/Fg; %Elastic Deformation Gradient
16 %----------------------------------------------------
17 %Kinematics
18 Je = det(Fe); %Jacobian Elastic
19 Ce = Fe’*Fe; %Right Cauchy Green(RCG) Tensor
20 I = eye(3); %Identity Tensor
21 Cinv = I/Ce; %Inverse RCG
22 I_c = Jeˆ(-2/3)*trace(Ce); %1st Invariant
23 Ic = trace(Ce);
24 Cinv_b = Cinv*Jeˆ(2/3);
25 %----------------------------------------------------
26 %NeoHookean Material Law:
27 %W = (mu/2)(I_c -3) + (1/D1)(J-1)ˆ2
28 Sig = mu*Jeˆ(-5/3)*(Fe*Fe’ - 1/3*trace(Fe*Fe’)*I)...
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29 + 2/D1*(Je-1)*I;
30
31 %Integration of Evolution Equation
32 Ls = Fe’*Sig/(Fe’); %Growth Deformation Rate
33 Fg = Fg + a*Ls*Fg*del_t; %Explict Time Integration
34
35 %Store Updated Growth Tensor(x,z,y)
36 G = growth_store(Fg,G,i,l,j);
214
APPENDIX C
APPENDIX C - ANSYS FILES
C.1 ANSYS USERHYPER
ANSYS allows users to implement custom constituitive material behavior. For
hyperelastic materials, the implementation is streamlined by the built-in sub-
routine USERHYPER. At every integration point, ANSYS will access USERHY-
PER to evaluate the hyperelastic potential and the 1st and 2nd partial deriva-
tives with respect to the strain invariants. The USERHYPER subroutine is ca-
pable of enforcing an incompressibility constraint using hybrid displacement -
pressure (u-p) elements. Hybrid elements include an extra degree of freedom
which approximates the pressure neccesary to enforce incompressibility. To en-
sure this pressure field is only associated with the volumetric deformation, the
deformation gradient (FiA) is decomposed into a deviatoric/volumetric split,
specifically,
FiA = J
  1
3FiA (C.1.1)
where J = det(FiA) is the Jacobian of the deformation gradiant. From this de-
composition we see that det( F ) = 1, and consequently the constitutive relations
can now be defined uniquely in terms of these deviatoric and volumetric vari-
ables. Therefore the arguments of an isotropic, hyperelastic material law include
only the 1st and 2nd invariants of the modified left Cauchy-Green stretch tensor,
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B = F F
T , and the Jacobian as listed below:
IB = tr( B)
IIB =
1
2
h
tr( B)2   tr( B2)
i
J = det(F )
ANSYS requires the 1st and 2nd partial derivatives of the material law in order
to calculate the Cauchy stress, ij , and tangent elasticity tensor, Cijkl, at every
integration point. The tangent elasticity tensor, called the material Jacobian in
the ANSYS documentation (Sec 6.4.1.2), predicts the next step of the Newton-
Raphson iteration used to solve each load step. The material law and partial
derivatives implemented in the USERHYPER for both the incompressible and
nearly incompressible cases are outlined below.
C.1.1 Fully Incompressible Case
We implemented in ANSYS the following exponential, isotropic, incompressible
hyperelastic material law with linear and nonlinear material parameters C and
, respectively.
 
 
IB

=
C
2

exp

(IB   3)
  1	 (C.1.2)
Below are the 1st and 2nd partial derivatives required by the ANSYS USERHY-
PER subroutine.
@ 
@ IB
=
C
2
exp

(IB   3)

@2 
@ I2B
=
2C
2
exp

(IB   3)

216
The Cauchy stress in this case has the following form,
ij =
C
J
exp


 
IB   3

Bij   1
3
Bkk ij

+ p ij (C.1.3)
where we have used the relation,
@ IB
@FiA
=  2
3
J 
2
3F 1Ai Bkk + 2J
  2
3FiA
and where p is the pressure associated with the incompressibility constraint.
C.1.2 Nearly Incompressible Case
For a nearly incompressible material, the free energy is identical to Eq C.1.2
except for the additional term containing the jacobian, J. Nearly incompressible
materials are implemented through a lagrange multiplier, or penalty method.
The paramter d1 is the inverse of the bulk modulus, , which is a measure of
a material’s resistance to volumetric expansion or contraction. The selection of
d1 determines the strictness of the incompressibility condition. J goes to 1 as
 = 1
d1
goes to 1. Near this limit, the material is ultra sensitive to changes in
volume which can result in a large Cauchy stresses and, consequently, an ill-
conditioned tangent elasticity tensor. Therefore the penatly method technique
can only model nearly incompressible materials, which in many situations is
sufficiently accurate. Below is the nearly incompressible hyperelastic potential
and respective derivatives.
 
 
IB; J

=
C
2

exp

(IB   3)
  1	+ 1
d1
(J   1)2 (C.1.4)
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1st and 2nd partial derivatives:
@ 
@ IB
=
C
2
exp

(IB   3)

@ 
@J
=
2
d1
(J   1)
@2 
@ I2B
=
2C
2
exp

(IB   3)

@2 
@J2
=
2
d1
@2 
@J @ IB
= 0
The Cauchy stress for the nearly incompressible case is a slightly modified form
of Eq. (C.1.3), due to the additional term in the free energy.
ij =
C
J
exp


 
IB   3

Bij   1
3
Bkk ij

+
2
d1
(J   1) ij (C.1.5)
C.1.3 Validation of USERHYPER Routine
The USERHYPER implementation was validated against analytical results for
the homogeneous deformations of uniaxial extension, uniaxial compression,
(Figure C.1) and simple shear (Figure C.2). The simulations were initialy per-
formed on an single 3D 8-node brick element. The problem was then solved
with a mesh. The fully incompressible results are presented in Figure C.1 & C.2.
For the uniaxial load simulation, the hydrostatic pressure p was determine by
assuming yy = zz = 0. With this assumption and the corresponding uniaxial
load deformation,
F = diag
 
;  1=2;  1=2

the analytical stress-strain relation for the axial stress reduces to,
xx = C exp



2 +
2

  3

2   1


(C.1.6)
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Similarly, using the simple shear deformation gradient,
Figure C.1: Plot of normalized axial stress, xy=C, versus axial stretch ra-
tio,  for a uniaxial tension and compression test. The plot
compares the ANSYS USERHYPER output with the analytical
result. C=10,  = 0:03
F =
266664
1 0 0
k 1 0
0 0 1
377775
we can derive the analytical expression for the Cauchy shear stress.
xy = C exp

k2

k (C.1.7)
The ANSYS results agreed well with the analytical results (Figure C.1 & C.2),
indicating that the material was correctly implemented.
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Figure C.2: Plot of normalized shear stress, xy=C, versus shear param-
eter, k, comparing the ANSYS USERHYPER output with the
analytical result. C=10,  = 0:5
C.1.4 USERHYPER Fortran Code
1 *deck,UserHyper USERDISTRIB parallel gal
2 subroutine UserHyper(
3 & prophy, incomp, nprophy, invar,
4 & potential, pInvDer)
5 c******************************************************************
6 c
7 c *** Example of user hyperelastic routine
8 c
9 c This is an exponential material law of the 1st
10 c invariant used for the isotropic modeling of
11 c the pipette experiment
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12 c
13 c input arguments
14 c ===============
15 c prophy (dp,ar(*),i) material property array
16 c nprophy (int,sc,i) # of material constants
17 c invar dp,ar(3) invariants
18 c
19 c output arguments
20 c ================
21 c incomp (log,sc,i) fully incompressible or compressible
22 c potential dp,sc value of potential
23 c pInvDer dp,ar(10) der of potential wrt i1,i2,j
24 c 1 - der of potential wrt i1
25 c 2 - der of potential wrt i2
26 c 3 - der of potential wrt i1i1
27 c 4 - der of potential wrt i1i2
28 c 5 - der of potential wrt i2i2
29 c 6 - der of potential wrt i1j
30 c 7 - der of potential wrt i2j
31 c 8 - der of potential wrt j
32 c 9 - der of potential wrt jj
33 c*******************************************************************
34 c --- parameters
35 #include "impcom.inc"
36 DOUBLE PRECISION ZERO, ONE, TWO, THREE, HALF, TOLER
37 PARAMETER (ZERO = 0.d00,
38 & ONE = 1.0d0,
39 & HALF = 0.5d0,
40 & TWO = 2.d0,
41 & THREE = 3.d0,
42 & TOLER = 1.0d-12)
43 EXTERNAL erhandler
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44 c
45 c --- argument list
46 c
47 INTEGER nprophy
48 DOUBLE PRECISION prophy(*), invar(*),
49 & potential, pInvDer(*)
50 LOGICAL incomp
51 c
52 c --- local variables
53 c
54 INTEGER i
55 DOUBLE PRECISION i1, i1i2, d1, jj,
56 & alpha, C, Q
57
58 i1 = invar(1)
59 jj = invar(3)
60 alpha = prophy(1)
61 C = prophy(2)
62 d1 = prophy(3)
63
64 c Incompressible Potential and Derivatives
65 Q = exp(alpha*(i1-THREE))
66 potential = C/TWO*(Q-ONE)
67
68 pInvDer(1) = alpha*C/TWO*Q
69 pInvDer(2) = ZERO
70 pInvDer(3) = (alpha**TWO)*C/TWO*Q
71 pInvDer(4) = ZERO
72 pInvDer(5) = ZERO
73 pInvDer(6) = ZERO
74 pInvDer(7) = ZERO
75 pInvDer(8) = ZERO
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76 pInvDer(9) = ZERO
77
78 incomp = .TRUE.
79 c Nearly Incompressible Potential and Derivatives
80 IF(d1 .gt. TOLER) THEN
81 incomp = .FALSE.
82 potential = potential + ONE/d1*(jj-ONE)**2
83 pInvDer(8) = TWO/d1*(jj-ONE)
84 pInvDer(9) = TWO/d1
85 END IF
86 RETURN
87 END
C.2 ANSYS USERMAT
The USERMAT subroutine allows for the incorporation of general material
behaviour. Inelastic and viscoelastic material behavior can be implemented
through this subroutine. At every integration point, ANSYS accesses the USER-
MAT to determine the current Cauchy stress, ij , and material jacobian matrix,
Cijkl, which is used to approximate the next iteration step. The subroutine al-
lows for the input and output of user-defined state variables (ustatev). Our pur-
pose for using the USERMAT subroutine was to integrate the evolution equa-
tions for the inelastic deformation of the growth model.
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C.2.1 Outline of ANSYS Solver Routine
At the every time step, ANSYS would input the current total deformation gra-
dient, F niA, where superscript n represents the nth (current) iteration. Given that
F n = fnFn and that the current inelastic deformation, Fn, was known, we
solved for the current elastic deformation, fn. The Cauchy stress and the ma-
terial jacobian matrix were then calculated using this elastic deformation. Then
each component of the inelastic deformation was updated using a forward Eu-
ler integration of the prescribed inelastic deformation rate, L.
Fij (t+t) = Fij (t) + Lim(t)Fmj(t)t: (C.2.1)
ANSYS would then take the stress and elasticity tensor and build the global
tangent stiffness matrix and the iteration residual. Table C.1 lists the built-in
ANSYS fortran functions that were used to perform these calculations.
Table C.1: Built-in ANSYS Fortran Functions
Name Description Operation
maxb(A,B,C,..) matrix multiplication C = A*B
matxb(A,B,C,..) matrix multiplication C = A’*B
symeqn linear system solver see ANSYS Sec 8.4.11
ANSYS solved the nonlinear FE problem using the Newton-Raphson (NR)
iteration scheme, which is outlined in the Matlab pseudo-code of Figure B.1 of
Appendix B.2. ANSYS used a Sparse Direct solver to calculate the displacement
increment for each NR loop, specifically,
[KT ] fug = fRg (C.2.2)
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where [KT ] is the global tangent stiffness matrix, fug the displacement incre-
ment, and fRg is the residual. The residual is the difference between the external
force vector and the internal force vector for the current NR iteration. ANSYS
solved Eq. C.2.2 using a Cholesky decomposition of [KT ]which is,
[KT ] = [L]

Lt

=

L

[D]

Lt

where [L] and

L

are a lower triangular matrices and [D] is a diagonal matrix.
ANSYS then back substitutes to solve for fug using,

L
 fwg = fRg
[D]

Lt
 fug = fwg
ANSYS reorders the rows and columns to reduced the amount of fill-in required
during the Cholesky decomposition. The Minimum Degree ordering and the
METIS ordering methods are used for the reordering. For complete details, see
ANSYS Theory Reference Sec. 15.9.
C.2.2 Material Jacobian Derivation
For nonlinear material analysis, the material Jacobian matrix (also known as the
spatial elasticity tensor), Cijkl, is required to predict the material properties of
the next iteration. In ANSYS, the elasticity tensor is defined as,
 = JC : d (C.2.3)
where  is the Jaumann rate of the Kirchoff stress and d is the symmetric part
of the elastic deformation rate tensor, l = _ff 1. The Jaumann rate is a objective
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time derivative expressed in terms of the spin tensor,!, which is the asymmetric
part of l.
 = _   ! + ! (C.2.4)
The general form of C for an isotropic material is presented in Lubarda and
Hoger (2002) [114], Eq 11.9 as,
Cijkl = 4 fifj
@2 
@c@c
fkfl +
1
2
(ljik + ikjl + lijk + kjil) (C.2.5)
where c = fifi is the right Cauchy Green stretch tensor. For the growth
model, we implemented an exponential material,
 (Ic; j) =
C
2
fexp [(Ic   3)]  1g+ 1
d1
(j   1)2 (C.2.6)
where Ic = tr(c) and j = det(f). Note that the deviatoric-volumetric split of the
invariants was not used in this formulation.
We now evaluate the partial derivatives of the 1st term of the elasticity tensor
in Eq. (C.2.5), where
S = 2
@ 
@c
= 2C exp [ (Ic   3)]  + 2
d1
j (j   1) c 1 (C.2.7)
defines the 2nd Piola-Kirchoff stress, S . We now calculate the 2nd partial of  
starting from the 2nd PK stress using K  C exp [ (Ic   3)].
@S
@c
= K
@cmm
@c
 +
2
d1
(2j   1) @j
@c
c 1 +
2
d1
j(j   1)@c
 1

@c
(C.2.8)
The partial derivatives in Eq (C.2.8) are as follows,
@cmm
@c
= 
@j
@c
=
1
2
j c 1
@c 1
@c
=
1
2
 
c 1 c
 1
 + c
 1
 c
 1


226
which after insertion into Eq C.2.8 yields,
@S
@c
= K +
1
d1
j(2j   1)c 1c 1  
1
d1
j(j   1)  c 1 c 1 + c 1 c 1  (C.2.9)
Finally, by plugging in the Kirchoff stress,
ij = C exp [ (Ic   3)] bij + 2
d1
j (j   1) ij (C.2.10)
and Eq. (C.2.9) into Eq. (C.2.5) we arrive at the elasticity tensor,
Cijkl = 2 fifj
@S
@c
fkfl +
1
2
(ljik + ikjl + lijk + kjil)
= 2Kbijbkl +
2
d1
j(2j   1)ijkl   2
d1
j(j   1) (ikjl + jkil)
+
K
2
(bljik + bikjl + blijk + bkjil) +
2j(j   1)
d1
(jlik + iljk)
with the final form of,
Cijkl = 2Kbijbkl+
2
d1
j(2j  1)ijkl+ K
2
(bljik + bikjl + blijk + bkjil) (C.2.11)
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C.2.3 USERMAT Fortran Code
1 *deck,usermat3d USERDISTRIB parallel gal
2 subroutine usermat3d_exp_growth3(
3 & matId, elemId,kDomIntPt, kLayer, kSectPt,
4 & ldstep,isubst,keycut,
5 & nDirect,nShear,ncomp,nStatev,nProp,
6 & Time,dTime,Temp,dTemp,
7 & stress,ustatev,dsdePl,sedEl,sedPl,epseq,
8 & Strain,dStrain, epsPl, prop, coords,
9 & var0, defGrad_t, defGrad,
10 & tsstif, epsZZ,
11 & var1, var2, var3, var4, var5,
12 & var6, var7, var8)
13 c****************************************************************
14 c *** primary function ***
15 c
16 c user defined material constitutive model
17 c
18 c Attention:
19 c User must define material constitutive law properly
20 c according to the stress state such as 3D, plane strain
21 c and axisymmetry, plane stress and beam.
22 c
23 c a 3D material constitutive model can use for
24 c plane strain and axisymmetry cases.
25 c
26 c When using shell elements, a plane stress algorithm
27 c must be used.
28 c
29 c The following demonstrates a USERMAT subroutine for
30 c a nearly incompressible exponential hyperelastic model
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31 c of 3D solid elements or plane elements in plane strain
32 c or axisymmetric stress state.
33 c
34 c See "ANSYS user material subroutine USERMAT" for detailed
35 c description of how to write a USERMAT routine.
36 c
37 c*****************************************************************
38 c
39 c input arguments
40 c ===============
41 c matId (int,sc,i) material #
42 c elemId (int,sc,i) element #
43 c kDomIntPt (int,sc,i) "k"th domain integration point
44 c kLayer (int,sc,i) "k"th layer
45 c kSectPt (int,sc,i) "k"th Section point
46 c ldstep (int,sc,i) load step number
47 c isubst (int,sc,i) substep number
48 c nDirect (int,sc,in) # of direct components
49 c nShear (int,sc,in) # of shear components
50 c ncomp (int,sc,in) nDirect + nShear
51 c nstatev (int,sc,l) Number of state variables
52 c nProp (int,sc,l) Number of material ocnstants
53 c
54 c Temp (dp,sc,in) temperature at beginning of
55 c time increment
56 c dTemp (dp,sc,in) temperature increment
57 c Time (dp,sc,in) time at beginning of increment (t)
58 c dTime (dp,sc,in) current time increment (dt)
59 c
60 c Strain (dp,ar(ncomp),i) Strain
61 c dStrain (dp,ar(ncomp),i) Strain increment
62 c prop (dp,ar(nprop),i) Material constants
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63 c coords (dp,ar(3),i) current coordinates
64 c defGrad_t(dp,ar(3,3),i) Def gradient at time t
65 c defGrad (dp,ar(3,3),i) Defgradient at time t+dt
66 c
67 c input output arguments
68 c ======================
69 c stress (dp,ar(nTesn),io) stress
70 c ustatev (dp,ar(nstatev),io) user state variable
71 c sedEl (dp,sc,io) elastic work
72 c sedPl (dp,sc,io) plastic work
73 c epseq (dp,sc,io) equivalent plastic strain
74 c
75 c output arguments
76 c ================
77 c keycut (int,sc,io) loading bisect/cut control
78 c 0 - no bisect/cut
79 c 1 - bisect/cut
80 c
81 c dsdePl (dp,ar(ncomp,ncomp),io) jacobian matrix
82 c epsZZ (dp,sc,o) strain epsZZ for plane stress,
83 c****************************************************************
84 c ncomp 6 for 3D (nshear=3)
85 c ncomp 4 for plane strain or axisymmetric (nShear = 1)
86 c ncomp 3 for plane stress (nShear = 1)
87 c ncomp 3 for 3d beam (nShear = 2)
88 c ncomp 1 for 1D (nShear = 0)
89 c
90 c stresss and strains, plastic strain vectors
91 c 11, 22, 33, 12, 23, 13 for 3D
92 c 11, 22, 33, 12 for plane strain or axisymmetry
93 c 11, 22, 12 for plane stress
94 c 11, 13, 12 for 3d beam
230
95 c 11 for 1D
96 c
97 c material jacobian matrix
98 c 3D
99 c dsdePl | 1111 1122 1133 1112 1123 1113 |
100 c dsdePl | 2211 2222 2233 2212 2223 2213 |
101 c dsdePl | 3311 3322 3333 3312 3323 3313 |
102 c dsdePl | 1211 1222 1233 1212 1223 1213 |
103 c dsdePl | 2311 2322 2333 2312 2323 2313 |
104 c dsdePl | 1311 1322 1333 1312 1323 1313 |
105 c plane strain or axisymmetric (11, 22, 33, 12)
106 c dsdePl | 1111 1122 1133 1112 |
107 c dsdePl | 2211 2222 2233 2212 |
108 c dsdePl | 3311 3322 3333 3312 |
109 c dsdePl | 1211 1222 1233 1212 |
110 c plane stress (11, 22, 12)
111 c dsdePl | 1111 1122 1112 |
112 c dsdePl | 2211 2222 2212 |
113 c dsdePl | 1211 1222 1212 |
114 c 3d beam (11, 13, 12)
115 c dsdePl | 1111 1113 1112 |
116 c dsdePl | 1311 1313 1312 |
117 c dsdePl | 1211 1213 1212 |
118 c 1d
119 c dsdePl | 1111 |
120 c
121 c**************************************************************
122 #include "impcom.inc"
123 c
124 INTEGER
125 & matId, elemId,
126 & kDomIntPt, kLayer, kSectPt,
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127 & ldstep,isubst,keycut,
128 & nDirect,nShear,ncomp,nStatev,nProp
129 DOUBLE PRECISION
130 & Time, dTime, Temp, dTemp,
131 & sedEl, sedPl, epseq, epsZZ
132 DOUBLE PRECISION
133 & stress (ncomp), ustatev (nStatev),
134 & dsdePl (ncomp,ncomp),
135 & Strain (ncomp), dStrain (ncomp ),
136 & epsPl (ncomp), prop (nProp ),
137 & coords (3),
138 & defGrad (3,3),defGrad_t(3,3),
139 & tsstif (2)
140 c
141 c***************** User defined part **************************
142 INTEGER mcomp, n, info
143 DOUBLE PRECISION HALF, THIRD, ONE, TWO, FOUR, SMALL,
144 & ZERO, TWOTHIRD, ONEDM02, ONEDM05,
145 & ONEHALF, sqTiny, THREE
146 PARAMETER (ZERO = 0.d0,
147 & HALF = 0.5d0,
148 & THIRD = 1.d0/3.d0,
149 & ONE = 1.d0,
150 & TWO = 2.d0,
151 & FOUR = 4.d0,
152 & SMALL = 1.d-08,
153 & sqTiny = 1.d-20,
154 & ONEDM02 = 1.d-02,
155 & ONEDM05 = 1.d-05,
156 & ONEHALF = 1.5d0,
157 & THREE = 3.d0,
158 & TWOTHIRD = 2.0d0/3.0d0,
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159 & mcomp = 6,
160 & n = 3)
161 c
162 c defGrad_F(dp,ar(3,3),l) total deformation gradient
163 c a (dp,sc,i) growth rate parameter a(r)
164 c alpha (dp,sc,i) nonlinear material parameter
165 c C10 (dp,sc,i) linear material parameter
166 c D1 (dp,sc,i) inverse bulk modulus
167 c G (dp,ar(3,3),io) Inelastic Deformation
168 c
169 c --- temperary variables for solution purpose
170 c i, j
171 c BBAR - Deviatoric Left Cauchy Green Strain
172 c BBARP - Principal Values of BBAR
173 c BBARN - Principal direction of BBAR
174 c DISTGR - Deviatoric Deformation Gradient
175 c DET - determinant of deformation gradient
176 EXTERNAL vzero, vmove, get_ElmData, eigen_calc,
177 & mctac, maxb, polar_decomp, svars_write,
178 & matxb, matba, felastic_write, symeqn
179 DOUBLE PRECISION sigElp(mcomp), dsdeEl(mcomp,mcomp),
180 & sigDev(mcomp), JM(mcomp,mcomp),
181 & dfds(mcomp),
182 & sigi (mcomp), strainEl(mcomp)
183 DOUBLE PRECISION var0, var1, var2, var3, var4, var5,
184 & var6, var7, var8
185 INTEGER i, j , k1, k2, IERR, indic
186 DOUBLE PRECISION C10, alpha, D1, a,
187 & DET_F, DET, DET_G,
188 & EG, EK, PR, EG23,
189 & BBAR(6), DISTGR(3,3),
190 & TRBBAR, DDSDDE(ncomp,ncomp),
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191 & AA(3,6), dG(3,3), IG(3,3),
192 & G(3,3), T(3,3), Iden(3,3),
193 & defGrad_F(3,3), IdefGrad(3,3)
194 c*************************************************************
195 keycut = 0
196 c Define Identity Matrix - "Iden"
197 call vzero(Iden(1,:),3)
198 call vzero(Iden(2,:),3)
199 call vzero(Iden(3,:),3)
200 Iden(1,1) = 1.d0; Iden(2,2) = 1.d0; Iden(3,3) = 1.d0;
201
202 c**** Get C10, alpha, and Bulk Modulusˆ-1, D1,
203 C10 = prop(2)
204 alpha = prop(3)
205 D1 = prop(4)
206 a = prop(5)
207 c Overall Deformation Gradient, F
208 defGrad_F = defGrad;
209 c Calculate the deteminant: J=det(F)
210 DET_F = defGrad_F(1,1)*defGrad_F(2,2)*defGrad_F(3,3)
211 & -defGrad_F(1,2)*defGrad_F(2,1)*defGrad_F(3,3)
212 IF (nShear .EQ. 3) THEN
213 DET_F = DET_F + defGrad_F(1,2)*defGrad_F(2,3)*defGrad_F(3,1)
214 & +defGrad_F(1,3)*defGrad_F(3,2)*defGrad_F(2,1)
215 & -defGrad_F(1,3)*defGrad_F(3,1)*defGrad_F(2,2)
216 & -defGrad_F(2,3)*defGrad_F(3,2)*defGrad_F(1,1)
217 end IF
218 C--------------------------------------------------------
219 C Initialize Growth Tensor, G
220 G(1,1) = ustatev(1); G(2,2) = ustatev(2); G(3,3) = ustatev(3);
221 G(1,2) = ustatev(4); G(1,3) = ustatev(5); G(2,1) = ustatev(6);
222 G(2,3) = ustatev(7); G(3,1) = ustatev(8); G(3,2) = ustatev(9);
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223 C--------------------------------------------------------------------
224 C Calculate Gˆ-1 = inv(G)
225 AA(1:3,1:3) = G
226 call symeqn(AA,3,3,-3,1)
227 IG = AA(1:3,4:6)
228
229 C Calculate f = F*inv(G)
230 call maxb(defGrad,IG,defGrad,3,3,3,3,3,3)
231 C---------------------------------------------------------------------
232 C Calculate the Elastic Cauchy Stress and Elasticity Tensor
233 C Calculate the Determinant of Elastic Deformation Gradient, j=det(f)
234 DET = defGrad(1,1)*defGrad(2,2)*defGrad(3,3)
235 & -defGrad(1,2)*defGrad(2,1)*defGrad(3,3)
236 IF (nShear.EQ.3) THEN
237 DET = DET + defGrad(1,2)*defGrad(2,3)*defGrad(3,1)
238 & +defGrad(1,3)*defGrad(3,2)*defGrad(2,1)
239 & -defGrad(1,3)*defGrad(3,1)*defGrad(2,2)
240 & -defGrad(2,3)*defGrad(3,2)*defGrad(1,1)
241 end IF
242 C Calculate the Determinant of Inelastic Deformation Gradient, det(G)
243 DET_G = G(1,1)*G(2,2)*G(3,3)-G(1,2)*G(2,1)*G(3,3)
244 IF (nShear.EQ.3) THEN
245 DET_G = DET_G + G(1,2)*G(2,3)*G(3,1)
246 & +G(1,3)*G(3,2)*G(2,1)-G(1,3)*G(3,1)*G(2,2)
247 & -G(2,3)*G(3,2)*G(1,1)
248 end IF
249
250 C Re-label Elastic Deformation Gradient
251 do k1=1,3
252 do k2=1,3
253 DISTGR(k2,k1) = defGrad(k2,k1)
254 end do
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255 end do
256 c Calculate Left Cauchy Green Strain, b = ffˆt
257 BBAR(1)=DISTGR(1,1)**2+DISTGR(1,2)**2+DISTGR(1,3)**2
258 BBAR(2)=DISTGR(2,1)**2+DISTGR(2,2)**2+DISTGR(2,3)**2
259 BBAR(3)=DISTGR(3,3)**2+DISTGR(3,1)**2+DISTGR(3,2)**2
260 BBAR(4)=DISTGR(1,1)*DISTGR(2,1)+DISTGR(1,2)*DISTGR(2,2)
261 & +DISTGR(1, 3)*DISTGR(2, 3)
262 IF(nShear.EQ.3) THEN
263 BBAR(6)=DISTGR(1, 1)*DISTGR(3, 1)+DISTGR(1, 2)*DISTGR(3, 2)
264 & +DISTGR(1, 3)*DISTGR(3, 3)
265 BBAR(5)=DISTGR(2, 1)*DISTGR(3, 1)+DISTGR(2, 2)*DISTGR(3, 2)
266 & +DISTGR(2, 3)*DISTGR(3, 3)
267 end if
268
269 c Calculate 1st Invariant of b, Ib
270 TRBBAR = BBAR(1) + BBAR(2) + BBAR(3)
271 EG = TWO*alpha*C10*exp(alpha*(TRBBAR - THREE))
272 EK = TWO*DET/D1*(TWO*DET-ONE)
273 PR = TWO/D1*(DET-ONE)
274 c call defG_write(Time,defGrad_F,defGrad,DET_F,DET,PR)
275 30 format (3f9.2)
276 c Calculate Cauchy Stress
277 do k1=1,nDirect
278 stress(k1) = HALF*EG*BBAR(k1)/DET + PR
279 end do
280 do k1 = nDirect+1, nDirect+nShear
281 stress(k1) = HALF*EG*BBAR(k1)/DET
282 end do
283
284 C CALCULATE THE TANGENT Elasticity Matrix
285 C EG23=EG*TWO*THIRD
286 DDSDDE(1, 1)= EG*(alpha*BBAR(1)**2+BBAR(1))+EK
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287 DDSDDE(2, 2)= EG*(alpha*BBAR(2)**2+BBAR(2))+EK
288 DDSDDE(3, 3)= EG*(alpha*BBAR(3)**2+BBAR(3))+EK
289 DDSDDE(1, 2)= alpha*EG*(BBAR(1)*BBAR(2)) +EK
290 DDSDDE(1, 3)= alpha*EG*(BBAR(1)*BBAR(3)) +EK
291 DDSDDE(2, 3)= alpha*EG*(BBAR(2)*BBAR(3)) +EK
292 DDSDDE(1, 4)= alpha*EG*(BBAR(1)*BBAR(4)) + EG/TWO*BBAR(4)
293 DDSDDE(2, 4)= alpha*EG*(BBAR(2)*BBAR(4)) + EG/TWO*BBAR(4)
294 DDSDDE(3, 4)= alpha*EG*(BBAR(3)*BBAR(4))
295 DDSDDE(4, 4)= alpha*EG*(BBAR(4)**2) + EG/TWO*(BBAR(1)+BBAR(2))
296 IF(nShear.EQ.3) THEN
297 DDSDDE(1, 6)= alpha*EG*(BBAR(1)*BBAR(6)) + EG/TWO*BBAR(6)
298 DDSDDE(2, 6)= alpha*EG*(BBAR(2)*BBAR(6))
299 DDSDDE(3, 6)= alpha*EG*(BBAR(3)*BBAR(6)) + EG/TWO*BBAR(6)
300 DDSDDE(1, 5)= alpha*EG*(BBAR(1)*BBAR(5))
301 DDSDDE(2, 5)= alpha*EG*(BBAR(2)*BBAR(5)) + EG/TWO*BBAR(5)
302 DDSDDE(3, 5)= alpha*EG*(BBAR(3)*BBAR(5)) + EG/TWO*BBAR(5)
303 DDSDDE(5, 5)= alpha*EG*(BBAR(5)**2) + EG/TWO*(BBAR(2)+BBAR(3))
304 DDSDDE(6, 6)= alpha*EG*(BBAR(6)**2) + EG/TWO*(BBAR(1)+BBAR(3))
305 DDSDDE(4,6)= alpha*EG*(BBAR(4)*BBAR(6)) + EG/FOUR*BBAR(5)
306 DDSDDE(4,5)= alpha*EG*(BBAR(4)*BBAR(5)) + EG/FOUR*BBAR(6)
307 DDSDDE(5,6)= alpha*EG*(BBAR(5)*BBAR(6)) + EG/FOUR*BBAR(4)
308 END IF
309 c Symmetry of Elasticity Matrix
310 DO K1=1, ncomp
311 DO K2=1, K1-1
312 DDSDDE(K1, K2)=DDSDDE(K2, K1)
313 END DO
314 END DO
315
316 dsdePl = DDSDDE
317
318 C--------------------------------------------------------------
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319 C Update Growth Tensor, dG = a ft*T*fˆ-t*G
320 C Write Cauchy Stress in matrix form
321 T(1,1) = stress(1); T(2,2)=stress(2); T(3,3)=stress(3);
322 T(1,2) = stress(4); T(1,3)=ZERO; T(2,3)=ZERO;
323 T(2,1) = T(1,2); T(3,1) = T(1,3); T(3,2)=T(2,3);
324 IF(nShear.EQ.3) THEN
325 T(1,3)=stress(6); T(2,3)=stress(5);
326 T(2,1) = T(1,2); T(3,1) = T(1,3); T(3,2)=T(2,3);
327 endif
328
329 C Isotropic Homeostatic Reference Stress
330 T(1,1) = T(1,1) - prop(8)
331 T(2,2) = T(2,2) - prop(8)
332 T(3,3) = T(3,3) - prop(8)
333
334 c Calculate fˆt*T
335 call matxb(defGrad,T,T,3,3,3,3,3,3)
336 c Calculate fˆ-1
337 AA(1:3,1:3) = defGrad
338 call symeqn(AA,3,3,-3,1)
339 IdefGrad = AA(1:3,4:6)
340
341 c Calculate fˆ-t
342 call matxb(IdefGrad,Iden,IdefGrad,3,3,3,3,3,3)
343 c Calculate fˆt*T*fˆ-t
344 call maxb(T,IdefGrad,IdefGrad,3,3,3,3,3,3)
345
346 c Calculate fˆt*T*fˆ-t*G
347 call maxb(IdefGrad,G,dG,3,3,3,3,3,3)
348
349 C Gradient in Growth Rate Parameter, a
350 if (coords(1) .ge. prop(6)) then
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351 a = 0.d0
352 else
353 a = prop(5)*(prop(6)-coords(1))/(prop(10))
354 endif
355
356 if (Time .ge. prop(7)) then
357 G(1,1) = G(1,1) + a*dTime*dG(1,1);
358 G(2,2) = G(2,2) + a*dTime*dG(2,2);
359 G(3,3) = G(3,3) + a*dTime*dG(3,3);
360 G(1,2) = G(1,2) + a*dTime*dG(1,2);
361 G(2,1) = G(2,1) + a*dTime*dG(2,1);
362 if (nShear.EQ.3) THEN
363 G(1,3) = G(1,3) + a*dTime*dG(1,3);
364 G(3,1) = G(3,1) + a*dTime*dG(3,1);
365 G(3,2) = G(3,2) + a*dTime*dG(3,2);
366 G(2,3) = G(2,3) + a*dTime*dG(2,3);
367 else
368 G(1,3) = ZERO; G(2,3) = ZERO; G(3,1) = ZERO; G(3,2) = ZERO;
369 endif
370 endif
371
372 c Store State Variable Quanities
373 ustatev(1) = G(1,1)
374 ustatev(2) = G(2,2)
375 ustatev(3) = G(3,3)
376 ustatev(4) = G(1,2)
377 ustatev(5) = G(1,3)
378 ustatev(6) = G(2,1)
379 ustatev(7) = G(2,3)
380 ustatev(8) = G(3,1)
381 ustatev(9) = G(3,2)
382 ustatev(10) = DET_F
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383 ustatev(11) = DET
384 ustatev(12) = DET_G
385 ustatev(13) = DET_G*(IdefGrad(1,1) + IdefGrad(2,2)
386 & + IdefGrad(3,3))
387 ustatev(14) = IdefGrad(1,1) + IdefGrad(2,2)
388 & + IdefGrad(3,3)
389 ustatev(15) = a*ustatev(14)
390 ustatev(16) = a*ustatev(13)
391 ustatev(17) = a
392 return
393 end
C.3 ANSYS Input Files
ANSYS has its own scripting language for building and solving the FE models.
Each file is stand only and can be run in ANSYS using the ”Read input File” op-
tion under the File directory, or can be run as a batch file. Loop and if statements
are coded using Fortran syntax.
C.3.1 Material Behaviour Validation ANSYS Input File
1
2 finish
3 /clear
4 !Validation File for ANSYS custom material las
5 !Uni-axial load of a single cube, to increase mesh
6 !density parameter "eSize" under the mesh section
7
8 !usermat3d_exp_growth1.f
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9 ! C10 = prop(2)
10 ! alpha = prop(3)
11 ! D1 = prop(4)
12 ! a = prop(5)
13 ! Ro* = prop(6)
14 ! to = prop(7)
15
16 /TITLE,GrowthExp_Uni
17 /FILNAME,GrowthExp_Uni,0
18
19 !Geometry Parameter Set
20 *SET,a,1 !Cube Side Dimension
21 *SET,p,5 !Applied Traction
22 *SET,Force,100 !Shear Displacement
23
24 !GUI Preferences
25 /NOPR
26 /NERR,0,500,,0,0
27 /PMETH,OFF,0
28
29 KEYW,PR_SET,1
30 KEYW,PR_STRUC,1
31 KEYW,PR_THERM,0
32 KEYW,PR_FLUID,0
33 KEYW,PR_ELMAG,0
34 KEYW,MAGNOD,0
35 KEYW,MAGEDG,0
36 KEYW,MAGHFE,0
37 KEYW,MAGELC,0
38 KEYW,PR_MULTI,0
39 KEYW,PR_CFD,0
40 /GO
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41
42 /PREP7
43 !Element Type
44 ET,1,solid185,,,1
45 KEYOPT,1,2,0 !Full Integration
46 KEYOPT,1,6,0 !Pure Displacement Formulations
47
48 !Material Properties
49 !TB,HYPER,1,,,NEO !Neo-Hookean data table
50 !TBDATA,1,4 !Define mu shear modulus
51 !TBDATA,2,0.000002 !Define incompressibility parameter
52
53 TB,USER,1,1,8, !Exponential - Inelastic User Material
54 TBTEMP,1
55 TBDATA,1,2,20,1.5,0.002,0,0 !grow file #, C, alpha,d1,a=0,bb
56 TBDATA,,0,0
57 TB,STATE,1,,20 !Number of UserState Variables
58 TBDATA,1,1,1,1,0,0,0 !Init. SVars G11,G22,G33,G12,G13,G21
59 TBDATA,,0,0,0,0,0,0 !7-12 G23,G31,G32
60 TBDATA,,0,0,0,0,0,0 !13-18
61 TBDATA,,0,0,0,0,0,0 !19-24
62
63 !Create Geometry
64 Block,0,a,0,a,0,a !Cube Test Element
65
66 !Mesh Regions
67 esize,0.1 !Distance btw nodes
68 type,1 !Element type 1 (Solid185)
69 mat,1 !Material type 1 (Neo or User)
70 vmesh,1 !Mesh Cube
71 ALLSEL,ALL
72
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73 FINISH !End PREP7 preprocessing
74
75 !-------------------------------------------------------
76 /SOLU ! Enter SOLUTION
77 ANTYPE,0 !Static Analysis
78 NLGEOM,1 !Nonlinear Geometry Effects
79 ! Load Step 1: Perturbation
80 NSEL,S,LOC,X,-0.05,0.05
81 NSEL,R,LOC,Y,-0.05,0.05
82 D,ALL,UX,0
83 ALLSEL,ALL
84 NSEL,S,LOC,Z,-0.05,0.05
85 NSEL,R,LOC,X,-0.05,0.05
86 D,ALL,UZ,0
87 ALLSEL,ALL
88 NSEL,S,LOC,Y,-0.05,0.05
89 NSEL,R,LOC,Z,-0.05,0.05
90 D,ALL,UY,0
91 ALLSEL,ALL
92 SFA,6,,PRES,-Force
93 ALLSEL,ALL
94
95 SOLCONTROL,ON
96 AUTOST,ON !ANSYS Automatic Time Stepping
97 TIME,1 !Solution Total Time Step
98 OUTRES,ALL,ALL !Output all
99 OUTRES,SVAR,ALL !Store state variables
100 NLDIAG,NRRE,ON !Nonlinear Diagnostics - NR Residuals
101
102 solve
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C.3.2 Valve Simulation ANSYS Input File
The following ANSYS input file is representative of the input files used for the
embryonic AV valve simulation. ANSYS uses time to parameterize the load
increment in nonlinear analyses. Since I am modeling an inelastic evolution,
time actually has physical significance. I was not able to disable growth during
the elastic loading step because ANSYS doesn’t allow on-the-fly changes to the
material properties. I therefore applied the load over a time, te, much smaller
than the inelastic load step, tg. Below is a pseudo-code to help with reading
the file.
Figure C.3: Psuedo-code of Valve Growth Simulation. te = 0:1, tg = 5
1 /batch
2 !finish
3 /clear
4 !ANSYS script for axi-symmetric model of initial
5 !semi-circle cushion under shear and normal
6 !tractions undergoing stress prescribed inelastic
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7 !deformation. USERMAT files required.
8 !Cushion growth only, no myo growth
9
10 !Pseudo Code
11 ! *DO
12 ! Fluid
13 ! Solid - Load
14 ! Solid - evolve
15 ! Solid - unload
16 ! upgeom - define new reference config
17 ! damorph - match solid/fluid interface
18 ! *ENDDO
19
20
21 !usermat3d_exp_growth3
22 !Isotropic Reference Stress [prop(7)]
23 !Growth Gradient in r dir [prop(5)]
24 !Velocity specified fluid
25 !Fluid Parameters in CGS Units [g,cm,s]
26 !Reference stress - T0 = 0
27
28 ! C10 = prop(2)/TWO
29 ! D1 = prop(3)
30 ! a = prop(4)
31 ! R* = prop(5)
32 ! to = prop(6)
33 ! T* = prop(7)
34
35 /FILNAME,HH27_Avg_T02,1
36
37 !Geometry Parameter Set
38 *SET,LFACT,1.E-01
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39 *SET,base,1*LFACT !Base length
40 *SET,r_c,0.25*LFACT !Cushion Radius
41 *SET,R,0.5*LFACT !Canal Radius
42 *SET,t_w,0.15*LFACT !Myocardial Thickness
43 *SET,Flow_ex,4*R !Flow Exit Length
44 *SET,Flow_en,4*R !Flow Entrance Length
45 *SET,mu,200
46 *SET,d1,0
47 *SET,alpha,18
48
49 !GUI Preferences
50 /NERR,0,500,,0,0
51 /UNITS,CGS
52 /PMETH,OFF,0
53 KEYW,PR_SET,1
54 KEYW,PR_STRUC,1
55 KEYW,PR_THERM,0
56 KEYW,PR_FLUID,0
57 KEYW,PR_ELMAG,0
58 KEYW,MAGNOD,0
59 KEYW,MAGEDG,0
60 KEYW,MAGHFE,0
61 KEYW,MAGELC,0
62 KEYW,PR_MULTI,0
63 KEYW,PR_CFD,0
64 /GO
65
66 /PREP7
67 !------------------------------Element Type------------
68 ET,1,141 ! Fluid - static mesh
69 KEYOPT,1,3,1 !Axisymmetric about y-axis
70 ET,2,182 !Hyperelastic element
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71 KEYOPT,2,3,1 !Axisymmetric about y-axis
72 ET,3,SURF153,,,1
73 KEYOPT,3,2,0 !Element Coord. Sys.
74 KEYOPT,3,3,1 !Axisymmetric
75 KEYOPT,3,4,1 !No midside node - to match Fluid domain
76 !------------------------------Create Geometry---------
77 *AFUN,DEG !Use DEG for Angular functions
78 K,1,0,0,0, !Origin
79 K,2,R-r_c,0,0,0,
80 K,3,R,-base/2,0,
81 K,4,R+t_w,-base/2,0,
82 K,5,R,base/2,0,
83 K,6,R+t_w,base/2,0
84 K,7,R,-r_c,0,
85 K,8,R,r_c,0,
86 K,9,0,0,1, !(0,0,1) for normal vector
87 K,10,R-r_c*sin(alpha),-cos(alpha)*r_c,0
88 K,11,R-sin(alpha)*r_c,cos(alpha)*r_c,0
89 K,12,R,1.4*r_c,0
90 K,13,R,-1.4*r_c,0
91 K,14,0,-2*r_c,0
92 K,15,0,2*r_c,0
93 K,16,0,-base/2,0
94 K,17,0,base/2,0
95 K,18,R,Flow_ex,0
96 K,19,R,-Flow_en,0
97 K,20,R+t_w,Flow_ex,0
98 K,21,R+t_w,-Flow_en,0
99 K,22,0,Flow_ex,0
100 K,23,0,-Flow_en,0
101 K,24,R+t_w,base/2,0
102 K,25,R+t_w,-base/2,0
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104 !--------Cushion & Myocardium Region--------------
105 L,3,13 !Line #1 - bot edge1
106 L,3,19 !Line #2 - bot edge2
107 L,19,21 !Line #3 - bot cap
108 L,21,25 !Line #4 - bot back
109 L,25,24 !Line #5 - cent back
110 L,24,20 !Line #6 - top back
111 L,20,18 !Line #7 - top cap
112 L,18,5 !Line #8 - top edge2
113 LARC,13,10,14,r_c/1.9 !Line #9 - bot fillet
114
115
116 !Cushion Initial Arcs
117 LARC,10,2,8,r_c, !Line #10 - bot arc
118 LARC,2,11,7,r_c, !Line #11 - top arc
119 LARC,11,12,15,r_c/1.9 !Line #12 - top fillet
120 L,12,5 !Line #13 - top edge1
121
122 L,24,5 !Line #14
123 L,3,25 !Line #15
124
125 lsel,s,LINE,,9,15,1
126 lsel,a,LINE,,1,,
127 lsel,a,LINE,,5,,
128 AL,ALL !Area #1 AV Cushion & Myocardium
129 ALLSEL,ALL
130 !----Morphing Region Geometry--------------------------
131 L,1,16 !Line #16 - Sym Axis neg
132 L,16,3 !Line #17 - Inflow
133 L,1,17 !Line #18 - Sym Axis pos
134 L,17,5 !Line #19 - Outflow
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135
136 AL,16,17,1,12,10,11,13,9,19,18 !Area#2 Morphing Fluid Region
137 ALLSEL,ALL
138 !-------Fluid Domain----------------------------------
139 L,17,22 !Line #20 - Sym Axis pos 2
140 L,16,23 !Line #21 - Sym Axis neg 2
141 L,22,18 !Line #22 - Flow Exit
142 L,23,19 !Line #23 - Flow Entrance
143
144 AL,20,22,8,19 !Area #3 Exit Fluid Area
145 ALLSEL,ALL
146 AL,21,23,2,17 !Area #4 Entrance Fluid Area
147 ALLSEL,ALL
148
149 AL,6,7,8,14 !Area #5
150 AL,2,3,4,15 !Area #6
151 ALLSEL,ALL
152 AGLUE,ALL
153
154 !-----------Meshing Criteria----------------
155 !Parameters
156 nEntx = 20
157 nEnty = 30
158 sEnty = 2
159 nExty = 30
160 sExty = 2
161 nMorph = 20
162 nMyo = 10
163 ncush = 50
164 nBase = 2*(nEnty+nExty+nMorph)
165 nCaps = 4
166 nfillet = 25
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167
168 lesize,23,,,nEntx,,, !Entrance Mesh x
169 lesize,2,,,nEnty,sEnty
170 lesize,4,,,nEnty,1/sEnty
171 lesize,21,,,nEnty,sEnty
172
173 lesize,22,,,nEntx,,,
174 lesize,8,,,nExty,1/sExty
175 lesize,6,,,nExty,sExty
176 lesize,20,,,nExty,sExty
177
178 lsel,s,LINE,,10,11,1,
179 lesize,ALL,,,ncush,
180 ALLSEL,ALL
181 lsel,s,LINE,,12
182 lsel,a,LINE,,9
183 lesize,ALL,,,nfillet,
184 ALLSEL,ALL
185 lesize,1,,,nMyo,0.4
186 lesize,13,,,nMyo,1/0.4
187 ALLSEL,ALL
188
189 lsel,s,LINE,,16,19,
190 lesize,ALL,,,nMorph,1
191 ALLSEL,ALL
192
193 lesize,5,,,2*nMorph,-0.75
194
195 lesize,3,,,nCaps,
196 lesize,7,,,nCaps,
197 lesize,14,,,nCaps,
198 lesize,15,,,nCaps,
250
199 ALLSEL,ALL
200
201 lsel,s,LINE,,16,19,1
202 cm,morph_Ln_ex,line !Lines to exclude during morphing
203 ALLSEL,ALL
204
205 !-----------!Assign Area Characteristics----------------
206 lsel,s,,,9,13,1 !Select BC Lines - MAT2,REAL3,TYPE3
207 lsel,a,,,1,1,1
208 latt,2,3,3
209 lmesh,all
210
211 allsel,all
212 lsel,s,,,9,12,1 !Select BC Lines
213 nsll,,1 !Select BC nodes
214 CM,BC_NODES,NODE !BC_NODES - component
215 allsel,all
216
217 asel,s,AREA,,2,4,1
218 aatt,1,1,1 !AREA #2-4 Fluid (MAT,REAL,TYPE) 2
219 amesh,all
220 ALLSEL,ALL
221
222 asel,s,AREA,,1,1,1 !AREA #1 Solid (MAT,REAL,TYPE) 1
223 !asel,a,AREA,,5,6,1
224 aatt,2,2,2
225 amesh,all
226 allsel,all
227
228 ! Create Fluid Physics Environment
229 ET,3,0 !Surf153 Null
230 ET,2,0 !Cushion is Null Element
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231 ET,1,FLUID141,,,1 !Fluid Element
232 KEYOPT,1,3,1 !Axisymmetric about y-axis
233
234 dens = 1.060 !g/cmˆ3 Density
235 visc = 0.030 !g/cm s Viscosity
236
237 ! CFD Solution Control
238 flda,solu,flow,T !Flow (Laminar) - ON
239 flda,solu,turb,T !Turbulent Flow - ON
240 flda,iter,exec,400 !Steady-state solution # global iterations
241 flda,outp,sumf,50 !Summary output interval
242 flda,outp,tauw,T !Output Wall Shear Stress
243
244 ! CFD Property Information
245 flda,prot,dens,constant
246 flda,prot,visc,constant
247 flda,nomi,dens,dens ! (g/cm3) for density - water
248 flda,nomi,visc,visc ! (g/cm-s) (viscosity of water)
249 flda,conv,pres,1.E-8 ! Tighten pressure equation convergence
250 flda,conv,vy,1.E-4
251 flda,conv,vx,1.E-4
252 flda,MIR,MOME,0 !Momentum Relaxation Factor
253 !flda,pres,refe,1 !Change Reference Pressure
254
255 ! CFD Boundary Conditions
256 lsel,s,LINE,,16,18,2
257 lsel,a,LINE,,20,21,1
258 dl,all,,vx,0,1
259 allsel,all
260
261 lsel,s,LINE,,1,2,1
262 lsel,a,LINE,,8,13,1
252
263 dl,all,,vx,0.,1 !Cush/Myo Surface Vx=0 (include ends)
264 dl,all,,vy,0.,1 !Cush/Myo Surface Vy=0 (include ends)
265 allsel,all
266
267 dl,23,,vx,0.,0 !Inlet Flow Vx=0
268 dl,23,,PRES,62,1 !Inlet Pressure
269 dl,22,,pres,0,0 !Outlet Press Po=0
270 allsel,all
271 !--------Cushion Component---------------------------
272 /title,Fluid Analysis
273 physics,write,fluid,fluid
274 physics,clear
275
276 !----------Create Solid Physics Environment-----------
277 ET,1,0 !Fluid is Null Region
278 ET,2,PLANE182 !Hyperelastic element
279 KEYOPT,2,3,1 !Axisymmetric about y-axis
280 ET,3,SURF153,,,1 !Shear Traction Element
281 KEYOPT,3,2,0 !Element Coord. Sys.
282 KEYOPT,3,3,1 !Axisymmetric
283 KEYOPT,3,4,1 !No midside node - to match Fluid domain
284
285
286 TB,USER,2,1,11, !Mat#2 - USERMAT/Growth
287 TBTEMP,1
288 TBDATA,1,4,1000,0.3,0.00002,1/1000,R !Exp-1, C, alpha, d1, a, R*
289 TBDATA,,0.1,-62/2,0,R,0 !t0, T*, 0, R, 0
290 TB,STATE,2,,20 !Number of UserState Variables
291 TBDATA,1,1,1,1,0,0,0 !Initilized SVars G11,G22,G33,G12,G13,G21
292 TBDATA,,0,0,0,0,0,0 !7-12 G23,G31,G32
293 TBDATA,,0,0,0,0,0,0 !13-18 DET_F, DET, DET_G
294 TBDATA,,0,0,0,0,0,0 !19-24
253
295 AllSEL,ALL
296
297 ! Boundary Conditions
298 lsel,s,line,,5,5,1
299 lsel,a,line,,14,15,1 !New Selections for lower number of elements
300 dl,all,,ux,0 !Fixed Base Ux=0
301 dl,all,,uy,0 !Fixed Base Uy=0
302 allsel,all
303
304 /title, Cushion Evolution
305 finish
306 /solu
307 antype,static
308 nlgeom,on
309 AUTOTS,ON
310 DELTIM,0.01,0.0001,0.01,OFF !Fixed Time Step
311 rescontrol,,none
312 !cnvtol,f,,,,-1
313 physics,write,struc,struc
314 physics,clear
315 save
316 finish
317
318 !-----------Fluid Solid Interaction Loop--------------------
319 nloops = 17 !# of Fluid update loops
320 GStep = 5 !Growth Increments
321 TM = 0 !Initial Time
322 cmsel,s,BC_NODES,, !Select BC Nodes
323 *GET,F_len,NODE,,COUNT !F_len = #BC nodes
324 *dim,NODE_F,array,F_len,3 !Array of BC Node #s
325 *dim,Shear,array,F_len,5 !Array of BC Node #s
326 *dim,TauW_Store,array,F_len,nloops
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327 *dim,Press_Store,array,F_len,nloops
328
329 nn=0
330 *DO,jj,1,F_len
331 *GET,NODE_F(jj,1),NODE,nn,NXTH !Store BC Node #s
332 nn = NODE_F(jj,1)
333 *ENDDO
334 !------------------------------------------------------
335 !----------------------------------------------------
336 *DO,i,1,nloops !Fluid/Solid Evolution Loop
337
338 /solu
339 physics,read,fluid !Read in Fluid Problem
340 flocheck,1 !Initialize Fluid Problem
341 *IF,i,ne,1,then
342 flda,iter,exec,600
343 *ENDIF
344 solve !Solve Fluid Problem
345 finish
346 *IF,i,gt,1,THEN
347 /COPY,HH27_Avg_T02,rfl,,HH27_Avg_T02_%i%,rfl,,
348 *ENDIF
349 !-----------------------------------------------------------
350 /post1 !Store PRES and SHEAR Tractions
351 set,last
352 *DO,jj,1,F_len
353 *GET,NODE_F(jj,2),NODE,NODE_F(jj,1),TAUW
354 *GET,Press_Store(jj,i),NODE,NODE_F(jj,1),PRES
355 *GET,TauW_Store(jj,i),NODE,NODE_F(jj,1),TAUW
356 *GET,NODE_F(jj,3),NODE,NODE_F(jj,1),LOC,Y
357 *ENDDO
358 finish
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359 !----------------------------------------------------------
360 physics,read,struc !Resume Solid Problem
361 /assign,esave,struc,esav!Files Restarting nonlinear structure
362 /assign,emat,struc,emat
363 *IF,i,gt,1,then !Structural Restart Loop
364 parsave,all !Save Parameters
365 resume !Resume DB - to return original node positions
366 parresume !Resume Parameters
367 /prep7
368 antype,stat,rest
369 finish
370 *ENDIF
371 !---------------------------Define Cushion BC Array-----------
372 *DO,jj,1,F_len
373 nsel,s,NODE,,NODE_F(jj,1)
374 esln,s,0,ALL
375 esel,r,TYPE,,3
376 *GET,Shear(jj,1),ELEM,0,NUM,MAX !Surf153 Element #
377 Shear(jj,2) = TauW_Store(jj,i) !Wall Shear Stress
378 Shear(jj,3) = Press_Store(jj,i) !Pressure
379 ALLSEL,ALL
380 *ENDDO
381 !-------------------------------------------------------------
382 /solu
383
384 AllSEL,ALL
385 !---------------------------Solid - Load BCs-------------------
386 tt = 0 !Initial Ramp increment
387 nRamp = 1 !# of Load Ramp Steps
388 *DO,kk,1,nRamp
389 tt = 0.1*(kk)/nRamp !Ramp Increment
390 jj = 0
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391 *DO,jj,1,F_len
392 SFE,Shear(jj,1),1,PRESS,1,(kk)/(nRamp)...
393 *(Shear(jj,3)-Shear(jj,5)) + Shear(jj,5)
394 SFE,Shear(jj,1),2,PRESS,1,(kk)/(nRamp)*...
395 (Shear(jj,2)-Shear(jj,4)) + Shear(jj,4)
396 *ENDDO
397 solcontrol,ON !Solution Control ON
398 rescontrol,,none !Deny Multi-frame Restart
399 NEQIT,50, !Max # NR Iterations
400 DELTIM,tt,0.00001,tt,OFF !Fixed Time Step
401 !cnvtol,f,,,,-1 !Force Convergence Tolerance
402 TIME,TM+tt !apriori Time Interval
403 OUTRES,ALL,last !Output ALL substep solutions
404 OUTRES,SVAR,last !Output ALL SVAR
405 NLDIAG,NRRE,ON !Nonlinear Diagnostics
406 solve
407 save
408 antype,stat,rest !Restart Analysis
409 *ENDDO
410 TM = TM + tt !Update Total Time Variable
411
412 !---------------------------Growth Deformation-------------------
413 solcontrol,off !Solution Control Off
414 NEQIT,50, !Max # NR Iterations
415 rescontrol,,none !Deny Multi-frame Restart
416 AUTOTS,ON !Automatic Time Increment
417 DELTIM,0.01,0.00001,0.01,OFF!Fixed Time Step Max 0.1, Min 0.0001
418 cnvtol,f,,,,-1 !Force Convergence Tolerance
419 TIME,TM + GStep !Growth for Time = GStep
420 OUTRES,ALL,100 !Output every 10 substep solutions
421 OUTRES,SVAR,100 !Output every 10 substep solutions
422 NLDIAG,NRRE,ON !Nonlinear Diagnostics
257
423 solve
424 save
425 TM = TM+GStep !Update Total Time Variable
426 finish
427 !------------------Store Current Load as Previous Load-----
428 *DO,jj,1,F_len
429 Shear(jj,4) = TauW_Store(jj,i) !Wall Shear Stress
430 Shear(jj,5) = Press_Store(jj,i) !Pressure
431 *ENDDO
432 !---------------------------Unload Solid ----------------------
433 /solu
434 AllSEL,ALL
435 antype,stat,rest !Restart Analysis
436 tt = 0 !Initial Ramp increment
437 nRamp = 1 !# of Load Ramp Steps
438 *DO,kk,1,nRamp
439 tt = 0.1*(kk) !Ramp Increment
440 jj = 0
441 *DO,jj,1,F_len
442 SFE,Shear(jj,1),1,PRESS,1,0
443 SFE,Shear(jj,1),2,PRESS,1,0
444 *ENDDO
445 solcontrol,ON !Solution Control ON
446 rescontrol,,none !Deny Multi-frame Restart
447 NEQIT,50, !Max # NR Iterations
448 DELTIM,0.01,0.00001,0.01,OFF!Fixed Time Step
449 TIME,TM + tt !apriori Time Interval
450 OUTRES,ALL,LAST !Output ALL substep solutions
451 OUTRES,SVAR,LAST !Output ALL SVAR
452 solve
453 save
454 antype,stat,rest !Restart Analysis
258
455 *ENDDO
456 TM = TM + tt !Update Total Time Variable
457 finish
458 !---------------------------Morph/Remesh Fluid Domain-----------
459 /prep7
460 *if,i,ne,nloops,then
461 !0 - remesh if morph fails, 1 - remesh only, 2 - morph only
462 mkey = 1
463 damorph,2,morph_Ln_ex,mkey
464 !Morph A2 exclude "morph_Ln_ex" component lines
465 *endif
466 finish
467 !RETURN & SOLVE FLUID PROBLEM
468 *ENDDO
469
470 save
471 finish
259
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